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B-lymphocyte hybridomas are routinely used for the production of monoclonal 
antibodies and it is now relatively easy to synthesize large quantities of antibody 
with specificity for a variety of antigens. Despite the widespread use of 
monoclonal antibodies, the physiology of hybridomas and their mechanisms of 
growth are still poorly understood. In this thesis a number of features of hybridoma 
cells have been investigated experimentally to obtain a better understanding of 
their growth and antibody secretion in vitro, with a view to improving the 
efficiency of antibody production. 
Initially the effect of immune derived mediators on the growth and secretion of 
hybridomas was explored as some of these mediators have been shown to play an 
important role in the growth and antibody secretion of B-cells in vivo. In particular 
interleukin-2 and interleukin-6 were studied and were shown, in some cases, to 
improve the rate of cell growth, but they had little or no effect on the level of 
antibody secretion. 
Using flow cytometry, the expression of antibody on the surface of a hybridoma 
cell was investigated.The presence of antibody on the cell surface was correlated 
with overall antibody secretion and to the stage of the cell cycle. It was shown that 
antibody that is in the process of being secreted from the cell can be detected and 
that it is related not only to the overall secretion of antibody but also to the stage of 
the cell cycle. Attempts to synchronize hybridoma cells in one phase of the cell 
cycle by well documented chemical means were unsuccessful, and a technique was 
developed to isolate a synchronous population using flow cytometly. A 
synchronous cell population was cultured and samples were analysed for cell 
surface antibody, stage of the cell cycle and antibody secretion at various points in 
the cell cycle. It was shown that the presence of antibody on the antibody cell 
surface is indicative of antibody secretion, and that antibody is found on the cell 
surface predominately during the S-phase of cell growth. 
The metabolism of two strains of a hybridoma cell line, an antibody producing and 
a related non-producing strain was studied to determine the utilisation of nutrients 
and the proportion of energy that is devoted to antibody secretion. Cells were 
grown in continuous culture at a variety of specific growth rates. The limiting 
nutrient was identified as glutamine and its metabolic quotient was calculated at a 
variety of growth rates. It was shown that the energy required for maintenance was 
lower for the non-producer than the producer, a difference that may be due to the 
energy penalty of antibody secretion. It was also shown that antibody secretion of 
the producing hybridoma was growth rate dependent. 
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1.1 The Humoral Immune Response and Antibody 
Production 
Most multicellular organisms, even the most simple, have evolved a set of 
mechanisms and cells to identify, attack and ultimately destroy any foreign 
organism or molecule. Antigens include bacteria, viruses, protozoa, parasites and 
foreign proteins or other molecules like snake venom that gain entry to the internal 
environment of that organism. Defence mechanisms range from simple innate 
exclusion methods like impermeable outer barriers or mucus produced at the 
portals of entry such as the lungs and the gut, to an incredibly complex variety of 
cellular and molecular interactions. The immune systems of mammals, insects and 
reptiles have evolved to a highly efficient state which is controlled by an extremely 
complex array of immune messengers, cells and cellular interactions. The acquired 
immune system of mammals can be divided into two parts, neither of which is 
completely distinct from the other. One consists of dedicated immune cells, called 
T-lymphocytes which control the initiation and amplification of an immune 
response, kill virus infected or tumour cells and lyse bacterial cells. The other 
consists of B-cells which produce antibody. Each B-lymphocyte is able to 
synthesise only one specificity of antibody. Undifferentiated, immature B-
lymphocytes are able to undergo gene rearrangements during maturation to 
determine which specificity is produced (see section 1.6.1). This is a random 
process resulting in B-lymphocytes able to secrete antibodies of predefined 
specificity (see section 1.6.2). 
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1.2 Antibody Structure and Function 
Each antibody molecule is made up of heavy and light chains and is composed of a 
number of different regions. The antibody is symmetrical and is composed of two 
heavy chains joined by disulphide links. To each heavy chain is attached a light 
chain. There are a number of different heavy chains and these determine the class 
of antibody. They are p., 6, ,y, e and a found in 1gM, IgD, IgG, Ig E and IgA 
respectively. The light chains are either k or X . Each chain is split into a set of 
homology units, each approximately 100 amino acids long which give a series of 
compact globular regions of the antibody. At the N-terminal region of the antibody 
the primary amino acid sequence is highly variable and is termed the variable (V) 
region. The amino acid sequence in the remainder of the molecule does not vary 
much and is termed the constant region. The association of the V-regions of the 
heavy and light chains forms the highly specific antigen binding site. Other regions 
of the antibody have different functions ranging from binding complement to 
association with cellular membranes and binding to receptors (see Figure 1.1). 
Each class of antibody is involved in a different aspect of the immune response 
[78] (see Figure 1.2). 
There are five classes of antibody in mammals, IgA, IgD, IgE, IgG and 1gM. Their 
structures are shown in Figure 1 .2.The classes of antibody are involved in different 
aspects of the immune response. 1gM is pentameric in structure and is composed of 
five antibody subunits with a molecular weight of approximately 900,000 D. The 
subunits are held together by disulphide bonds and 1gM also contains a further 
polypeptide of 15000 D termed the J-chain which is thought to aid binding of the 





sites) 1gM, 	although having a low antigen affinity binds readily to antigen. It 
comprises only 5% of the total serum immunoglobulins and is the antibody 
produced predominantly in the primary immune response (see Figure 1.1) 
x"s N -I /+Y. 
C00- COO- 
CH-Constant Region of the Heavy Chain VH Variable Region of the Heavy Chain 
CL-Constant Region of the Light Chain 	VLvanable Rgeion of the Light Chain 
Figure 1.1 Two Chain Structure of Immunoglobulin 
IgG is the most abundant immunoglobulin in serum and is composed of two heavy 
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and two light chains. IgO has the highest antigen affinity compared with the other 
immunoglobulin classes. In most mammals there are a number of IgG subclasses. 
For example in the mouse there are four - Igi, Ig2a, Ig2b, and 1g3. These 
molecules are structurally very similar and have almost identical molecular 
weights, but their functions are different. The function of IgD is unknown, It is 
very rarely secreted from lymphocytes, is not involved in mast cell degranulation 
and is not localised in any area of the body or in any secretions (see Figure 
1.2).The primary function of IgE is in allergic reactions and hypersensitivity. IgE 
binds to mast cells causing degranulation, following antigenic stimulation. Its 
concentration in serum is very low. IgA is found in most secretory body fluids such 
as tears, saliva, colostrum and intestinal secretions. It is also found in low 
concentrations in serum. The secreted form consists of a a2X2 dimer which also 
contains the J chain and a secretory component. The main function of IgA is the 
neutralisation of bacteria and viruses on body surfaces and the removal of antigen 
via the bile duct. 
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Figure 1.2 Structure of The Immunoglobulin Sub-Classes 
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1.3 Preparation of Antibodies 
The unique monospecific properties of antibody are exploited in a number of 
useful techniques such as sensitive assays, diagnostic procedures and most 
recently as a therapy for a number of diseases including cancer. Until recently the 
production of large quantities of pure antibody remained difficult. For many years 
polyclonal antisera were used, which are the serum product of an immunized 
animal such as a sheep or donkey. A polyclonal antiserum contains many different 
antibody specificities to structurally different antigenic determinants, and is the 
response of many clonally different B-cells to an antigen. Polyclonal antisera are 
highly heterogenous and contain antibodies which differ not only in specificity, but 
vary also in the classes and subclasses of antibody, concentration and affinity. 
Each antibody also varies in its specificity to the antigen. To prepare unispecific 
antisera of high affinity requires purified antigen to prevent cross reactivity, but 
even small antigens possess multiple antigen determinants and produce 
heterogeneous polysera. 
The isolation of one specificity of antibody uncontaminated by other cross reacting 
antibodies can be solved by the preparation of monoclonal antibodies. They can 
also be produced in unlimited quantities with low batch variability. 
The production of monoclonal antibodies derived from one B-cell clone reactive to 
one antigenic determinant of the desired antigen and the culture of these cells in 
vitro is difficult as B-lymphocytes cannot be cultured in vitro and die rapidly 
upon removal from the host organism. A number of attempts to produce 
monoclonal antibody using myeloma cell lines, which are derived from B- 
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lymphocyte tumours, and which can be cultured indefinitely were made. The 
myeloma cell lines allowed researchers to produce large quantities of antibody for 
experimental study but did not yield monoclonal antibody directed against a 
specific antigen. A long lived immortal cell line that produced one specificity"Of 
antibody, was first achieved by Kohler and Milstein in 1975 [39]. These workers 
fused a myeloma cell line, MOPC-21, with spleen cells from a mouse immunized 
with sheep red blood cells. In addition they managed to separate the desired fusion 
between the myeloma cell and a specific B-lymphocyte, from the fusion of two or 
more myeloma cells, or the fusion of two or more B-lymphocytes or other multiple 
fusions. Immortal B-cells which grow in culture and produce monoclonal antibody 
are termed hybridoma cells. Even though monoclonal antibodies can be easily 
produced, many aspects of hybridoma cells are still poorly understood and 
antibody production remains time consuming and expensive. 
1. 4 Preparation of Hybridomas 
1.4.1 Preparation of Sensitized Lymphocytes 
The production of monoclonal antibody requires the availability of the antigen, 
either in an impure or pure form. If the antigen is impure more stringent selection 
procedures to determine the specificity of the hybridoma are needed. The antigen is 
injected into a mouse or other suitable animal either as an aggregate or in solution 
often in association with an adjuvant such as Freund' s complete adjuvant (FCA). 
The adjuvant augments the strength of the immune response by acting as a vehicle 
for slow antigen release, thus prolonging the length of time the immune system is 
in contact with the antigen. Some adjuvants act as an irritant to the immune system 
augmenting the strength of the immune response 
page 8 
Introduction 
After the primary immunization, boosters are given once or twice every two to 
eight weeks, culminating in a final boost a few days before fusion. Normally more 
than one animal is immunized allowing selection of the one with the highest 
antibody titre. The mouse is killed and the spleen removed. A single cell 
suspension is obtained by agitating the spleen through a fine sieve. The fatty 
architecture of the spleen is removed by centrifugation and the cells counted. 
1.4.2 Myeloma Cell Lines 
If two antibody secreting cell lines are fused, hybrids of the light and heavy chains 
are formed. In the endoplasmic reticulum where all protein is synthesised, the light 
chain of one myeloma will combine with the heavy chain of the other, i.e. if two 
light chains are synthesised each will combine with the heavy chain making 
desired and undesired antibody. This can result in hybridomas with only 25% of 
the desired specificity. It is therefore preferable to use non producing myeloma cell 
lines to fuse with the B-lymphocytes. The first cell line developed was a variant of 
the MOPC-1 myeloma isolated by Kohler in 1976. This cell line lacks heavy chain 
synthesis. The K chain is synthesised but it is not secreted and is destroyed 
intracellularly. This line was initially termed P3-NS1-Ag4-1 but is now known as 
NS-l. Further developments gave totally non-secreting cell lines such as Sp2/0-
Ag-14, X63-Ag-8.653, and NSO/l. 
1.4.3 Cell Fusion Techniques 
Cells do not fuse spontaneously and several techniques are available to facilitate 
this. Early hybridomas were formed using Sendai virus, but high concentrations 
of polyethylene glycol (approximately 40 -50% MWt 1500-4000) are now used. 
page 9 
Introduction 
Both these methods appear to work by weakening the cell membrane allowing the 
cytoplasm to mix. After the fusion a number of distinct nuclei are visible and the 
cells are called heterokaryons. After the first cell division the nuclei fuse, and the 
resultant hybridoma cells contain approximately equal amounts of parental DNA. 
The usual procedure for the production of hybridoma cells fuses 1 x 10 7 
splenocytes with 1 x 108  myeloma cells. 
1.4.4 Selection 
Unfused myeloma cells will overgrow fused myeloma cells in culture as the 
former do not have the metabolic load of antibody production. Fusions composed 
of only splemc B-lymphocytes do not pose this problem as the unfused cells die 
rapidly in culture. 
A selection procedure was devised by Littlefield in 1964 and is based on the 
biosynthetic pathway for DNA nucleotides. There are two pathways for the 
production of DNA precursors- the classical and the salvage pathways. Myeloma 
cell lines used in fusion have been engineered to be deficient in hpoxanthine-
guanine phoribosyl transferase (HGPRT) an enzyme vital for the salvage pathway. 
Newly formed hybridomas are cultured for three to four days in medium 
containing aminopterin, a folic acid antagonist to block classical DNA synthesis, 
hypoxanthine and thymidine (termed HAT medium), the last two being required 
for salvage synthesis. Cells are grown in this medium for three or four days. Any 
fusions not containing a wild type lymphocyte do not grow and die rapidly due to 
aminopterin inhibition. After the selection stage hybridoma cells are cloned several 
times to select stable cell lines and screened for antibody production. The cloning 
steps involve the use of peritoneal macrophages from mice as feeder cells as the 
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newly formed hybridomas which will not survive single cell culture. The 
macrophages are thought to secrete molecules into the medium that enhance and 
support hybridoma growth. Those cells that secrete high levels of specific antibody 
are cultured and can be stored frozen in liquid nitrogen 
1. 5 Cellular Physiology of Hybridomas and Growth in 
vitro 
1.5.1 Physiology of Hybridomas 
A monoclonal antibody producing hybridoma is the result of the fusion of two 
cells, both of which carry a full genetic complement. After fusion a number of 
distinct nuclei can be seen but as the cell grows and divides these fuse to form a 
single nucleus. Loss of genes (or parts of chromosomes) often occurs and the 
genetic instability of hybridomas can result in the loss of antibody production. As 
outlined in section 1. 7, B-lymphocytes in vivo are constantly under the influence 
of a vast array of cytokines. Hybridoma cells grow slowly in suspension and 
produce low levels of antibody, approximately 10 J.Lg/ml to 100 gg/ml. 
To overcome the difficulties of growth in vitro traditional methods of culture 
require supplementing the medium with foetal calf serum (FCS) at fairly high 
levels, usually at concentrations of between 5 and 20%. The use of foetal calf 
serum is undesirable for a number of reasons, the most important being, the ethics 
and safety of using an animal product, the high cost, the difficulty of removing 
serum proteins from the monoclonal antibody during purification and the extreme 
variability between different batches of serum. FCS may act as a source of lipids, a 
variety of growth factors such as cytokines, hormones such as insulin and trace 
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elements such as iron and selenium. Serum may also contain vital minerals, 
vitamins and cofactors. The effect of low serum concentrations on the growth of 
hybridomas has been documented by a number of authors. Dodge et al [18]did not 
see serum limitation in batch culture at serum levels of between 5 and 10%, but 
serum concentrations below these did limit cell growth. Ozturk et a! [70]showed 
that long term exposure of hybridoma cells to low serum medium reduced specific 
antibody production but increased growth, even after a period of adaption. 
1.5.2 Hybridoma Metabolism 
1.5.2 a Serum and Serum Free Formulations 
Some progress has been made in the development of serum-free formulations 
summarised by Kovar [41, 42, 43, 44, 38, 46].  By growing hybridomas in medium 
supplemented with various compounds, a formula was found that can support the 
growth of many different cells. This serum free formulation contains bovine serum 
albumin (BSA) as a carrier for lipids and a cell protection agent, and lipids which 
are essential for cell membrane fluidity and integrity. Lipids are also likely to be 
required as cell metabolites. Other additions are insulin for the uptake of glucose, 
transferrin as an iron source, trace amounts of selenite for cell metabolism, and 
ethanolamine (see section 2.2.2). The use of BSA in these serum free formulations 
does not remove the variability inherent in a natural product and the insolubility of 
the lipids poses a number of problems in their presentation to the cells. Not all cell 
lines used for the production of monoclonal antibody can grow in these 
formulations and some cell lines grow poorly. Generally cells grown in serum free 
or low serum medium (below 5%) grow to a lower cell density and produce less 
antibody [70, 961. 
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So far a totally artificial formulation which does not contain animal products is 
limited to the culture of a limited number of cell lines. 
1.5.3 Metabolism of Nutrients by Hybridoma Cells 
1.5.3 b Introduction 
Apart from sera and serum supplements, tissue culture media also contain amino 
acids, vitamins and cofactors, glucose and glutamine. The main energy sources 
provided are glucose and glutamine. Hybridomas grown in batch culture will grow 
exponentially to a maximal cell density at which point the medium will be 
deficient in at least one of the nutrients vital for cell growth, and toxic metabolites 
may inhibit the cells. The cells then stop dividing, enter a decline phase and begin 
to die. A higher concentration of one or more of the metabolites required for 
growth can significantly increase cell concentration and increase the concentration 
of antibody secreted (see section 1.5.3 c). Culturing the cells in an environment 
where the supply of medium is continuous with constant provision of nutrients and 
the removal of toxic metabolites can also increase antibody secretion. In 
continuous culture, which is often used for metabolic studies and for commercial 
production of antibody, the rate of cell growth will be determined by the 
availability of the limiting nutrient, which is supplied in the feed. Therefore the 
flow of medium into a continuous culture system will influence the rate of cell 
growth (see section 1.5.3 h). 
Hybridoma cells can utilise a number of pathways for the generation of energy in 
the form of ATP. Although the pathways used are very similar to those of other 
cultured animal and microbial cells, the actual metabolism of hybndomas can often 
page 13 
Introduction 
be quite different from other cells in terms of nutrient utilisation and the main 
pathways of energy utilisation. 
The initial starting concentrations of glucose and glutamine vary widely between 
different media. RPMI 1640 (see section 2. 2) used for all experiments in this 
thesis contains 11.1 mM glucose and 2mM glutamine. 
1.5.3 c Metabolism of Glucose 
The main pathway for the metabolism of glucose is glycolysis where one molecule 
of glucose is degraded to two molecules of pyruvate, although some glucose is 
converted to five carbon sugars for cellular biosynthesis, via the pentose phosphate 
pathway. Glycolysis generates 2 moles of ATP per mole of glucose metabolised. 
Wholly aerobic metabolism by oxidative phosphorylation generates far more 
energy than glycolysis, 38 moles of ATP per mole of glucose. The conversion of 
pyruvate to lactate or to acetyl CoA, for entry into the TCA cycle is dependant on a 
number of factors, such as the amount of oxygen available, the extracellular 
concentration of glucose and other metabolites and the presence of waste 
metabolites. Hybridomas often convert pyruvate to lactate and excrete it from the 
cell (see section 1.5.3 e). It has been shown that some hybridomas convert as much 
as 50% of glucose to lactate and have accelerated glycolytic activity when 
compared with other respiring cell lines [53,86]. The metabolism of glucose and 
the proportion of glucose converted to lactate by hybridomas has been studied by a 
number of authors, and results vary depending which hybridoma line is used. By 
culturing hybridomas at limiting concentrations of glucose, two types of 
metabolism have been shown. The first type is when a limitation of glucose causes 
a change in the metabolism of the cell, with more glucose and glutamine being fed 
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into pathways such as the TCA cycle which yield more ATP per molecule utilised 
[31, 75]. This results in a reduction in the secretion of toxic metabolites such as 
lactate which is discussed later (see section 1.5.3 e). Other authors have studied 
glucose limitation and seen no reduction in the conversion of glucose to lactate.. - at 
low glucose concentrations, cell growth being inhibited [9,60] . Both glucose and 
glutamine limitation have been demonstrated for hybridoma cell lines , but other 
molecules can also act as limiting nutrients . Glucose has been shown to be the 
limiting nutrient by some authors [8,22, 24] but the limiting nutrient depends on 
which hybridomas are studied. Some authors have also described joint nutrient 
limitation with glutamine[61]. 
As discussed above, the proportion of glucose converted to lactate also depends on 
the availability of oxygen or the presence of waste metabolites. It has also been 
shown that, if the extracellular concentration of glucose is high, glucose transport 
switches from active transport to passive diffusion into the cell and glucose can 
become toxic within the cell. To overcome this, the cell will convert the glucose to 
lactate and transport it from the cell [53]. The relationship between glucose 
metabolism and oxygen concentration has been studied by a number of authors. 
Miller et a! [62] examined hybridoma cells in continuous culture and showed a 
decrease in glucose consumption by the cells but an increased production of lactate 
and ammonia at low dissolved oxygen concentrations (d02). Glutamine 
breakdown was greater at low d02. As d02 decreases the metabolism of glucose 
was negatively affected and glutamine was used to compensate for the loss of 
energy generation from glucose. Other metabolites in the medium, such as amino 
acids were also depleted at low 02  concentrations. The overall cellular generation 
of ATP at low d02 was similar to that calculated for high d02, suggesting that 
hybridomas are capable of switching their metabolism from aerobic to anaerobic. 
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Reuveny et al [76] showed that hybridoma cells in batch culture grow more rapidly 
at high levels of d02 and glucose was depleted more quickly than at low 
concentrations of d02, where cell growth was inhibited. 
As well as optimisation of feeding strategies and continuous supply of fresh 
medium, attempts have been made to increase the flow of glucose into the TCA 
cycle by activating the pyruvate dehydrogenase complex of enzymes. [68]. Using 
this method the proportion of glucose converted to lactate is decreased but the 
secretion of antibody is not increased. 
1.5.3 d Metabolism of Glutamine 
The main pathway for the metabolism of glutamine is the TCA cycle. Glutamine is 
first converted to glutamate and ammonia, and glutamate is converted to a-
ketoglutarate, a key intermediate of the TCA cycle and completely oxidised to 
CO2. Complete oxidation of glutamine in this way yields 21 mmol of ATP per 
mmol glutamine. Glutamine can also be converted to aspartate or lactate which 
yields less ATP per mol of glutamine (12 and 6 mmol respectively). Metabolism of 
glutamine yields either 1 or 2 mmol of ammonia per mmol of glutamine depending 
on the pathway used [31]. Hybridoma cells can utilise these pathways 
simultaneously depending on the nutrient status of the cells. It has been shown that 
glutainine can substitute for glucose at limiting concentrations of glucose or dO2 
and that the metabolism of glutamine is oxygen dependant [62]. Apart from the 
pathways described above, Haggsrom [32] has identified eight theoretical 
pathways involving glutarnine in animal cells, but these fall broadly into the three 
pathways described above, with complete oxidation yielding the most ATP and the 
production of amino acids and lactate yielding least. Ammonia produced can range 
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from 1 to 3 mmol per mmol glutamine [31]. 
Glutamine has been shown to be the limiting nutrient for hybridoma cells by a 
number of authors [15, 58,59,79]. Jenkins et al [37] studied the glutamine 
metabolism of two related murine hybridomas, produced in the same fusion which 
secreted widely varying amounts of antibody, and, as well as demonstrating 
glutamine depletion and the onset of cell death even when glucose was still 
plentiful, it was shown that glutamine metabolism was very similar in these two 
hybridomas. The exhaustion of glutamine at fairly high glucose concentrations was 
also seen by Dodge et al [18], suggesting that in the cell lines studied glutamine is 
the primary nutrient source. Dalii et al [15]studied the growth of hybndomas in 
batch culture at concentrations of glutamine ranging from 0.5 to 4mM and showed 
that glutarnine exhaustion in cultures containing up to 2mM glutamine preceded 
the onset of cell death. Cell death occurred in those cultures containing greater than 
2mM glutaniine when glutamine was still plentiful. This suggests that glutamine 
limitation for these cells is the major factor in the onset of cell death, but when 
glutamine is plentiful other nutrients will become limiting. 
1.5.3 e Production of Toxic Metabolites and Hybridoma Inhibition 
As mentioned above (section 1.5.3 cand 1.5.3 d) the main by-products of 
hybridoma cell metabolism are ammonia and lactate. Lactate is often produced at 
high concentrations and causes acidification of the medium retarding hybridoma 
cell growth. Ammonia is toxic to hybridomas and is often present in the cell 
supernatant at fairly high concentrations (2-4mM). Ammonia, present in the 
culture supernatant, is not only produced by hybridoma cells but FCS often 
contains high levels of NH3 (2-4mM), 
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A number of authors have studied ammonia inhibition, and it has been shown that 
the tolerance to ammonia varies widely between differing cell lines. Reuveny et al 
[76] studied NH3 inhibition in batch culture of a hybridoma line and found 
concentrations of 2mM and above to be toxic. The inhibition by ammonia of a 
series of cell lines including hybridomas was studied by Butler et al [11]. A wide 
variability in inhibition was seen at concentrations of between 0.8 and 5.1 MM 
NH3. The toxic effects of NH3 were increased at high pH, and as the ratio of NH3 
to NH4 varies at high pH, it was postulated that NH4' was more toxic than NH3. 
By adding lactate to the supernatant in addition to NH 3, inhibition was reduced 
suggesting that lactate can protect cells from the toxic effects of NH 3 . It appears 
that compounds such as a-keto acids reduced the toxicity of NH3 in culture. It was 
also shown that nutrient utilisation increases at high NH 3 concentrations and this 
may be a response by the cell to produce compounds such as pyruvate and lactate 
which may detoxify the medium. The protective effect of lactate at high NH 3 
concentrations was also seen by Dodge et al [18]. Lactate above concentrations of 
6mM was shown to be toxic as were NH3 concentrations of 3mM on hybridoma 
cells in batch culture. Inhibition by NH3 of hybridoma cells grown in batch culture 
was also seen by Glacken et al [31] although it was shown that cells could become 
adapted to increasing concentrations. The adaption to NH 3 by hybridomas in 
continuous culture was also seen by Miller et al [63], as was the change in nutrient 
utilization. Using murine hybridoma cells in continuous culture, it was also shown 
that the specific glutaniine consumption rate (qgim)  was unaltered at high NH3 
which suggests that glutaniine can be metabolised through several pathways which 
are unaffected by extracellular NH 3 concentrations, d02 consumption rate also 
increased. The increase in metabolism and a higher glucose to lactate conversion 
rate of cells exposed to NH3 was also seen by MacQueen et al [59], studying 
hybridomas cells in batch culture. The decreased yield of NH3 from glutaniine 
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consumed by hybridomas in continuous culture at reduced growth rates was 
demonstrated by Schmid et al [79], again suggesting that a proportion of 
hybndoma lines can optimize metabolism at limiting nutrient concentrations. 
1.5.3 f Amino Acids 
It has been shown, that depletion of amino acids can result in the halting of 
antibody production and the onset of the decline phase in batch culture of 
hybridoma cells. A number of authors have analysed the amino acid depletion 
pattern of particular hybndoma cell lines in batch and continuous culture, and 
produced a profile of amino acids showing those that are limiting, and those that 
either increase or decrease slightly. By increasing the concentration of those that 
are depleted at the onset of ceffi death the length of the exponential phase can be 
increased and antibody secretion enhanced [20, Wilson, J pers.comm]. Amino acid 
depletion patterns appear to be a feature of individual hybridoma cells and cannot 
be applied generally. 
1.5.3 g Mechanisms of Antibody Secretion and Production Kinetics 
Antibody is manufactured in the rough endoplasmic reticulum and after 
transcriptional modifications in the golgi bodies, is packaged in vesicles which 
then move through the cytoplasm to burst through the membrane and release the 
antibody to the outside. The presence of antibody containing vesicles in the 
cytoplasm of the hybridoma and the endoplasmic reticulum have been seen by 
electron microscopy [3] Secretion of antibody is initiated by a leader sequence 
carried on the 3'end of the gene [28, 55]. The relationship between hybridoma 
metabolism and the secretion of antibody (as opposed to the relationship between 
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antibody secretion and the cell cycle, section 1. 9) has been studied by a number of 
authors. Borth et al [8] studied both a murine hybridoma and a human mouse 
heterohybridoma. It was shown that in the case of the hetero-hybridoma most 
antibody is produced by non-proliferating cells which are nutrient limited in batch 
culture and is not growth associated. In the case of the murine hybridoma, antibody 
production was growth associated and was greatest at high dilution rates when the 
cells were rapidly dividing, suggesting antibody production is growth associated. 
Using three different hybridoma cell lines, grown in batch culture Merten et al [58] 
showed three types of antibody production kinetics. The first was secretion early in 
culture during the lag phase and continued into exponential phase. The second was 
a high initial secretion rate which, decreased during the maximum growth phase 
and increased again as the cell died and lysed. The third type of secretion was 
stable secretion during the batch cycle with no production during death. Growth 
associated antibody production has also been shown by Robinson et al in a 
transfected myeloma cell line and in a hybridoma by Frame et al. 
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Figure 13 Metabolic Pathways used by Hybridomas 
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1.5.3 h Continuous Culture 
Growth and antibody secretion rates of hybridoma cells can often be optimised by 
using a continuous system whereby medium is being constantly fed and waste 
removed. This approach is often used for the commercial or laboratory production 
of monoclonal antibody as large quantities of antibody can be produced [54] and is 
also often used to study metabolism and growth kinetics of hybridomas and other 
cell lines [25,34, 60].  A feature of continuous culture is, that like a batch system 
nutrient limitation of growth occurs but unlike a batch system where a decline 
phase occurs, the cells reach a so-called steady state where the rate of cell growth 
is controlled by the rate of medium flow into the system. The rate of medium flow 
defines the dilution rate which is calculated as being the flow rate divided by the 
reactor volume. If the specific cell growth rate (about 0.05 hr -1 for many 
hybridomas) is equal to the dilution rate then the chemostat will reach steady state. 
Growth is controlled by the addition of the limiting nutrient in the feed. In this 
thesis hybridoma cells were grown in continuous culture at a variety of dilution 
rates. In a chemostat, at steady state, the dilution rate will equal the specific growth 
rate (p.)(see section 5. 2, Equation 11). By plotting i versus the metabolic quotient 
of the limiting nutrient at various flow rates, it was possible to determine the 
maintenance coefficient and the growth yield for the limiting nutrient. The method 




1. 6 Generation of an Immune Response 
The formation of primary, immune-reactive B-cells is the first stage of the humoral 
immune response. The development of B-cells can be divided into two discrete 
pathways. The first is when an undifferentiated stem cell develops into a 
morphologically distinct B-lymphocyte. This occurs prior to the encountering of 
antigen, and results in a cell capable of secreting only one specificity of antibody, 
and the expression of this antibody, usually as 1gM, on the cell surface. It is during 
these early stages that gene rearrangements occur that predispose the cell to the 
production of one specificity of antibody (see section 1.6.2). The second is after 
antigen is encountered and the cell is enlarging and dividing and secreting antibody 
(as described in section 1.6.1). 
There are many specialised cells involved in the generation of an immune 
response, which are arranged into lymphoid tissues or organs. These organs are the 
sites of immune cell development and include the thymus, bone marrow, spleen, 
lymph nodes and collections of mucosal associated lymphoid tissues (MALT). 
They can be differentiated into two types, primary and secondary. The primary 
lymphoid organs are the sites where immune cells develop and include the thymus, 
where T-cells develop, and the bone marrow where B-cells develop. The 
secondary lymphoid organs include the lymph nodes and the spleen in which 
lymphocytes interact with antigen and with other immune cells and from which the 
immune response is spread once it has been generated. 
The first stage in an immune response is the recognition, processing and 
presentation of an antigen by specialised cells, known as antigen presenting cells 
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(APCs), such as macrophages, dendritic cells and Langerhans cells. The second 
stage involves the interaction of APCs with specific T-lymphocytes which are then 
activated and stimulate other parts of the immune response, including B-cells. 
1.6.1 Development of Immune Competent B-lymphocytes 
In adult mammals B-lymphocytes develop in the bone marrow from the pluripotent 
stem cell. This cell gives rise to all the cells of the immune response. The first 
developmental stage is antigen independent the first part of which is the 
differentiation of the stem cell to a lymphoid progenitor. This is reversible i.e. the 
cells can return to a stem cell under the right conditions. All further stages are 
irreversible (see Figure 1.4). 
The development of a B-lymphocyte from an undifferentiated pluripotent stem cell 
to a mature immune competent cell can be seen in a number of ways, such as the 
presence of immunoglobulin in the cytoplasm or on the cell surface, the expression 
of cell surface markers, and the gene rearrangements that commit the cell to the 
production of one specificity of antibody for the rest of its life. The first cell 
formed from the lymphoid progenitor is recognisably a B-lymphocyte as it has 
undergone rearrangement of the V-region chains for the p. type heavy chain. This is 
termed the pro-pre B-lymphocyte or the B-cell progenitor. This does not synthesis 
any immunoglobulin chains and no whole immunoglobulin can be detected in the 
cytoplasm. This cell does express major histocompatibiity class II antigens (MHC 
II) on the surface. It rapidly divides and increases in size. Antibody genes are 
rearranged but antibody is not secreted. The next recognisable stage is when 
immunoglobulin is expressed in the cytoplasm. This cell is termed a pre B-
lymphocyte. This cell has also lost CD10, a cell surface marker which is indicative 
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of a very early lymphoid cell. The cell stops dividing, decreases in size and 
undergoes rearrangement of the L-chain V genes. It forms a non secreting 
immature B-lymphocyte that expresses only one specificity of antibody on the cell 
surface. It moves from the bone marrow to the periphery where stimulation by T-
cells results in full antibody production (see section 1.6.4) Unstimulated B-
lymphocytes, formed in the bone marrow are the source of all peripheral B-
lymphocytes. These cells are short lived and are constantly replaced. The 
development of fully differentiated B-cells that move to the periphery is under the 
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1.6.2 Generation of Antibody Diversity 
Each stem cell carries a series of gene segments that, when they undergo 
recombination, can generate one of the millions of antibody genes. These regions 
termed V, D and J combine to form a complete heavy chain gene. In light chains 
D is absent. 
Each region has many different genes for example the V region comprises about 
1000 genes the D 12 and the J 4. During B-cell differentiation in the marrow these 
genes individually combine - one from each region - to give a complete antibody 
gene. The heavy and light chains combine in the endoplasmic reticulum forming 
whole antibody.This series of recombinations gives a potential antibody repertoire 
of greater than 106  antibody specificities which are expressed on the circulating B-
lymphocytes. Memory B-lymphocytes like primary B-lymphocytes require 
stimulation by T-helper cells (TH).  During the second encounter the level of 
antigen required is much lower and this is thought to be because of more specific 
immunoglobulin expressed on the cell surface and at a much higher concentration. 
When an antigen is encountered for the first time 1gM is mainly produced whereas 
the second and subsequent times antigen is encountered IgG makes up the majority 
of antibody [78]. The process whereby only stimulated B-lymphocytes divide and 
produce antibody results in an increase in antibody specificity over time a process 
termed affinity maturation. Thus antibody with a high avidity is formed and a more 




1.6.3 Antigen Presentation and Stimulation of 1-cells 
APCs such as macrophages internalise antigen, which can be either whole cells, 
parts of cells or a protein, by absorbing it on the cell membrane and wrapping the 
membrane around it forming a vesicle. The antigen is partially degraded by oxygen 
free-radicals and is then re-expressed on the cell surface, not as complete native 
antigen, but as a series of small processed antigenic determinants. These are found 
in close association with major histocompatibility complex molecules (MHC) and 
are small enough to be recognised by T-cells via the T-cell receptor (TCR). Two 
classes of MHC are found. Class I is found on all cells whereas class II is found 
only on some types of cells such as APCs and B-lymphocytes. The TCR, like 
immunoglobulin has hypervariable regions and each T-cell in a population carries 
this receptor which varies at the molecular level. Each T-cell is able to respond via 
the TCR to one specific antigenic peptide expressed on the surface of APCs. The 
interaction of T helper (TH)  cells and APC forms reactive specific T-cells (see 
section 1.6.4) some of which can stimulate specific B-lymphocytes. Another 
population of T-cells is the cytotoxic T-cells (T c) which kill virus infected or 
tumour cells and recognise antigen in association with MHC class I. Some T 
respond to MHC class II antigens. The recognition of MHC molecules is achieved 
by each subpopulation of T-cells expressing either CD4 or CD8 molecules on their 
surface. CD4 and CD8 have differing affinities to MHC I and MHC H. CD8 in 
association with the TCR binds to MHC I and is expressed on Tc  cells. CD4 is 
found on TH  cells and binds to MBC H. 
1.6.4 Stimulation of B- cells by TH  Cells 
There are three ways in which B-cells can be stimulated by antigen, which are 
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summarized below. The most important of these is T-dependent stimulation. 
1.6.4 a T-dependent Stimulation 
Primary B-cells, which bind antigen to the immunoglobulin molecules on their 
surface and are stimulated by specific T-cells will divide and begin to produce 
antibody. Primary B-cells are short lived and will not further divide, differentiate 
and produce antibody unless stimulated by both antigen and T-cells. B-cells are 
able to bind whole native antigen to the immunoglobulin molecules expressed on 
their cell surface. Once antigen is bound to the cell surface but before the cell 
interacts with a TH  cell a number of physiological changes occurs. The level of 
MHC expression on the cell surface increases which will be important for further 
activation by TH cells, DNA synthesis increases and the cell begins to move into 
G1 phase from resting G0 [78]. Under the influence of TH  cells the cells increase in 
size and divide rapidly. These rapidly become antibody forming or plasma cells 
and secrete antibody. Plasma cells initially produce 1gM but can switch isotype 
soon after antibody secretion begins. 1gM is produced initially as although it has 
low antigen specificity, the pentamethc structure confers high affinity. An antigen 
that has been previously encountered stimulates the production of IgG 
predominantly. 
As previously mentioned (see section 1.6.3) T-cells are unable to recognise native 
antigen, so a stimulated T-cell will be unable to recognise B-cells binding native 
antigen to the immunoglobulin expressed on the surface. It has been shown [78] 
that B-cells, like antigen processing cells, can process antigen although at much 
lower concentrations than those required to stimulate other presenting cells, which 
is probably due to the many highly specific immunoglobulin molecules expressed 
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on the cell surface. Any membrane bound antigen is internalised by the B-cells and 
processed. This processed antigen is expressed on the surface of the B-cell in 
association with MHC class II. It appears that specific stimulated T-cells bind to B-
cells with the processed antigen acting as a bridge. This binding occurs in the 
germinal centres of the secondary lymphoid organs such as the lymph nodes and 
the spleen. It is only once TH cells bind to stimulated B-cells that the B-cell starts 
to divide rapidly and to produce antibody. This is thought to involve cytokines 
released by the T-cell (see section 1. 7) as well as cell surface interactions. It 
should be noted that B-cells that bind antigen to their cell surface immunoglobulin 
but are not subsequently stimulated by a specific TH  cell do not differentiate and 
rapidly die.The growth and division of only those B-cells that bind antigen is 
termed clonal selection. Memory cells like primary B-lymphocytes require 
stimulation by TH cells. They are formed during the immune response at the same 
time as antibody forming cells and are found in the germinal centres of secondary 
lymphoid organs where they are formed by repeated stimulation by follicular 
dendritic cells. Memory B-cells leave the lymphoid organ and circulate in the 
periphery. Unlike primary unstimulated B-cells, they are long lived. Upon 
encountering antigen they respond in the same way as primary B-cells but to much 
lower concentrations of antigen. Affinity maturation increases antibody specificity, 
i.e. the more avidly an antigen is bound to cell surface immunoglobulin, the higher 
the stimulation of antibody synthesis. 
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Figure 1.5 Antigen Processing and Presentation by B-Lymphocytes 
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1.6.4 b Type 1 T-independent Stimulation 
Type 1 T-independent stimulation is far less important than T-dependant 
stimulation in the production of antibody. Type 1 independent stimulation is often 
polyclonal and generates very little memory. The antigens which stimulate B-cells 
in this way cross link immunoglobulin on the cell surface with other cell surface 
molecules such as MHC II, resulting in autostimulation. Molecules like bacterial 
lipopolysaccharide (LPS) at high concentrations stimulate B-cells independently of 
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T-cell help. However at low concentrations LPS stimulates B-cells in association 
with T-cells [49, 78]. 
1.6.4 c Type II T-independent Stimulation 
This is very similar to type I but instead of cross-linking immunoglobulin and cell 
surface markers, some antigens with repeating antigenic determinants can cross 
link inimunoglobulin on the cell surface and stimulate B-cells. The stimulation of 
B-cells in this way closely resembles the changes in B-cells seen when stimulated 
by T-cells and again suggests that T-cell stimulation may occur in this way. 
1.7 The Cytokine Network. 
1.7.1 Introduction 
As previously stated (see section 1.1) the immune system of vertebrates is highly 
complex and involves the direct interaction of T and B-lymphocytes. One 
extremely important method of control is through the secretion of soluble 
mediators known as cytokines. These molecules are synthesised not only by the 
cells of the immune response such as T helper cells during stimulation of B-cells 
but by many other cells at the site of an immune response [5]. Cytokines facilitate 
the control, amplification and maintenance of an immune response [1]. The 
cytokine network comprises a wide range of factors that activate lymphocytes 
(lymphokines)and mononuclear cells such as macrophages (monokines). All 
cytokines identified to date are composed of a single polypeptide chain and are 
often glycoproteins.They are usually pleiotropic, having a wide range of biological 
effects. Many of them are released by APCs upon stimulation by antigen [1] and 
are extremely important control factors in the generation of the immune response 
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[7, 9, 10].  They can augment or initiate a response, control the level of the response 
or recruit cells to the site of the immune response [1, 51. They are also involved in 
the formation and maturation of immune competent cells from the pluripotent 
cells, and maintain regulatory networks between lymphoid, haematopoetic and 
endothelial cells [1].  They are also implicated in the antigen presentation and the 
activation of B-lymphocytes. Many of the effects of cytokines are not antigen 
dependant. 
1.7.2 The Effect of Cytokines on Mature B-lymphocytes - B-cell 
Growth and Differentiation Factors 
The method by which specific stimulated TH  cells stimulate B-cells to proliferate 
and produce antibody as described in section 1.3.2 has gradually been elucidated 
over the past fifteen years [78]. It has been shown that soluble factors secreted by 
TH cells are vital in the production of immunoglobulin by B-cells [49]. Although 
these factors are secreted by T-cells, they are not exclusive to T-cells, being 
secreted by a number of other cell types such as macrophages and fibroblasts [5, 
19]. The activation, proliferation and production of many antigen reactive B-cells, 
and differentiation to antibody forming cells and memory cells are not mediated by 
a vast array of individual discrete cytokines but by a small number of cytokines 
exhibiting multiple effects. Thus one cytokine can exhibit multiple effects on a 
single cell type, acting both as a growth and a differentiation factor at different 
stages of B-cell development. These multiple action molecules have been termed 
interleukins (11), and those which exhibit the greatest range of effects on mature B-
cells are 11-1,11-2,11-4 and 11-6 
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1.7.2 a Il-i 
This was the first interleukin described and is extremely pleiotropic. It has many 
functions, acting as a mediator in host defence, inflammation and response to 
injury It is produced by many cell types and its activities are similar to tumour 
necrosis factor a (TNF-a) and 11-6 [17]. It was first shown to be secreted by 
macrophages activated by antigen but has since been shown to be released by 
fibroblasts, keratinocytes and T and B-lymphocytes among others. The activity 
first demonstrated was as a pyrogen, inducing fever, but EL-1 is also a regulatory 
molecule. It also acts on very primitive progenitor cells in the bone marrow [71]. 
fl-i receptors are expressed on the surface of pre B-cells [4]. 11-1 exists as two 
distinct peptides alpha and beta, which have complementary effects. The action of 
11-1 in stimulating B-lymphocytes is not direct but appears to stem from its ability 
to elicit the secretion of 11-6 from other cell types [93] although B-lymphocyte 
growth and differentiation by 11-1 has been shown [12, 94] and 11-1 stimulates B-
cells to move from a resting G0 stage to S phase [12,73]. It appears that 11-1 is 
important in the stimulation of B-cells just after antigen binding but before the 
actions of TH  cells and that its action on B-cells that have bound antigen and are 
responsive to T-cell stimulation is limited to the initiation of the secretion of other 
cytokines. 
1.7.2 b Interleukin 2 (11-2) 
11-2 is a more specific molecule than 11-1 and it acts on fewer cell types. It was first 
shown to act on T-lymphocytes [4,] and its main role is in the activation of T -
lymphocytes. However 11-2 also acts on activated B-lymphocytes [4, 641. B-
lymphocytes express 11-2 receptors and have been shown to proliferate in response 
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to 11-2 [102]. 11-2 is secreted by a wide variety of cell types such as macrophages 
and T-lymphocytes [5].  It does not appear to increase the level of antibody 
secretion of B-lymphocytes, but positively affects the growth and proliferation of 
B-lymphocytes [4].  11-2, unlike 11-1 may affect the later stages of B-cell 
differentiation, supporting and augmenting the growth of antibody secreting 
mature B-lymphocytes. There is some evidence is that 11-2 acts in synergy with 11-
6 [85] 
1.7.2 c Interleukin 4 (11-4) 
11-4 is involved in the isotype regulation of B-lymphocytes and has been shown to 
cause isotype switching [72]. It enhances the production of IgG and IgE and 
inhibits 1gM production [50], acting by heavy chain class switching, not by 
selection of secreting clones. 11-4 is also involved in the differentiation of non-
secreting B-cells to secreting B-cells [50, 72].  11-4 appears to act later than 11-1 but 
still in the earlier stages, unlike 11-2. 11-4 has also been shown to act on B-cell 
isotype regulation and differentiation [7] 
1.7.2 d Interleukin 6 
11-6 has many physiological effects and is secreted by several cell types [19]. 11-6 is 
very important in the overall generation of an immune response. The identification 
of 11-6 as one pleiotropic cytokine with many diverse effects resulted from the 
convergence of a number of different areas of research. The first identification of 
11-6 was as a second major transcription molecule in virus treated fibroblasts and 
was simply termed 26kD protein by elucidation of the mRNA size [93]or  as 
interferon -2 (]FN-2) due to its antiviral activity. The antiviral activity of 11-6 is 
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weak compared with other interferons. Further work showed that this 26kD protein 
was identical to several previously known, but uncharacterised, B-cell growth 
factors that acted on certain types of transformed B-lymphocytes such as myeloma 
and plasmacytoma cells [98] and EBV transformed B-cells [90]. Finally 11-6 was 
shown to be secreted by T-cells and could induce antibody production by B-cells 
[14, 29, 331. The later stages of B-cell growth during which antibody is being 
produced are affected by 11-6. 
1. 8 Role of Cytokines on the Growth and Antibody 
Production of Hybridoma Cells 
Although hybridomas are derived from the fusion of two immune cells, both B-
lymphocytes or B-lymphocyte derived, which in vivo are constantly under the 
influence of cytokines, there is little direct evidence for the role of cytokines on 
hybridoma cells. It may be assumed that hybridoma cells will be influenced by 
immune cell factors such as cytokines as they are immune derived, but what effect 
the fusion of two cell types and the immortality of the cells in culture, will have on 
the cells responsiveness is not known. There is some evidence to suggest that 
hybridomas are responsive to cytokines, such as the use of macrophage feeder cells 
in the initial cloning steps (see section 1.4) and the culturing of hybridomas in FCS 
(see section 1.5.2 a). The importance of a variety of cytokiries on B-cell physiology 
has been demonstrated (see section 1.7.2) and as a B-lymphocyte is the parent in 
both halves of the fusion, it may be that the effects of cytokines on B-cells will be 
similar to those on hybridoma cells. As hybndomas are produced from mature 
antibody producing B-cells the cytokines that may be the most relevant in the 
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stimulation of hybridoma cells are those that act on late B-cells, namely 11-2 and JI-
6 and to a limited extent 11-4. These molecules cause proliferation and antibody 
secretion in mature B-lymphocytes. Very little work has been published this area 
but it is known that certain cytokines, especially 11-6, can augment or replace 
macrophages in the initial cloning steps where macrophages are routinely used [6]. 
As stated previously (see section 1. 7) macrophages are capable of secreting a vast 
number of highly potent cytokines and it is thought that these aid the establishment 
of the newly formed hybridomas. The use of macrophages or pure cytokines may 
be a valuable method of reducing or replacing serum concentrations and may 
increase the level of antibody secretion or cell growth. 
The effects of cytokines on human hybridomas (see below) has been studied, but 
none appears to be available for murine hybridomas. The production of murine 
hybridomas is more advanced and many of the problems which are associated with 
human hybridomas are not found with murine hybridomas. 
James et al [36] investigated the effects of both recombinant 11-2, 11-4, and 11-6 at a 
variety of concentrations and cytokine rich supernatants (Conditioned medium 
(CM)) from other immortalized B-lymphocytes on two EBV immortalised 
peripheral blood B-lymphocytes which were derived from healthy human 
volunteers. These cell lines constantly secreted either high or low levels of 
antibody. It was shown that low concentrations of 11-2 enhanced cell growth of 
both cell lines and high levels had no effect on some of the cell lines but inhibited 
the growth of others. 11-6 at high concentrations inhibited the cell growth of both 
cell lines and low concentrations had no effect or inhibited cell growth. No effect 
on the antibody secretion of high producing cell lines was found, but all 
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concentrations of recombinant interleukins increased the antibody secretion of the 
low secreting line. The same cell lines were used for the investigation of the effects 
of conditioned medium, as well as hybridomas that produced antibody against 
hepatitis B and hybridomas (high and low secreting lines) which produce antibody 
directed against tetanus. Each cell line was grown in supernatants which had 
previously been used to grow the other hybridomas. For all cell lines no increase in 
antibody secretion was seen. Increased growth was seen in a few cell lines and 
inhibition of growth was seen in others. 
McCormack et al [56] also investigated human-human hybridoma growth in the 
presence of recombinant 11-2. The three cell lines used secreted antibody directed 
against streptococcal M protein. Cells were grown in three concentrations of 
recombinant 11-2 from fusion. Hybridomas not cultured in rll-2 immediately after 
fusion rapidly lost the ability to secrete antibody. It was shown that hybridomas 
cultured in the presence of high levels of 11-2 produced significantly more antibody 
than those cells in the presence of low concentrations. When cells were grown in 
the presence of high levels of 11-2 for a long time high levels of immunoglobulin 
were produced, but if 11-2 was removed immunoglobulin secretion dropped to that 
of untreated hybridomas. 
1. 9 The Cell Cycle 
Cell division and antibody production for B-lymphocytes occurs by an ordered 
sequence of stages that comprise the cell cycle. Upon stimulation by antigen the 
cell moves from a resting non-secreting phase termed G0 and begins to divide 
rapidly. Cell division occurs in the mitotic, or M phase. This is usually the shortest 
phase. In the M phase, the replicated chromosomes condense, becoming visible, 
page 38 
Introduction 
the DNA separates into opposite ends of the cell, the cytoplasm is divided and the 
cell divides forming two identical cells. This is followed by a gap, G, prior to the 
synthesis phase, S. In the S phase not only is DNA synthesised, but protein may 
also be secreted. During S phase DNA synthesis starts and the cell readies itself for 
cell division. The amount of DNA increases in this phase and peaks in the M-
phase. Thus by measuring DNA-content, the stage of the cell cycle can be 
determined (see section 2. 11). 
Figure 1.6 The Cell Cycle 
S Phase E GI Phase IM 
M phase N G2Phase IS 
The growth, division and protein production of eukaryotic cells follows an 
ordered series of phases. Cells show a secretory phase (S), a mitotic phase 
(M) and resting phases (G1 and G2). These phases are shown, but the length 
of each phase varies between cell lines and the above figure does not show 
the relative length of each phase. 
Mature B-lymphocytes express immunoglobulin on their cell surface. This 
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antibody can be present for a number of reasons. It could be expressed in the same 
way as in primary B-cells (see section 1. 6) or it could be antibody that is in the 
process of being secreted from the cell. It has been demonstrated by several authors 
that antibody is secreted mainly in the S-phase. Buell et al [10] used 
immunoglobulin secreting lymphoid cell lines which were synchronised by 
thymidine/colcemid blocking. It was demonstrated that antibody secretion 
occurred exclusively in S-phase. Garatun-Tjedeldsto et al [26]studied a 
synchronized plasmacytoma cell line and it was again demonstrated that antibody 
was secreted in S-phase. Al Rubeai et al [2]demonstrated in a synchronised 
hybridoma that antibody was also secreted in S-phase. 
1.9.1 Cell Cycle Control 
Cell cycle control has been proposed as a method of improving antibody yield 
from hybridomas [2].  Hybridomas are locked into continuous cell division. As 
cells only secrete antibody in the S phase the production of antibody could be made 
continual if the cells could be maintained in this phase. Attempts to achieve this 
using thymidine, a DNA replication antagonist, resulted in a loss of cell viability 
and cell death. It appears that division is a vital feature of the physiology of 
hybridoma cells and if cells are prevented from dividing the cell will die. 
1. 10 Flow Cytometric Analysis of Hybridoma Cells 
1.10.1 Introduction 
The development of high quality cell analytical techniques has been very important 
in the elucidation of many biological systems, such as differentiation of cell types 
in immunology, the identification of sub-clones in cell populations, the 
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determination of developmental pathways and mechanisms of cell interaction. 
Flow cytometry has been used widely in the study of animal cell culture systems to 
determine the role of batch kinetics or continuous culture kinetics on cell growth, 
physiology and product secretion. 
Cells to be analysed by flow cytometry are passed in a stream of liquid across a 
focused light beam. As each cell passes the beam, a circuit is tripped and the cell is 
detected.The light source can be either a mercury lamp, which can emit differing 
wavelengths by the addition of filters, or a single wavelength laser. The angle of 
light scatter is detected and is classed as being either high angle or low angle 
scatter. This defines cell size, as larger cells have a higher surface area, and allows 
differentiation of cells within a population on the basis of cell size. The reflected 
light is amplified by a photomultiplier detector tube and the light is divided into 
channels depending on the intensity and the angle of scatter. These are analysed by 
a computer and can be presented in a number of forms. The simplest is as a 
histogram, but data can also be displayed as a density contour plot, a dot plot or as 
three dimensional distribution. 
With the easy availability of MAbs and a number of fluorochromes which can be 
detected by a single wavelength laser, cells can be stained for multiple analyses. 
The identification of phenotypically differing populations and two or even three 
colour analysis of a cell population are possible. 
By measuring cellular DNA content with propidium iodide or ethidium bromide 
stains histograms showing the number of cells in each stage of the cell cycle can be 
produced. Cells in a particular phase can be easily be identified and isolated. 
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One other method used to differentiate cell populations is the attachment of a 
specific antibody, tagged using a fluorescent marker, onto specific cell surface 
markers. This technique is often employed to isolate subpopulations or can be used 
with two differing antibodies tagged with different fluorescent markers. 
Fluorescently tagged antibodies can be used to determine cell surface antibody on 
B-cells or hybridoma cells and can be coupled to a cell cycle stain as described 
above. The proportion of cells in each phase that are positive or negative for cell 
surface antibody can be determined and plotted in a four stage histogram. 
1.10.2 Uses of Flow Cytometry for Hybridoma Culture 
Flow cytometry has been used to investigate the physiological mechanisms of the 
cell by determining the relationship between cellular metabolism, antibody 
production and secretion. 
Sen et al [80] used flow cytometry to analyse the correlation between the 
expression of antibody on the cell surface and antibody production in a hybridoma. 
Light scatter was used to differentiate between viable and dead cells as dead cells 
interfere with the analysis. Dead cells were shown to be smaller. It was shown that 
there was a linear and uniform relationship between mean cell surface fluorescence 
and antibody secretion. When applied to batch culture the curve obtained for the 
cell line used showed a typical antibody secretion rate, the highest secretion being 
at the beginning of exponential growth, reaching a plateau at mid exponential and 
decreasing at decline and death phases of the culture. The mean surface 
fluorescence mirrored the production rates suggesting that antibody expression on 
the cell surface indicates antibody secretion. 
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Coco-Martin et al [13]also  used light scatter to differentiate between live and dead 
hybridoma cells. A small non-heterogeneous population was identified as being 
non- viable and the larger more uniform population as viable. By measuring both 
cell surface (CSAb)and cytoplasmic antibody levels and also by analysing cell 
cycle it was demonstrated that not all antibody produced by the cells was secreted 
but a proportion was stored, as there was no correlation between mean membrane 
concentration and cytoplasmic concentration. It was also shown that most antibody 
was stored when the cell is in G1 phase Again a correlation between CSAb and 
antibody secretion was shown. 
Meilhoc et al [57] measured mean surface fluorescence, total cell associated 
immunoglobulin, cytoplasmic mRNA and specific secretion rates of a hybndoma 
and found a correlation between mean cell surface fluorescence and cell associated 
immunoglobulin. By contrast with the findings Coco-Martin et al [13] and -Sen et 
a! [80], a correlation between secreted antibody and cell surface fluorescence was 
not found. It was also shown that the proportion of cells expressing low levels of 
surface IgG increased as batch culture proceeded. mRNA increased as culture time 
progressed but appears not to be translated as no new antibody was released. 
Dalili et a! [16] using fluorescent RNA stains analysed by flow cytometry 
demonstrated that mR.NA levels were higher in antibody producing hybridoma 
cells as compared with non-producing hybridomas, suggesting that cellular mRNA 
levels are useful in monitoring antibody productivity. 
Borth et al [9]studied  the fluorescence of rhodamine 123 stained cells in relation to 
glucose levels in the supernatant. It was shown that cell fluorescence correlated 
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linearly with glucose uptake. Rhodaniine 123 has been shown to relate to 
mitochondrial activity and the relationship of glucose concentration to 
mitochondrial activity and hence metabolic health of the cells was demonstrated. 
Flow cytometry when allied to specific stains gives new insights into hybridoma 
cell physiology. In a further study of hybridoma growth Borth et al [9] showed by 
flow cytometry that most antibody production was in late 01  phase, which agrees 
with other evidence (see section 1. 9) but may also be due to antibody storage as 
demonstrated by Coco-Martin et al [13] 
1. 11 Aims of the Project 
1.11.1 Stimulation of Hybridomas by Cytokines 
As described in section 1.7.2, cytokines play an important role in the physiology of 
B-lymphocytes. Hybridoma cells are B-lymphocyte derived and certain aspects of 
their growth and antibody production may be influenced by cytokines. Some 
evidence for the effects of cytokines on human-human hybridomas is available, 
and in this thesis the influence of two cytokines, 11-2 and 11-6, on the growth and 
antibody production of a murine hybridoma cell, ES-4, in batch culture was 
investigated. 11-2 and 11-6 have been identified as having a significant role on the 
later stages of B-cell development (see section 1. 7), and as hybridomas are derived 
from the fusion of two mature B-cells they may also be important in hybridoma 
cell growth and antibody production in vitro. These cytokines were added to batch 
cultures of hybridoma cells in two forms, as conditioned medium (CM), a cytokine 
rich but impure cell supernatant, produced by stimulating peripheral blood 
lymphocytes with lectins (see section 2. 7), or as pure recombinant interleukins. 
Recombinant interleukins were added to hybridoma cells cultured in serum free 
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medium, to eliminate serum factors from cell stimulation. Both types of 
interleukins was be added to the hybridoma cell culture at the start of batch growth 
and later as the culture progresses, and growth and antibody production was be 
monitored over the period of growth. To determine if these cytokines were present 
in FCS the concentration of both these interleukins in serum was measured. 
1.11.2 Studies on Hybridoma Cell Metabolism 
The metabolism of hybridomas (as described in section 1. 5) and their growth in 
vitro is dependent on the 1 concentration of nutrients supplied in the feed medium 
(see section 1. 5). It has been shown that the level of antibody secretion is 
dependant on hybridoma growth and the cells growth is dependant on the 
availability of the limiting nutrient. It has also been shown that the metabolic status 
of the cells is related to antibody secretion. In this thesis the metabolism of the 
hybridoma ES-4 (see section 2. 1) in both batch and continuous culture in the 
presence and absence of serum was determined. 
Initially the catabolism of the main nutrients in batch culture was determined in 
serum free and serum supplemented media. The work was also carried out on cells 
grown in continuous culture in a chemostat. By growing cells initially at the 
maximum specific growth rate (at high flow rates) and by gradually reducing the 
flow of medium into the reactor it was possible to obtain a series of steady states 
where cell growth was limited and controlled by the flow of nutrients into the 
chemostat. Using this, the metabolism of the hybridoma cells as nutrients become 
limiting was determined. Specific growth rates decrease as nutrient levels decrease 
and by plotting the specific growth rate against the metabolic quotient of the 
limiting nutrient maintenance energy was calculated. The secretion of antibody at 
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limiting growth was also investigated to determine whether the production kinetics 
of the hybridoma ES-4 were growth associated or, whether the inhibition of cell 
growth increases specific antibody secretion rates by holding the cells for longer in 
a phase where antibody is produced. 
1.11.3 Flow Cytometric Analyses of Hybridoma Cells 
There are two ways that antibody can be present on the outside of the cell. The first 
is through the expression of antibody as mimunoglobulin surface molecules that 
are present on the outside of primary B-cells and are involved in the initial 
stimulation of the cell through binding of antigen (see section the humoral immune 
response) The other way is through the presence of open or partially open vesicles 
that are transporting antibody out of the cell which can be detected by fluorescent 
antibodies. The detection and isolation of antibody secreting subclones may be 
useful due to the instability of hybridoma cells in long-term culture which results 
in loss of overall antibody secretion. This is thought to be due to chromosome 
deletions which are the result of a double genome. 
Another way that flow cytometry may be useful is in the determination of the 
relationship between cell cycle and cell surface antibody. If cell surface antibody is 
present only in one phase (the secretory or S phase) then it could be postulated that 
the antibody is not present as a cell surface marker as is found on primary B-cells 
but is a function of secretion. It has been demonstrated that antibody production is 
secreted in only one phase of the cell cycle (see section 1. 9). Some authors have 
also shown a relationship between cell size and activity [80]. Large cells do not 
secrete antibody as they are in the process of undergoing mitosis. The isolation of 
the most active cells in a mixed population could be extremely useful in the 
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maintenance and control of a culture and makes determination of culture 
characteristics far easier. The methods available are mostly chemical, forcing or 
inhibiting the cells into various stages of the cell cycle. This will place strain on 
the cells and as it has been shown that some hybridomas are unstable in relaton to 
antibody secretion may not be desirable for some cell lines. A method of isolating 
mitotic cells was developed in this thesis using flow cytometry. 
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2. 1 Cell Lines Used 
The cell line ES-4 was used for most stimulation experiments. This is a murine-
murine hybridoma which secretes an 1gM antibody against human blood cells 
carrying the B-antigen and was first characterized by researchers in the 
Department of Surgery at Edinburgh University. Two cell lines also used were the 
B9 for the assay of 11-6 and the CTLL-2 used for the assay of IL-2 [30]. Another 
cell line, LKJ, was investigated for use as an example of a high and low antibody 
producing culture. It was produced from B-cells in leukaemic mice and was 
provided by K.Samuels (Department of Zoology, Edinburgh University). It proved 
unsuccessful however as the cells ceased to produce antibody after storage in 
liquid nitrogen. One other cell line used was non-producing ES-4 which arose 
spontaneously in culture, and was shown to produce no antibody when assayed by 
haemagglutination (see section 2. 6). 
2.2 Preparation and Composition of Media 
2.2.1 Serum Supplemented Medium 
All cells were grown in RPMT -1640 medium (Gibco). RPMI 1640 was prepared 
by dissolving powdered medium in double distilled (tissue culture) water in 25 litre 
batches. To this was added 2g of sodium bicarbonate per litre and the pH was 
adjusted.The medium was sterilized by filtration through a 0.22 p.m filter 
(Millipore). Liquid medium was stored for up to 3 months at 4 ° C. Prior to use this 
basal medium was supplemented with 50 ml foetal calf serum (Sera Labs), 10 ml 
(100 mlvi) pyruvate solution (Gibco), 10 ml (200mIvI) L-glutamine (Gibco) and 10 
ml (100 iu/ml penicillin, 100 mg/ml streptomycin) of penstrep solution (Gibco) per 
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litre. 
2.2.2 Serum Free Medium 
Serum free medium was used for all recombinant cytokine work as it is chemically 
defined and is not likely to contain any proteins or other growth factors that could 
interfere with the effects of cytokines. The serum free formula was based on that of 
Kovar [41, 42, 43, 44, 38]. All reagents were supplied by Sigma. Each constituent 
was prepared as a stock concentrate, filter sterilized and added to RPMI-1640 at 
the appropriate concentration. 
Table 2.1 Composition of Serum Free Medium. 
Component Stock Concentration Final Concentration 
Bovine Serum Albumin 175 g/l 700 mg/i 
Linoleic Acid 25 g/l (in abs ethanol) 5 mg/I 
Oleic Acid 20 g/l (in abs ethanol) 4 mg/I 
Ethanolamine 1.24 mi/I 1.24 j.Ll /1 
Mercaptoethanol 4.40 mi/i 4.40 p1 /I 
Insulin lg/l 1p1/1 
Sodium Selenite 1x10 	M lxlO -6  M 
Transferrin 50 g/l 5 mg/I 
The lipids were complexed to the BSA due to their insolubility in water, by the 
following method. Sterile stock solutions were prepared separately and complexed 
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aseptically by mixing overnight at room temperature. The complexed BSA/lipid 
was not filter sterilized as this could remove the lipid from the BSA. The serum 
free supplement was added to basal RPMI-1640 supplemented with pyruvate, 
antibiotics and glutamine in the concentrations outlined in section 2. 2. 
2.3 Preparation of a Cell Bank and Recovery of Cells from 
Storage 
Cells were grown in 300 ml volumes at 37 °C in tissue culture flats (Nunc) until 
confluent. The cells were shaken into the medium and centrifuged at 1000 rpm for 
8 minutes. They were resuspended in foetal calf serum containing 10% dimethyl 
sulfoxide at a density of 1x10 7 cells per ml and aliquoted into imi samples in 
cryotubes (Nunc) which were packed into a polystyrene tray. The tubes were 
stored in a -70 °C freezer for 24 hours and transferred to liquid nitrogen storage. 
2.3.1 Cell Culture from Cell Bank 
Vials were removed from liquid nitrogen storage and plunged into a water bath at 
37°C to thaw. The cell suspension was transferred immediately to 30 ml of warm 
medium, and centrifuged to remove the DMSO which is toxic. The cell pellet was 
resuspended in supplemented RPMI-1640 (see section 2.2)and cultured for 3-4 
days at 370 before use. 
2.3.2 Serum Free Conditioning 
For serum free conditioning the cells were transferred to serum free medium 
immediately after thawing. The serum present from freezing (0.9 ml in 30 ml ie 
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3%) was diluted out gradually by adding serum free medium for 2-3 days and the 
cells were then spun down and resuspended in serum free medium prior to use. 
2.3.3 Routine Culture of ES-4 Cells 
Cells were grown at 2x 10 5 cells per ml and subcultured daily prior to being used in 
experiments. This produced cells at optimum concentrations for growth, and did 
not unduly stress them. 
2. 4 Estimation of Cell Number 
2.4.1 Haemocytometer Counting and Trypan Blue Exclusion 
To determine the number of viable cells, a trypan blue stain was used. Tiypan blue 
stains only those cells in which the membrane is not intact and which are therefore 
dead. Thus the total number of cells and a viable cell count can be obtained. A 
small sample of cell supernatant was removed aseptically and added in a 1:1 ratio 
to trypan blue stain (Sigma). A cover slip was placed tightly over the chambers of a 
haemocytometer and a small amount of cell suspension and stain was added to 
both chambers. Each chamber consisting of nine areas of the grid was counted and 
the cell number calculated. The space between the cover slip and the 
haemocytometer is calibrated to give a set volume over each area. The cell number 
was calculated by multiplying the number of cells by the dilution factor (usually 2) 
and dividing by the number of squares counted. 
To determine the accuracy of this method it was compared with a number of other 
methods for estimating cell growth which are outlined below. Normally three 
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samples were taken and each sample counted twice (in each half of the 
haemocytometer). Mean cell numbers were calculated. 
2.4.2 Automated Counting 
A 0.5 ml sample of the cell suspension was diluted 1:1 with phosphate buffered 
saline (PBS) to give a volume large enough to cover the electrode and it was placed 
over the electrode of a Coulter counter. The solution was drawn into the electrode 
and counted. After counting approximately 10,000 - 20,000 cells, the volume 
drawn up and the number of cells was noted, from which the cell number was 
calculated. Two samples were measured and the average value taken. It was not 
easy to distinguish dead and viable cells by this method but cell size can be seen 
and small cells which are usually dead were excluded from the count. 
2.4.3 Uptake of Tritiated Thymidine 
Cells were grown in 96 well tissue culture plates (Nunc) in replicates of five at 
37°C and 5% CO2 in air. Four hours prior to harvesting 3H Thymidine was added 
to each well and incubation continued at 37 °C. The plate was placed on a cell 
harvester and the contents of each well were drawn on to glass fibre discs. The 
discs containing the cells were dried thoroughly and placed in scintillation vials 
containing imi of scintillant which were then counted in a Scintillation counter 
(Packard) for one minute per sample. Means of the five replicates were calculated. 
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2.4.4 MTT ((3-(4,5-dimethytthiazol-2-yI)-2,5-diphenyl tetrazolium 
bromide) Assay 
This assay is very similar to the uptake of tritiated thymidine (as described in 
section 2.4.3) and is used as a means of determining cell growth. Whereas tritiated 
thymidine shows the increase of DNA in the cells, MTT degradation shows the 
activity of dehydrogenases in the mitochondria. The cells take up MTT and 
degrade it to a insoluble blue precipitate. The cells to be tested were cultured in 96 
well flat bottomed tissue culture plates (Nunc) for the desired length of time (i.e. 
72 hours for the 11-6 assay, 24 hours for the 11-2 assay) after which 10 p.1 of M'IT 
solution (5mg/nil in PBS) was added. After four hours incubation at 37 ° C, the 
precipitate was solubilized by the addition of 100 p.1 acid -isopropanol (0.1N HO 
in isopropanol). The absorbance of each well was read at a reference wavelength of 
630nm and a test wavelength of 570nm and a calibration setting of 1.99 [66]. 
Samples were read within one hour of the addition of isopropanol. For each sample 
three replicates were calculated and means were taken. 
2.5 Analysis of Antibody Concentration By Sandwich 
ELISA 
Ninety six well flat bottomed, irradiated ELISA plates (Dynatech) were coated 
overnight at 4°C with a 1:1000 dilution of a goat-anti mouse 1gM antibody (Caltag 
M31500), suspended in 100 p.1 phosphate buffered saline (0.01M pH 7.2; PBS). 
The plates were thoroughly washed, and to each well 100 p.1 of test sample diluted 
1:20 in diluent buffer (500m1 PBS containing 1 mg/nil BSA) or a varying 
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concentration of 1gM, to construct a standard curve, at an initial concentration of 
500ug/ml were added. Doubling dilutions of the initial samples were made in the 
wells and the plates were incubated at room temperature for 30 minutes. The plates 
were washed in wash buffer (PBS containing 0.05% TW.EEN 20) and to each well 
0.2 jil (in 10 ml diluent) of goat anti-mouse 1gM conjugated to alkaline 
phosphatase (Sigma) were added The plates were further incubated for 30 minutes 
at room temperature after which they were washed thoroughly and 100 p.1 of 
substrate solution.was added per well. The substrate contained Tetramethyl 
benzidine and hydrogen peroxide in acetate citrate buffer (Kirkgard and Perry). 
After 15 minutes or good colour development, 25 p.1 sulphuric acid (0.2M) was 
added per well to stop the reaction. Absorbance was read by a dynatech plate 
reader at 450nm and antibody concentration in the samples was calculated by 
comparison with the standard curve using the program RTACa1c. 
2. 6 Analysis of Antibody Titre by Haemagglutination 
To determine the titre of specific whole antibody in hybridoma cell supernatant 
haemagglutination was used. As ES4 produces anti-blood group B the 
agglutination of red blood cells will occur in the presence of ES-4 supernatant. 
This method detects only complete irnmunoglobulin not fragments. 
Doubling dilutions of the test sample were prepared across a U welled microtitre 
plate in PBS containing 2% BSA. To each well was added 40 p.1 of a solution of B 
group red blood cells (2-4% suspension in diluent). The samples were thoroughly 
mixed and incubated at room temperature for one hour. After incubation the plates 
were centrifuged at 1000 rpm for 1 minute and agglutinates were resuspended by 
shaking. The plates were read by eye. The lowest dilution at which clumping 
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occurred was recorded. The values were noted as reciprocals of the dilution to give 
an antibody titre. 
2.7 Preparation of Conditioned Medium 
Conditioned media were prepared from human peripheral blood mononuclear cells 
(PBMC) stimulated with either lipopolysaccharide (LPS) (E.Coli Sigma) (11-6) or 
phytohaemagglutinin (PHA) (11-2) [1,]. Typically 40 ml of whole venous blood 
was collected into preservative free heparin and PBMC were separated by density 
centrifugation on Ficoll hypaque gradient (Lymphopaque). Cells were taken from 
the interface and washed several times with supplemented RPMT. (2.2. 1) Cells 
were counted and the yield was usually approximately 100 million PBMC from 40 
ml of whole blood. They were diluted to 1 million cells per ml and cultured in flat 
bottomed flasks for 24 hours in the presence of lOng/mi LPS(E.Coli: Sigma) or 
lOng/ml PHA at 37 0C. The cells were then removed by centrifugation and the 
Conditioned medium stored in aliquots at -20 °C until required. 
2.8 Assay of Conditioned Medium 
Using the cytokine sensitive cell lines B9 and CTLL-2, 11-2 (CTLL-2) and 11-6 
(B9) can be accurately assayed. 
2.8.1 Assay of 11-6 
Using a 96 well tissue culture plate (Nunc) 50xl doubling dilutions in triplicate of 
recombinant 11-6 (British Biotechnology, starling concentration of 200pg/ml) were 
prepared across the plate in RPMI-1640 containing 1% FCS. In quintuplicate, 50 
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p.1 doubling dilutions of the medium to be tested were also prepared across the 
plate. To each well, 50p.1 of B9 cell suspension was added (1 xl& cells I ml) 
giving a final concentration of 0.5x 10 cells/ml, and the plate was incubated at 
37°C for 72 hours and at 5% CO2. After incubation, 100 p.1 of MTT solution (1mg/ 
ml) was added to each well and left for four hours at 37 °C after which 100 p.1 acid-
isopropanol per well was added. Absorbances were read as outlined in section 
2.4.4 
2.8.2 Assay of 11-2 
Using the method above (see section 2.8.1), samples to be tested for 11-2 were 
added to a 96 well tissue culture plate followed by CTLL-2 cells and incubated for 
24 hours. After incubation, staining with MTT was carried out as previously 
described (see section 2.8.1) and standards calculated as before using recombinant 
11-2 (British Biotechnology) as a standard. 
2. 9 Operation of a Chemostat 
Some experiments used cells grown in a chemostat. All continuous culture 
experiments were carried out in a 500m1 vessel (Beilco). ES-4 hybridomas (see 
section 2. 1) were grown in 300m1 volumes and were cultured at 37 °C in a 
waterbath. The vessel was continuously stirred using a magnetic stirrer. Two 
chemostats were run simultaneously, one growing non-producing hybridomas and 
the other growing producing hybridomas. Two complete sets of pumps and 
rotameters were used, and the headspace of both chemostats were aerated by 
separate air lines. The pump used for all non-producing runs had a flow rate which 
could not be set much lower than maximal hybridoma growth rates. To achieve 
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growth rates lower than this the flow rate was controlled by turning the pump on 
and off by connecting the pump to a relay which was controlled by a BBC 
microcomputer. A BASIC program was used to switch the pump off and on at a 
time ratio of 1:4 n a five minute cycle. The pump for the producing runs had loser 
flow rates and did not need to be controlled in this way. Medium was continually 
pumped into the reactor from a sterile feed bottle. The volume was maintained by 
an overflow tube which reached into the vessel to the 300m1 mark. The overflow 
was continually pumped out to a sterile waste bottle. The vessel was aerated by 
continually passing humidified air across the headspace of the vessel and the pH 
was maintained at 7.2 by adding CO2 at an approximate concentration of 5% to the 
air stream. Measurements of the disolved oxygen (d0 2) concentration were taken 
regularly using an oxygen electrode. The oxygen electrode was calibrated using 
distilled water saturated with nitrogen, to act as a blank and saturated with air for 
maximum d02 concentration. It was found that the d0 2 concentration of the 
medium in the chemostat was greater than that of air saturated distilled water. It 
was assumed that the concentration of d02 in the chemostat was greater than 20% 
of air saturation at all times and that the cells were not oxygen limited. Cells were 
initially inoculated at between 0.5 and 1 x 105 cells per ml and grown with the 
medium feed pump switched off until a cell density of approximately 3x10 5 cells 
per ml had been reached. At this point the flow was started and adjusted to give 
maximal dilution rates. . Prior to steady state culture the maximum flow rate was 
calculated by culturing the cells in the chemostat with the pump off. Once the cells 
had reached a density of approximately 3x10 5 ml, the pump was started at a 
dilution rate of approximately 0.5 day and gradually adjusted over two to three 
days. The flow rate was gradually increased until the cell number was no longer 
increasing. The cells were assumed to be at steady state when both cell number 
and dilution rate, which was calculated by dividing the flow rate by the reactor 
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volume, remained unchanged over three time points. The pump speed was not 
altered during periods of steady state. Once steady state had been maintained for 
approximately 100 hours, the flow was reduced by approximately 10% and the 
cells were again allowed to reach steady state and were maintained as above. The 
reactor was sampled twice daily and metabolite concentrations, cell number and 
antibody concentration were determined (see sections 2. 4, 2. 5 and 2. 12 to 2. 15). 
Cell viability was regularly determined , and was found to exceed 90% at all 
times. Dilution rates, were calculated by aseptically measuring the volume 
remaining in the feed vessel after each time period, and calculating flow rates. The 
feed medium was replenished twice daily from sterile stock medium stored at 0 °C. 
Figure 2.1 Simple Chemostat 
Drt 
Feed 	 Bioreactor 	 Waste 
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2. 10 Analysis of Cell Surface Antibody 
As outlined in section 1. 10 some antibody is found on the cell surface of 
hybridoma cells and can be detected by fluorescently or enzyme tagged 
antibodies.To determine if there was any antibody present on the surface of the 
non-producing ES-4 cell line, which would signal that the cell is manufacturing 
some antibody but had a defect in the transport mechanism, an antibody raised 
against mouse 1gM was used to detect those cells expressing antibody on the cell 
surface. A two stage method made the staining as sensitive as possible and 
removed problems associated with non-specific binding. The primary antibody 
was polyclonal goat anti mouse 1gM (Sigma) which binds to many antigenic 
determinants on the antigen. The second antibody was donkey anti goat 
immunoglobulins labelled with FITC or horseradish peroxidase (HRP) (both 
Sigma). 
2.10.1 Slide Method 
A 200 pl sample of ES-4 cell culture was spun onto a glass microscope slide using 
a cytocentrifuge. The cells were fixed with acetone and washed with tris-HCL 
buffer. Goat anti mouse 1gM antibody, diluted 1:100 in PBS containing 1% BSA 
was added to the slide and incubated for 30 minutes at room temperature. The slide 
was washed with PBS/BSA. HRP labelled anti goat Ig, diluted 1:100 with PBS! 
BSA was added to the slide which was incubated for a further 30 minutes. The 
cells were washed and a small volume of substrate, sufficient to cover the cells 
added. The substrate was composed of 3,3' di arninobenzidine dissolved in PBS 
containing 30 .tl peroxide. It was left for colour development at room temperature 
(approximately 10 minutes) and read qualitatively under a microscope. This was 
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compared with the control in which the first antibody was substituted by goat anti 
mouse IgG and results were noted qualitatively. 
The initial results were ambiguous so the above method was modified firstly by 
blocking endogenous peroxidase activity by incubating the cells after fixation with 
0.03% peroxide solution for 30 minutes and secondly by not fixing the cells in 
acetone as this reduced the level of detection of cell surface antibody. 
2.10.2 Flow Cytometry 
Approximately one ml of culture containing 5x10 5 ES-4 cells per ml was 
centrifuged and the pellet suspended in imi PBS containing 1% BSA. After a 
further centrifugation, 50 j.tl of primary antibody (goat anti mouse 1gM Sigma) 
diluted 1:100 was added to the cells and they were incubated for 30 minutes on ice. 
The cells were washed twice in cold PBS/BSA and the pellet resuspended in 50p.l 
of F1TC-labelled donkey anti goat Immunoglobulin antibody (Sigma) diluted 
1:100 in PBS/BSA which was FJTC tagged After a further incubation for 30 
minutes on ice, the cells were washed and resuspended in lml PBS/BSA 
containing 1% formol saline. Control cells were stained in parallel using an 
irrelevant primary antibody (goat anti-mouse IgG). 
Cells were then analysed by flow cytometry in a Coulter Electronics EPICS 'C', 
equipped with a 5 Watt laser operated at 100 mW and tuned to 488nin. Cells were 
run at a rate of 600 per second and green fluorescence analysed on a 255 channel 
histogram using log amplification. Background non-specific green fluorescence 
was set to approximately 1% of the total histogram on the control cell population, 
prior to analysing test cell populations. 
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In order to perform cell cycle analyses on cells stained for surface 1gM, the cells 
were first stained as above, fixed in PBS/BSA /formol saline for 60 minutes at 
room temperature, then counterstained with propidium iodide (see section 2. 11) to 
determine their DNA content. 
For optical separation of the two colours staining the cells (ie green FITC and red 
propidium iodide), a 530 short pass dichromic mirror was used followed by a 530/ 
30 band pass filter in front of the green photomultiplier tube (PMT), and a 610 long 
pass filter in front of the red PMT. Any spectral overlap of residual green 
fluorescence onto the red PMT was removed by electronic compensation. Thus a 
two parameter histogram was obtained of F1TC-positive cells and their DNA 
content from gated forward angle light scatter signals. Alternatively, a one 
parameter linear red fluorescence DNA histogram could be obtained from gated 
F1TC positive cells. Calculation of cell cycle phase was performed on the Coulter 
software QUADSTAT or the S-FIT program on CYTOLOGIC software for two 
and one parameter histograms respectively. 
2. 11 Determination of Stage in Cell Cycle of Hybridoma 
Cells 
2.11.1 Method 
A sample of culture containing approximately 50,000 cells was centrifuged at 1000 
rpm and the cells resuspended in 200 I.Ll citrate buffer (see below). To this 200 p.1 of 
trypsin solution (Solution A see below) was added and the mixture incubated for 
10 minutes at room temperature. After the first incubation 200 p.1 of trypsin 
inhibitor and ribonuclease A (Solution B see below) was added and the mixture 
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incubated for ten minutes art room temperature. Finally 50 .tl of propidium iodide 
solution (Solution C see below) was added and samples stored at 00  C [97]. Stained 
cells were filtered through nylon wool or a 70 gm filter prior to analyses by flow 
cytometry. 
2.11.2 Solutions Used For DNA (Cell Cycle) Staining 
Citrate Buffer: 85.5g sucrose and 11.76g trisodium citrate dissolved in 800m1 
distilled water. 50 ml DMSO was added and the volume made up to 1000ml with 
distilled water. pH was adjusted to 7.6. 
Stock Solution: 2000mg trisodium citrate, 121mg Tris, 1044mg spermine 
tetrahydrochioride and 2m1 Nomdet P40 were dissolved in distilled water to 
2000m1. Adjusted to pH 7.6 
Solution A: 15mg trypsin was dissolved in 500m1 stock solution. It was stored 
frozen and brought to room temperature prior to use. 
Solution B: 250 mg trypsin inhibitor and 50mg ribonuclease A in 500m1 stock 
solution. It was stored frozen and brought to room temperature before use. 
Solution C: 208mg propidium iodide and 500mg spermine tetrahydrochioride 
were dissolved in 500m1 stock solution. It was stored frozen and brought to 00  C 
prior to use. 
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2. 12 Assay of Glucose Concentration 
This assay is based on the conversion of glucose to gluconic acid by glucose 
oxidase, with the associated conversion of water to hydrogen peroxide. The 
production of peroxide is measured by the oxidation of colorless o-dianisidine to 
its brown oxidized form. 
One PGO capsule containing glucose oxidase and peroxide (Sigma 510-6) was 
dissolved in 100 ml distilled H20 containing 1.6 ml o-dianisidine dihydrochioride 
(Sigma 510-50) to prepare the stock enzyme solution. Each sample was diluted 
1:20 with distilled H20 and to 0.1ml of each sample imi of the above stock 
enzyme solution was added. Each sample was incubated at 37 0C for 20 -25 
minutes and read at 425 nm in a spectrophotometer (Phillips). Standards of known 
glucose concentration were prepared from a stock concentrate of lgl-1 at 
concentrations of 11.1, 8.9, 6.7, 4.4, and 2.2 mM with distilled water used as a 
blank. Standards were plotted against absorbance and the best straight line 
obtained by regression. This gave an equation which was used to calculate the 
concentration of glucose in the samples 
2. 13 Assay of Ammonia Concentration 
In the presence of nitroprusside ammonia reacts with phenol hypochionte to 
produce indophenol which is blue in colour. This can be monitored 
spectrophotometrically. 
50 j.tl of each sample was diluted 1:20 in distilled water and to each was added 0.5 
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ml phenol mtroprusside solution and 0.5 ml alkaline hypochiorite solution (both 
Sigma). Samples were incubated at room temperature for 25 minutes and read at 
525 nm. Standards of 40 m to 0.125 mM ammonium chloride were prepared and 
the equation of the best fit straight line calculated as above (see section 2. 12). 
2. 14 Assay of Glutamine Concentration 
Glutamine is measured by converting it to glutamate and ammonia and then 
measuring the ammonia produced by the method described above (see section 2. 
13). 
To 25 p1 of each sample was added 25 p.1 of 0.1 M sodium acetate buffer pH 4.9. 
To this mixture 10 p.! of glutaniinase (5 units /ml Sigma) was added and the tubes 
were incubated for 45 minutes. Ammonia was then assayed. Background readings 
of ammonia in the samples were. calculated and subtracted from glutamine 
calculations. A glutamine standard curve of 2mM, 1.6mM, 1.2mM, 0.8mM, 
0.4mM, and 0mM was prepared and all glutarnine samples read from this. The 
ammonia concentration was subtracted from the glutaniine concentration (after 
compensating for background), to give remaining glutamine. 
2. 15 Assay of Lactate Concentration 
Lactate is converted to pyruvate and H 202 by lactate oxidase. The peroxide 
generated then reacts with chromogen precursors, in the presence of horseradish 
peroxidase, to produce a coloured dye. 
To 10 p.1 of each sample 1 ml of lactate assay solution (Sigma 735-10) was added. 
page 65 
Materials and Methods 
The colour produced was read in a spectrophotometer at 540 nm after 5 - 10 
minutes. Lactate standards of 0.4 to 0.025 gl-1 were prepared and calculated as 
above (see section 2. 12). 
2. 16 Assay of Pyruvate Concentration 
Pyruvate is converted to lactate by lactate dehydrogenase with the associated 
oxidation of NADH to NAD. NADH strongly absorbs ultraviolet light at 340nm so 
the decrease in absorbance is equivalent to the concentration of pyruvate in the 
sample. 
Standard NADH solution was prepared by the addition of 2.2m1 of TRIZMA (1.5 
mol/L) base solution into a preweighed vial of NADH (1.0 mg) (Sigma). To a lml 
sample of cell supernatant (diluted 1:20), 0.5 ml of TRIZMA was added and mixed 
thoroughly. To each sample 0.5 ml of the standard solution of NADH was then 
added. This was read at 340nm to give an initial absorbance. Finally 10 !.L1 lactate 
dehydrogenase (100 U/mi Sigma) was added and after 5 minutes the absorbance 
was read at 340nm. A further reading was taken after 5 minutes to ensure that a 
minimum had been reached. The absorbance after the addition of lactate 
dehydrogenase was subtracted from the absorbance prior to the addition of lactate 
dehydrogenase to give the final absorbance value 
Standards of known pyruvate concentration were included and calculated as above 
(see section 2. 12). 
2. 17 Synchronisation of Hybridoma Cells 
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2.17.1 Thymidine Blocking 
Thymidine inhibits actively growing cultures and stops cell growth in the S-phase, 
and has been used by a number of authors to obtain a synchronous cell population. 
[57]. 
Cells in the exponential phase of cell growth were adjusted to 3 x10 5 cells/nil and 
resuspended in standard supplemented medium (see section 2. 2) containing 2mM 
thymidine (Sigma). After 20 hours at 37 °C the cells were centrifuged at 1000rpm 
for 8 minutes and resuspended in medium without thymidine for 8 hours at 37 °C. 
After this time cells were suspended in medium containing 2mM thymidine for 16 
hours at 37°C. The cells were transferred to medium without thymidine and 
cultured for 48 hours at 370  C with regular samples being taken and analysed for 
stage of the cell cycle by propidium iodine staining (see section 2. 11) and for cell 
number (see section 2. 4). 
2.17.2 Serum Starvation 
Serum starvation was also attempted as a method of synchronizing cells. Cells 
starved of serum - a vital source of metabolic precursors- are growth inhibited and 
the period of the cycle when the cell is most active and requires most of the 
precursors is the S-phase. It is therefore postulated that cells in the absence of 
serum are prevented from entering G2 and M phases and would be predominately 
in the S-phase. 
Initially cells in the exponential phase of growth were removed from culture and 
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adjusted to 2 xl& cells per ml in 0, 0.1 and 1 and 5% serum in supplemented 
RPMT. Cells were cultured for 24 hours at 37 0C- approximately one cell cycle - 
before being centrifuged and resuspended in RPMI medium containing 5% serum 
at 37°C. Samples were taken regularly thereafter and analysed for stage of the cell 
cycle (see section 2. 11) and cell number (see section 2. 4). 
Further studies used a starvation period of 20 hours at 37 °C followed by 
resuspension of cells in 10% serum. 
2.17.2 a Isolation of Mitotic Cells 
It has shown that cells in the mitotic phase of cell division increase in size and this 
parameter can be used for separating cells at different stages of the cell cycle. One 
possibility which is to use a flow cytometer which can identify and sort cells on the 
basis of size or a fluorescent marker. Another method is density gradient 
centrifugation used commonly for the separation of blood cells (see section 2. 
7).Both these methods were attempted and are described below. 
2.17.2 b Isolation of Mitotic Cells By Flow Cytometry 
Cell suspensions at 2x10 6 /ml were analysed in a 1 parameter histogram measuring 
forward light scatter (size) on a log scale. On this basis two populations were 
observed which could be gated for separation by sorting. Cell sorting was 
performed in sterile PBS with cells being collected into culture medium (RPMI 
1640 supplemented as previously described, (see section 2. 2) except 20% FCS 
was used for cell protection). Cells were sorted at a flow rate of 600-1000 cells per 
second at a laser power of 150mW. Collected cell populations were then aliquoted 
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for cell culture and DNA analyses. DNA histograms were generated after cells had 
been treated according to the technique described by Vindelov et a! [97]. (see 
section 2. 11). Occasionally, two distinct cell populations were not visible on the 
basis of size alone, but when examined on a two parameter histogram displaying 
both 900  light scatter (i.e. complexity of the cell) and also forward angle light 
scatter (FALS), two populations could be detected. Sorting these populations was 
performed by drawing bit maps around each population and proceeding as above. 
2.17.2 c Separation by Density Centrifugation 
A stock solution of Percoll (Sigma) was diluted in PBS to give concentrations of 
80% and 60%. Gradients were prepared in 15 ml conical centrifuge tubes (Sterilin) 
by adding 3m1 of 80% Percol to the bottom of the tube and then very carefully 
adding 3m1 of 60% Percoll above this. These solutions were always prepared 
immediately prior to use. Initial experiments were performed using peripheral 
blood collected into heparin (see section 2. 7). The whole blood was then diluted 
with an equal volume of culture medium and lOmi layered on top of the gradient. 
The loaded gradient was then centrifuged at 3000 rpm for 15 minutes at room 
temperature. During separation cells of differing densities separated into specific 
bands throughout the gradient and could be harvested. Test (hybridoma) cell lines 
were similarly layered onto gradients at 5 x106 cells/ml in an attempt to separate 
cells of different size. Bands of cells were harvested and washed in PBS before 
being cultured or stained for DNA (cell cycle) analysis. 
Similarly, cell separation on lymphopaque (Nyegaard) was attempted after. 10 ml 
of cell suspension at a density of 1 x10 6 cells /ml were layered onto 9m1 
lymphopaque in a 20m1 universal container (Sterilin) and centrifuged at 3000 rpm 
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for 20 minutes. Cells were harvested from the lymphopaque / medium interface 
and also from the pellet, cultured and processed for DNA staining to be analysed 
by flow cytometry. 
2. 18 Stimulation of Hybridomas by Cytokines 
The murine hybridoma ES-4 was grown in batch culture in 10 cm 3 tissue culture 
flasks in humidified air containing 5% CO2 at 37°C. Interleukin stock solutions 
were prepared from lyophilized samples by dissolving in sterile, serum 
supplemented tissue culture medium, and filter sterilising using a syringe filter. 
Cell growth was measured using a haemocytometer as described in section 2. 4, 
and antibody concentration by a sandwich ELISA as described in section 2. 5. 
Each experiment and the control were carried out in duplicate in tissue culture 
flasks, with samples being taken daily, counted and averaged. Antibody 
concentrations for each duplicate flask were determined and also averaged. The 
standard deviation from the mean were calculated. 
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Chapter 3 
Stimulation of Hybridomas by Cytokines 
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3. 1 Introduction 
As described in section 1. 8 cytokines play an important role in the in vivo 
development, stimulation, growth and antibody secretion of B-lymphocytes. 
Cytokines, in vitro, have also been shown to play a role in the growth of newly 
formed hybridomas. However the effects of cytokines on murine hybridomas in 
vitro remains unknown, although some work has been done to determine the action 
of cytokines on human-human hybridomas. 
It was therefore decided to carry out a series of experiments to determine the 
effects of cytokines on murine hybridoma cells using 
1.Conditioned Medium (CM) 
2. Recombinant 11-2 and 11-6 in serum free medium 
For all stimulation experiments conditioned medium prepared using human blood 
cells and human recombinant interleukins were used. It has been found that the 
majority of interleukns are non-species specific, ie human 11-6 and 11-2 will 
stimulate murine cells, one exception is 11-4 which is species specific. 
The experiments were carried out as described in section 2. 18. Prior to the start of 
each experiment, a stock culture of ES-4 hybridomas, recently resuscitated from 
liquid nitrogen and in the middle of the exponential phase were counted, 
centrifuged and resuspended at 1 x 105 cells per ml in fresh tissue culture medium. 
This culture was aliquoted into each flask, to which conditioned medium or 
interleukin stock solution was added. All cultures were adjusted to an identical 
volume using fresh medium, and incubated. Each experiment was repeated at least 
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twice, and the experiments using conditioned medium were performed three 
times. 
The effect on hybridoma cells of medium containing 5% interleukin-6, and 50% 
interleukin-2 conditioned medium, and both human recombinant interleukin-6 and 
interleukin-2 at concentrations of 40, 20, 10, 4, 2, and 1 ng/ml were investigated. 
The concentrations of CM used were based on the concentrations shown to be 
stimulatory by other authors, and to be in excess of the concentrations required for 
the growth of B-9 and CTLL-2 cells. The range of concentrations of recombinant 
interleukins were also based on the concentrations used by other authors, and to 
also provide a high and a low range of concentrations to determine concentration 
dependant effects. 
3.2 Preliminary Results 
3.2.1 Estimation of Cell Number 
To determine the best method of estimating cell growth, batch cultures were 
carried out, with samples being taken daily. Each sample was measured (1) by 
haemocytometer counting, three samples being counted and averaged for each time 
point, (2) by a Coulter counter, two samples being measured and averaged for each 
point and (3) by pulsing with tritiated thymidine for 4 hours, six samples being 
measured and averaged for each time point (see section 2. 4). Samples to be 
measured by the uptake of tritiated thymidine were grown in tissue culture plates, 
and individual wells were pulsed and harvested at each time point. The values for 
tritiated thymidine represent the uptake of tritiated thymidine for that time period 
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Figure 3.1 Growth as Measured by Haemocytometer and Coulter Counting 
Figure 3.2 Uptake of Tritiated Thymidine 
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The Coulter counter and haemocytometer gave similar results. The experiments 
using tritiated thymidine pulsing were slightly different, the graph levelled off 
sooner than the other methods which may be due to decreased metabolic activity of 
the cells as they begin to enter the decline phase. It was decided to use 
haemocytometer counting for all further experiments, as the Coulter counter 
method required large sample sizes, of approximately 1 ml, to give accurate 
measurements and would therefore require large volumes of hybridoma culture 
and hence large quantities of cytokines. The tritiated thymidine method was not 
used further because the incorporation of radioactivity did not increase or decrease 
as the cells entered decline phase. It was thus less representative of cell growth and 
there were logistical problems in using radioactive compounds and in the 
measurement of samples using a scintillation counter. Estimation of growth by 
tritiated thymidine uptake also took longer than direct counting of cell numbers. 
Haemocytometer counting once shown to be accurate and reproducible was 
preferable as small volumes of sample could be routinely measured very quickly. 
3.2.2 Assay of Conditioned Medium 
The conditioned medium used in all stimulation experiments was prepared as 
described in section 2. 7. Prior to use, each batch was assayed for the concentration 
of the relevant interleukin, using the MTT assay (see section 2.4.4). A standard 
curve was first prepared using recombinant interleukins at a variety of 
concentrations. The graph of this reached a point of maximal absorbance after 
which increasing concentrations caused no further increase. The portion of the 
graph where absorbance was increasing, but prior to the flattening off at higher 
concentrations was used for the determination of interleukins in the conditioned 
media. The regression equation of this portion was calculated and used to estimate 
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the concentration in the conditioned media. Conditioned media were assayed at a 
variety of concentrations, and the concentration which caused maximal stimulation 
was compared with the equation derived from the standard curve and the 
concentration calculated (see Figures 3.3and 3.5). The concentrations of 11-6 in the 
CM was determined to be approximately 10 ng/ml and for the 11-2 CM was 
determined to be 2.2ng/ml. 
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3.2.3 Estimation of Antibody Concentration 
All antibody concentrations were measured using an anti-mouse 1gM antibody 
sandwich ELISA (see section 2. 5). To eliminate the variability from different 
samples being assayed at different times, all samples from one stimulation 
experiment were assayed together. In addition the concentration of antibody 
secreted by the hybridomas was also regularly assayed using haemagglutination 
(see section 2. 6), to ensure that the concentrations obtained by ELISA were 
accurate, and to ensure that the antibody had correct functionality. 
3.2.4 Addition of Cytokines to Hybridoma Cultures 
The following graphs (Figures 3.7 to 3.22) show the growth and antibody secretion 
of ES-4 hybridomas in the presence of conditioned medium, and recombinant 11-2 
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and 11-6 concentrations of 4 and 40ng/ml. The other concentrations tried are not 
shown in the following graphs, but are summarised in Table 3.2. Each graph shows 
either cell growth or antibody secretion of cultures in the presence and absence of 
each interleukin at the concentrations used. For cell growth 3 samples were taken 
from each duplicate flask, and for antibody concentration one sample was taken 
from each flask. The values were averaged and the standard deviation of each 
value is shown as error bars. 
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Figure 3.7 Cell Growth in the Presence of 11-6 CM 
6 
	
Addition of 5% 11-6 Conditioned Medium to ES-4 Hybridoma 
Cell Growth 
I •--- 
5 - 5%11-6 CM 
S 	S 
Control 
















Figure 3.8 Antibody Secretion in the Presence of 11-6 CM 
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Figure 3.9 Cell Growth in the Presence of 11-2 CM 
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Figure 3.10 Antibody Secretion in the Presence of 11-2 CM 
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Figure 3.11 Cell Growth in the Presence of High rIl-6 
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Figure 3.13 Cell Growth in the Presence of Low rII-6 
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Figure 3.16 Antibody Secretion in the Presence of High rIl-2 
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Figure 3.17 Cell Growth in the Presence of Low rIl-2 
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Figure 3.19 Cell Growth in the Presence of 11-2 and 11-6 
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Figure 3.21 Cell Growth after Addition of 11-6 
Figure 3.22 Antibody Secretion after Addition of 11-6 
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The slopes of each exponential growth phase were calculated by using the 
regression equation to find the best fit straight line and deriving the slope from this, 
to compare the rate of growth in each experiment. The secretion of antibody per 
cell was also calculated by plotting antibody concentrations against cell number 
and again calculating the slopes of the exponential phase of growth as above. 
These are shown below (Tables 3.land 3.2). The units for cell growth are cells. 
(x105) hr and for antibody are p.g of antibody per 10 5 cells hr 
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Table 3.1 Comparison of Rates of Exponential Growth and Antibody Secretion (shown 
in Figures 3.4 to 3.22) 
Growth Rate Antibody tg/10 5ce1ls 
Experiment Control Stimulated Control Stimulated 
11-6 Conditioned Medium 0.039 0.056 0.82 0.86 
11-2 Conditioned Medium 0.037 0.040 1.24 0.98 
Recombinant 11-6: High (40ng/ml) 0.055 0.049 1.20 0.77 
Recombinant 11-6: Low (4 ng/ml) 0.048 0.050 0.76 0.93 
Recombinant 11-2: High (40ng/ml) 0.046 0.042 0.62 0.62 
Recombinant 11-2: Low (4 ng/ml) 0.075 0.081 0.50 0.45 
Recombinant 11-2 plus 11-6 0.037 0.047 0.51 0.46 
Late Addition of 11-6 0.042 0.037 0.88 0.85 
Table 3.2 Comparison of Rates of Exponential Growth and Antibody Secretion 
Growth Rate Antibody p.g/105cells 
Experiment Control Stimulated Control Stimulated 
Recombinant 11-620 ng/ml 0.055 0.058 1.67 1.34 
Recombinant 11-6 lOng/mi 0.055 0.060 1.67 1.76 
Recombinant 11-62 ng/ml 0.048 0.042 0.61 0.74 
Recombinant 11-6 1 ng/ml 0.048 0.041 0.61 1.90 
Recombinant 11-220 ng/ml 0.046 0.050 0.62 0.66 
Recombinant 11-2 10 ng/ml 0.046 0.048 0.62 0.93 
Recombinant 11-2 2 ng/ml 0.061 0.060 0.77 0.60 
Recombinant 11-2 1 ng/ml 0.061 0.056 0.77 0.56 
Tables 3.1 and 3.2 showing the slopes of the exponential part of cell growth for each 
experiment to allow comparison of rates of cell growth. Cell number was plotted versus 
antibody concentration to give values of antibody secretion as .Lg per 10 cells 
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3.3 Discussion 
3.3.1 Previous Studies 
The effects of both conditioned medium and recombinant interleukins on the 
growth and antibody secretion of human-human hybridomas have been 
investigated by several authors. 
James et al [36]investigated  the effects on the growth and antibody secretion of 
Epstein Barr virus (EBV) immortalised human peripheral B-lymphocytes of 
recombinant 11-2, and 11-6 at two concentrations (100 u/mi (0.1 ng/ml) and 1000 u/ 
ml 11-2 (1 ng/ml), and 100 and 200 u/mi 11-6) and cytokine rich supernatants 
prepared by culturing immortalized B-lymphocytes in tissue culture medium 
(Conditioned Medium (CM)). It was shown that low levels of 11-2 enhanced the 
growth of some cell lines, but inhibited the growth of others. 11-6 at high levels 
inhibited the cell growth of some cell lines and low levels had no effect on other 
cell lines used. A number of cell lines were grown in medium which had 
previously been used to culture hybridomas (CM). For some cell lines increased 
growth occurred and in others inhibition of growth occurred. No increase of 
antibody secretion was seen for any of the cell lines at the concentrations of 
interleukin or conditioned medium used. 
McCormack et al also investigated human-human hybridoma growth in the 
presence of recombinant 11-2. Cells were grown in three concentrations of 
recombinant 11-2, 1, 100 and 1000u/ml. Cells were cultured from the stage of the 
initial cell fusion in 1, 100, and 1000 u/mi 11-2. It was shown that hybridomas 
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cultured in 100 and 1000 u/mi 11-2 from fusion produced significantly more 
antibody than those cultured in the presence of 1 ug/mI. Hybridomas not cultured 
in rll-2 immediately after fusion or with 11-2 removed during culture rapidly lost 
the ability to secrete antibody. 
33.2 Stimulation of ES-4 Hybridoma by Conditioned Medium 
As seen in Figures 3.7 and 3.8 and Table 3.1 the addition of 11-6 conditioned 
medium caused an increase in the rate of cell growth and a higher peak cell density. 
Although the rate of cell growth and final cell density was higher in those cultures 
exposed to 11-6 conditioned medium the total antibody secretion and the antibody 
secretion per cell were similar. This suggests that 11-6 conditioned medium 
supports growth but does not increase total antibody secretion. 
Unlike 11-6 conditioned medium, addition of 50% 11-2 conditioned medium to 
batch cultures of hybridoma (Figures 3.9 and 3.10 and Table 3.2) resulted in a 
slightly decreased peak cell density, and the slope of the exponential growth phase 
was similar. Antibody concentrations reached a lower concentration at the end of 
the exponential growth phase and the slope of the line was slightly decreased. The 
inhibition of hybridoma growth by 11-2 could be due to a number of factors which 
may not be related to the presence of 11-2 in the medium. 11-2 and 11-6 conditioned 
media (prepared as described in section 2. 7 ) might be deficient in glucose and 
other nutrients, as cells had been previously cultured in it. Conditioned medium 
may also contain toxic metabolites which have been shown to inhibit hybridoma 
growth (see section 1.5.3 e). As 11-2 CM was used at a higher concentration (50%) 
as the level of 11-2 in the 11-2 CM was lower than the concentration of 11-6 in the 11-
6 CM (5%), the deficiency in nutrients and the levels of toxic metabolites in the 11- 
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2 CM would have a greater effect on the cells. Prior to use, the concentration of 
each interleukin was determined (see section 3.2.2) and the conditioned medium 
was diluted in fresh culture medium for each experiment. 
There may be a number of reasons for the higher cell density and the increase in 
the rate of cell growth in those cultures when 11-6 CM is added. As previously 
mentioned conditioned medium is impure and poorly defined and may contain 
many interleukins. Cytokines in vivo act on B-lymphocytes not as single discrete 
molecules but as a network and exert multiple effects in series with other cytokines 
(as described in section 1. 7). The reason may be that the stimulatory effect of the 
conditioned medium is not due to one cytokine but to two or more acting in 
synergy. 
3.3.3 Effects of Recombinant Cytokines on Hybridomas 
Following on from the experiments using conditioned medium, pure recombinant 
interleukins were tested in batch cultures of hybridoma cells. Serum free medium 
was used to eliminate the effects of undefined growth factors in serum, which may 
interfere with the effects of the cytokines. Recombinant cytokines may improve the 
growth and secretion of antibody of cells cultured in serum free medium. A wide 
variety of concentrations of recombinant interleukins were used, as it has been 
shown that depending on the concentration, the interleukin can inhibit or stimulate 
the cells [36]. The concentrations used were 40, 20, 10, 4, 2, and 1 ng/ml, and each 
experiment was performed at least twice at each of the concentrations. As seen in 
Figures 3.10 to 3.18 and Tables 3.1 and 3.2, no increase in growth or antibody 
secretion was seen for either of the interleukiiis at any of the concentrations tried. 
To test if the presence of two cytokines will stimulate hybndoma cells, both rll-2 
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and rll-6 (at 40ng/ml) were added to batch cultures of hybridomas (see Figures 
3.19 and 3.20). Cell growth was enhanced but antibody secretion was unaffected. 
Previous research has shown an enhancement of B-cell stimulation by 11-6 when 11-
2 is present [85] and this could be the reason for the enhanced growth when both 
cytokines are present. 
One problem could be that the presentation of the interleukins to the cells was 
inappropriate. To determine if addition of 11-6 at the exponential phase of cell 
growth affects the response of the cells to interleukins, 11-6 was added at the middle 
of the exponential phase, as seen in Figures 3.21 and 3.22. Addition of 11-6 in mid-
exponential phase extended the length of cell growth for approximately one day. 
The results which show that the time of addition of 11-6 to the cultures is important 
suggests that 11-6 does play a role in the growth of B-cell hybridomas. However 
these results indicate that the stage of batch growth, and hence the stage of the cell 
cycle are important for 11-6 to be effective on the cells. There could be a number of 
reasons why 11-6 exerts an effect at one stage of growth and not at another. It may 
be that at the start of batch culture when the cells are readying for the onset of cell 
division no 11-6 receptors are expressed, but as the cells proceed through the cell 
cycle these receptors are expressed on the cell surface and can bind 11-6. This cell 
cycle expression has previously been described by several authors (see section 4. 
4). 11-6 is likely to have a short half life in the culture medium, which at the 
temperature used for culture and the presence of many other molecules would 
degrade the activity of 11-6 before it can influence the cells. It may also be that 
although 11-6 receptors are expressed, which can bind 11-6, all the 11-6 added at the 
start of culture is being absorbed immediately, but has no effect, and that as cells 
are only responsive at certain stages of growth. This cell cycle dependant 
stimulation may be an important regulatory feature in the immune response, 
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ensuring that only cells in one phase of growth are responsive to a particular 
cytokine, and those cells that are not in the correct phase of growth internalise the 
cytokines and destroy them, but are not stimulated by them. This could prevent 
constant uncontrolled cell stimulation by a constant presence of an inflammatory 
cytokine. 
Recombinant interleukins were shown in this study to have no effect on the level of 
antibody produced. Both the total antibody concentration at the end of the culture 
time and the antibody production per cell were unchanged. Other authors have 
shown 11-2 to be important for the growth and antibody secretion of human-human 
hybridomas [56], but the hybridomas used were cultured from fusion in 11-2 
containing medium. The work of James et al which is more closely related to the 
present work showed that low levels of 11-2 enhanced growth and high levels 
inhibited it. The concentrations of 11-2 present in 11-2 CM prepared for this work 
are slightly higher than the concentrations of recombinant 11-2 used by James et al, 
but inhibitory effects of 11-2 were not seen. James et al showed that the effect of 
cytokines was cell line dependant. 
The addition of both 11-2 and 11-6 at the start of a batch culture of ES-4 hybridomas 
also caused an increase in cell growth. There could be a number of reasons for the 
stimulatory effect of both cytokine, but not individually. As previously described, 
11-2 has been shown to be required for the stimulation of B-cells by 11-6 [85]. 11-2 
does act on B-cells at a slightly earlier period of B-cell division than 11-6, so it may 
be that 11-2 increases the responsiveness of the cells allowing 11-6 to exert an effect. 
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3. 4 Conclusions 
For the experiments carried out in this area 11-2 and 11-6 were chosen because the 
effects of these cytokines on mature B- lymphocytes, the closest model of a 
hybridoma cell available, are well documented. 11-6 and 11-2 were added to batch 
cultures of a hybridoma cell line to determine the effect on growth or antibody 
secretion. Both 11-2 and 11-6 conditioned media and pure cytokines were used. 
Addition of 11-6 conditioned medium, but not 11-2 conditioned medium, resulted in 
an increase in the rate of cell growth and the peak cell density obtained. All 
concentrations of recombinant interleukins added at the start of batch culture failed 
to increase the rate of cell growth or the peak cell density obtained. When 11-6 was 
added at mid-exponential phase exponential cell growth was extended for a further 
day. 11-2 and 11-6, used in conjunction, also caused an increase in the growth rate 
and peak cell density achieved. Neither 11-2 or 11-6 caused any increase in the level 
of antibody secretion or the final antibody concentration. 
The addition of cytokines which may have provided a means of increasing 
antibody yields and improving the in vitro culture of hybridomas had little or no 
effect on cell growth of ES-4 and no effect on antibody secretion rates. Because of 
the high cost of recombinant interleukins, and the difficulty of preparation of 
conditioned medium, its batch variability and regulatory aspects, the use of 
interleukins to enhance the commercial production of antibody is not 
recommended. Further work could investigate the effects of culturing hybridoma 
cells in the presence of cells that are known to secrete large quantities of cytokines 
such as macrophages, or to continuously add condition medium from a 
macrophage culture to a hybridoma culture as in this work it has been shown that 
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macrophage supernatants enhance cell growth. 
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Chapter 4 
Flow Cytometric Analyses of Hybridoma Cells 
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4. 1 Introduction 
As described in section 1. 10, flow cytometry is widely used in the study of cell 
development and function in a number of fields. Flow cytometry can be used to 
differentiate cells on the basis of cell size, stage of the cell cycle, and, with the use 
of specific fluorescent labelled MAbs, to determine cell surface markers and 
differentiate between cell types. Cells to be analysed by flow cytometry are passed 
in a stream of buffer through a focused laser beam and are detected electronically. 
The angle of light scatter can be used to determine cell size and the presence or 
absence of fluorescence on the cell surface can be used to show the presence or 
absence of a cell surface marker (see section 1. 10). 
Flow cytometry has been used by a number of authors to determine the relationship 
between hybridoma cell growth and physiology, the cell cycle and the secretion of 
antibody. The correlation between cell surface expressed antibody (CSAb) and 
antibody production, the differences in cell size and the transcription of antibody 
has been studied in a number of hybridoma cell lines by different authors and these 
results are described in detail in section 1.10.2. Briefly total antibody secretion 
rates have been correlated with the expression of antibody by Sen et at [80]and  by 
Coco-martin et al [13]. This correlation was not found however by Meilhoc et at 
[57]. Levels of mRNA specific for immunoglobulin were studied by Meilhoc et al 
[57] and Daliui et a! [16] and were shown to be related to antibody secretion. The 
secretion of antibody in various stages of the cell cycle has also been investigated 
using antibody secreting plasmacytomas [26]and  lymphoid cells [10] and it has 
been shown that antibody secretion occurs mainly in the S-phase of cell growth. Al 
Rubeai et al [2] has also shown that antibody secretion occurs in the S-phase of a 
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hybridoma cell culture. Differences in cell size have been used to differentiate 
between live and dead hybridomas by Sen et al [80] and Coco-martin et a! [13]. 
During the maturation of B-cells from the pluripotent stem cell, specific cell-
surface antibody appears prior to stimulation by antigen. Cell surface antibody 
binds antigen and stimulates the cell to secrete antibody. Once the cell has been 
stimulated, antibody is produced and is packaged in the endoplasmic reticulum and 
is transported across the membrane (see section 1.5.3 g). Antibody that is in the 
process of being secreted by the cells might also be detected on the cell surface. It 
is not known if hybridoma cells express antibody on the cell surface as a marker, as 
is the case for unstimulated B-cells, or whether antibody on the surface is in the 
process of being secreted. 
The aim of this series of experiments was to determine the presence of antibody on 
a hybridoma cell surface both by microscopic techniques and by flow cytometry, 
and to correlate this with the amount of antibody secretion and with the stage of the 
cell cycle. The presence of cell surface expressed antibody (CSAb) was compared 
on both producing and non-producing sub-clones (see section 2. 1) to determine if 
CSAb is related to antibody secretion or if it is indicative of overall antibody 
secretion (see section 1.11.3). 
4.2 Detection of Cell Surface Antibody on a Producer and 
a Non-Producer Sub-Clone 
Initially cell surface antibody was detected using horseradish peroxidase (}{RP) 
conjugated antibody and the presence of antibody was detected by the colour 
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change of an HIRP substrate. An indirect staining method was used to increase the 
sensitivity. The primary antibody used was goat anti-mouse 1gM and the secondary 
antibody was HRP conjugated rabbit anti-goat IgG (see section 2. 10). After 
addition of substrate, samples were examined microscopically. Individual cells that 
express CSAb could be detected by the colour change. No antibody was detected 
when the cells were fixed with acetone prior to staining, but when unfixed cells 
were stained the producing cells stained positive for cell surface antibody. 
These results show that the non-producing cells expressed no surface associated 
antibody and that a proportion of the producing cells exhibited cell surface 
antibody. Therefore the presence of antibody on the cell surface is indicative of 
antibody secretion by the cell population, cells which do not secrete antibody do 
not express antibody on their cell surface. 
Further experiments used flow cytometly to determine differences between cells in 
the producing population. Factors such as cell size, stage of the cell cycle and cell 
surface antibody, in relation to the overall secretion of antibody were investigated. 
Antibody producing ES-4 cells were cultured in batch and analysed by flow 
cytometry to determine the range of cell sizes, the proportion of cells exhibiting 
cell surface antibody and the stage of the cell cycle. 
To determine the range of cell sizes present in a culture of ES-4 hybridomas, a 
population of cells was analysed by flow cytometry. The forward angle light 
scatter (FALS) which corresponds to cell size was determined. The number of cells 
(y-axis) were plotted against FALS or cell size (x-axis). These results are shown in 
Figure 4.1. It was found that two subpopulations of the hybridoma, on the basis of 
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cell size, were present. Each population can be separated by placing gates around 
them and can be further analysed for a second parameter such as CSAb or cell 
cycle. The cells can also be sorted into separate populations using the cell sorting 
facility within the flow cytometer (see section 1. 10). 
Figure 4.1 Histogram of ES-4 Hybridoma Showing Two Cell Populations 
A two parameter histogram showing FALS against side scatter showing two distinct cell 
populations. Each population can be separated by gates and sorted 
It is also possible using flow cytometry to determine the level and frequency of 
CSAb amongst individual cells in a mixed population. Cells were grown in batch 
culture and were stained with the same primary antibody as was used in HRP 
staining, with the secondary antibody being substituted by a F1TC conjugated 
antibody, which can be detected by flow cytometry (as described in section 
2.10.2). Individual cells, within a population, which express cell surface antibody 
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could be easily detected and. if desired, isolated. Figure 4.2 shows the proportion 
of cells that stained positive for cell surface antibody (CSAb). The cells to the 
right of the cursor are positive those to the left are negative. The flow cytometer 
was calibrated using cells that were stained in the same way as the normal 
population except that the primary antibody was substituted with an irrelevant 
antibody (goat anti-mouse IgG). This eliminates false positives due to non-specific 
binding of the monoclonal antibody. It was found that 23% of the cells were 
positive for CSAb. 
Figure 4.2 Staining of Cell Surface Antibody of a ES-4 Cells 
A single parameter histogram of green fluorescence on a log scale measuring the total per- 
centage of cells expressing surface antibody. Positive cells are shown to the right of the 
cursor. 
23% of the cells are CSAb. 
page 102 
Flow Cytometric Analyses of Hybridoma Cells 
Using flow cytometry it is also possible to analyse each cell in a population for the 
stage of the cell cycle it is in. Using propidium iodide staining, the DNA in each 
cell can be stained and used to determine the proportion of cells in each stage of the 
cell cycle. The results are analysed using PARA- 1 software and are displayed as a 
histogram (see section 2.10.2). Cells were stained for both CSAb and for stage of 
the cell cycle (see sections 2. 10 and 2. 11) and analysed using the flow cytometer. 
Those cells that were CSAb were isolated by placing gates around them and were 
further analysed for stage of the cell cycle. Figure 4.3 shows the proportion of cells 
in each phase of cell growth for the CSAb population. The x-axis shows cell 
fluorescence, used to determine the stage of the cell cycle, and the y-axis denotes 
the number of cells. The peak on the left Contains those cells in the G011 -phase, the 
peak on the right contains those cells in the G2M phase and the plateau between the 
two peaks contains those cells in S-phase of the cell cycle. The two cursors are 
positioned to show those cells in S+G2M phases of the cell cycle. 
As previously mentioned it is possible to separate the two cell populations, and to 
analyse individually the large and the small cell populations shown in Figure 4.1. 
Figure 4.4 shows the expression of CSAb of the small cells, 46% of which are 
CSAb and Figure 4.6 for the large cells, 12% of which are CSAb. To determine 
if the differences in cell size and cell surface fluorescence were due to the 
differences in phases of the cycle, each cell population was stained with propidium 
iodide and analysed for stage of the cell cycle (as described in section 2. 11). 
Figure 4.5 shows a DNA histogram of the small cells and it was found that only 8% 
were in S+G2M phase. Figure 4.7 shows a DNA histogram of the large cell 
population and these cells were found to be predominantly in the S+G 2M phases of 
growth (72%). 
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Figure 4.3 Cell Cycle Analysis of a Hybridoma Population 
This histogram shows a population of CSAb hvbridoma cells stained with propidium 
iodide and analysed by PARA-1 software. By measuring the uptake of propidium iodide of 
the cells a DNA histogram is obtained. 
34.1% of the cells were in the S+G 2M phases of the cell cycle. 
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Analysis of small cell population, showing the proportion of cells that are CSAb. Iiic 
cells to the right of the cursor are positive. 
The proportion of small cells which are expressing CSAb is 46% 
Figure 4.5 Analysis of Small Cell Population - Cell Cycle 
DNA histogram of small cell population stained with propidium iodide and analysed with 
PARA-1. 
8% of the small cells in S+G 2 I phases of the cell cycle 
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Figure 4.6 Analysis of Large Population - Cell Surface Antibody 
cells to the right of the cursor are positive. 
The proportion of large cells which are expressing CSAb is 12% 
Figure 4.7 Analysis of Large Population - Cell Cycle 
DNA histogram of large cell population stained with propidium iodide and analysed with 
PARA-1. 
72% of the large cells in S+G 2 M phases of the cell cycle 
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From these results it can be concluded that two cell populations are present in the 
batch culture of hybridoma cells. When the populations were compared for cell 
cycle it was shown that the large cells are mainly in the DNA and protein synthesis 
and mitotic phases of cell growth and the small cells are in the G01 1 phase. As the 
cells proceed through the cell cycle they increase in size until just after division. 
The larger cells are those in the mitotic phase, and are in the process of dividing. 
The small cells are those which have just divided and are in a quiescent stage of the 
cell cycle.The expression of cell surface antibody of these cells also differs. The 
proportion of small cells expressing CSAb is almost four times greater than the 
proportion of large cells expressing CSAb. Therefore CSAb is predominantly 
expressed on cells in GO/, phase of the cell cycle. 
As described in section 1. 9 the secretion of antibody is cell cycle dependant in a 
number of antibody secreting cell lines, including hybridoma cells. The results 
obtained here show that the expression of CSAb is also cell cycle dependant. It is 
likely that the expression of antibody on the cell surface is antibody in the process 
of being secreted, not antibody that is present as a cell surface marker, as cells 
which are producing antibody do not express CSAb at all stages of the cell cycle, 
and non-producing cells do not express CSAb. Hybridoma cells do not appear to 
express antibody as a cell surface marker as mature B-cells do, but it is possible 
that CSAb markers cannot be detected by this technique. It can therefore be 
concluded that the expression of CSAb is related to the stage of the cell cycle and 
is not present when the cells are in the process of dividing. 
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4.3 Synchronisation of a Hybridoma Cell Population 
To determine if the expression of antibody on the cell surface, which was shown in 
the previous section to be dependant on the cell cycle, is related to the secretion of 
antibody, attempts were made to synchronise a cell population to obtain a 
homogeneous population, where the majority of the cells are in one phase of the 
cell cycle. Many methods for synchronisation have been described, but one of the 
most widespread is thymidine blocking. Thymidine causes the cells to cease 
division and to accumulate in the S-phase. Thymidine blocking was the first 
method attempted, as described by Al Rubeai et a! [2] for the synchronisation of a 
hybndoma cell line (see section 2.17.1). 
After treatment samples were taken every four hours for twenty four hours and 
counted. Cells were also analysed for stage of the cell cycle by flow cytometxy 
after propidium iodide staining. Thymidine blocking caused a slow but irreversible 
decline in cell number and viability both during and after blocking and the cells 
failed to recover and enter cell division upon release. DNA histograms could not be 
obtained for cells blocked using thymidine which further suggests that serious 
damage had been done to the cells and further division was impossible. Despite 
varying the conditions of the thymidine block, this technique proved unsuccessful. 
and was abandoned. 
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The next method used to obtain a synchronous population was serum starvation. 
Serum is a vital source of growth factors and hormones and its absence may be 
expected to inhibit growth. As DNA and protein synthesis occur mainly during the 
S-phase of the cell cycle, a deficiency of the vital cell metabolites and growth 
factors which are present in serum would be expected to exert the greatest 
inhibition in this phase. Cells were grown from frozen stocks in medium 
containing 5% serum (see section 2. 3) until exponential growth had been reached. 
Cells were then transferred to fresh medium containing 1, 0.1% and 5% FCS, the 
last to act as a control, for 24 hours. After starvation cells were resuspended in 
medium containing 5% serum and cultured. Samples were taken at regular 
intervals and counted and the proportion of cells in each stage of the cell cycle was 
determined. 
This method appeared promising with cells being found mostly in S-phase and the 
cells recovered well from starvation. Further experiments to increase synchrony 
using 0% serum were not as successful in accumulating cells in S-phase. Cells 
were grown in the same way as the previous experiment and analysed both during 
the starvation and once the cells were resuspended in 5% FCS medium. Table 4.1 
shows the results of cells grown in 0% serum which when returned to 5% serum, 
appeared to be mostly in the G0 11 phase, with very few in the G 2M phase, after 24 
hours, which suggests that cells are being halted before division and were more 
synchronous than the control. However after a 24 hour starvation there was a long 
lag phase of approximately 20 hours and the cells gradually became less 
synchronous. An attempt was made to reduce this lag phase by shortening the 
length of starvation to 20 hours and resuspending the cells in medium 
supplemented with 10% serum after starvation. Table 4.2 shows these results and 
again the cells accumulate in with the length of the lag phase being similar. It 
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appears that serum starvation halts the cells in the phase of growth that they are in 
prior to the starvation, preventing them from dividing, and that the cells do not 
remain predominantly in one phase of growth for any significant time, but 
gradually lose any synchrony. 
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Table 4.1 Growth of Hybridoma Cells in both 5% (as a control) and 0% FCS for 24 
Hours in an Attempt to Obtain a Synchronous Population. 
(Not all samples could be determined for both S- phase and G 2M, and in those samples labelled * the anal-
ysis is for S plus G2M only. Viable cell number only is shown) 
Time 5%FCS 0%FCS 
Hours Cell No. GfG1 S G2M Cell No. GO/G1  S G2M 
number % cells % cells % cells number % cells % cells % cells 
of 	cells of 	cells 
X105 x105  
per ml  per ml  
0 1.9 34.1 35.6 30.3 2.1 34.7 65.3* 
4 2.5 27.1 28.0 44.9 2.1 27.0 73.0* 
8 3.0 31.6 33.2 35.2 2.1 29.2 13.5 57.2 
12 3.0 31.7 41.5 26.8 3.0 34.1 35.3 30.6 
16 3.2 30.7 69.3* 2.0 30.9 55.8 13.3 
20 3.1 21.4 78.6* 2.1 37.2 34.6 28.2 
24 3.0 22.6 20.3 57.1 2.0 55.8 35.0 9.2 
Return to 5% 	Serum 
4 2.2 15.1 84.9* 2.1 42.8 17.3 39.9 
8 1.9 29.6 70.4* 1.8 36.9 24.1 38.0 
12 2.5 12.5 87.4* 1.7 40.6 33.5 25.0 
16 4.0 42.7 47.1 FiO.2 2.4 34.5 65.5* 
20 5.1 30.9 69.1* 2.2 33.6 66.4* 
24 4.0 33.5 10.6 53.9 2.1 37.9 62.1* 
48 6.8 40.6 5.5 53.9 4.0 41.2 12.5 1 46.3 
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Table 4.2 Growth of Hybridoma Cells in both 5% (as a control) and 0% FCS for 20 Hours 
in an Attempt to Obtain a Synchronous Population. 
All values are expressed as percentages of the whole population,. 
Time 	 5%FCS 	 0%FCS 
Hours Cell No. G>IG1 	S 	G2M 	Cell No. GO/G1 	S 	G2M 
number % cells % cells % cells number % cells % cells % cells 




per ml per ml 
0 2.1 37 15 48 2.0 41 29 31 
8 1.8 35 22 43 1.4 29 16 56 
20 4.0 31 44 25 1.1 53 20 28 
Return 	to 10% 	Serum 
12 1.6 32 49 20 1.5 30 43 •27 
24 2.1 57 24 19 1.5 41 37 22 
36 2.9 22 37 41 1.5 26 36 38 
48 4.2 28 49 23 3.2 32 49 27 
60 5.6 21 4 76 4.4 28 47 25 
72 6.4 38 18 45 5.2 30 27 44 
The next method tried to obtain a synchronised cell population was the isolation of 
mitotic cells. It has been shown previously that large cells are predominantly in the 
mitotic phase of cell growth (see Figure 4.7) and an attempt was made to isolate 
these cells. Initially density centrifugation was tried but proved unsuccessful and 
cell sorting was used. The large and small cells were separated as described in 
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section 2.17.2 b. Using propidium iodide staining (see section 2. 11), DNA 
histograms were obtained for both the large and the small cells as well as for the 
unsorted population. The proportion of cells in each phase of the cell cycle for the 
control unsorted population is shown in Figure 4.8. Both the left and the right hand 
peaks can be clearly seen, with cells showing a typical DNA histogram with cells 
in all phases of cell growth. When the cells were sorted into large and small cells, 
distinct differences are apparent. Figure 4.9 shows the DNA histogram obtained 
for the small cells. It can be seen that although the left hand peak, which contains 
cells in G011 phase of the cell cycle, and that the plateau, which contains S-phase 
cells are both very similar to the DNA histogram of the control cell population, the 
right hand peak, containing the mitotic or G2M-phase cells is almost completely 
absent. When both Figures 4.8 and 4.9 are compared with Figure 4.10, which 
shows the DNA histogram of the large cells, separated by flow cytometry, it can be 
clearly seen that the left hand peak is almost entirely absent, and the right hand 
peak is greatly increased. Of the control cells 40% are in 02M-phase, of the small 
cells 6.0%, and of large cells over 80%. Using this method a population can 
therefore be obtained of which 83.4% of the cells are in G2M phase, as compared 
with approximately 40.1% of the initial cell population, and this provides a 
synchronous population for further study. 
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Histogram of control cell population stained ith propidiuni odide and analysed b\ 
PARA-1 software. 40.1 Ic of the cells in the S+G2\I phases of the cell cycle. The cursors 
show those cells in S+G2M Phase of the cell cycle. 
Figure 4.9 Isolation of Mitotic Cells by Flow Cvtometrv - Small Cells 
Histogram of small cell popuiation separated b eel! sortne. 	f the ccii in the 
S+G2M phases of the cell cycle between the cursors. 
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Figure 4.10 Isolation of Mitotic Cells by Flow Cytometrv -Large Cells 
D\\ histogram of larac 	p pulanon 	pacU h cell .onir. '- 	 of the celk are in 
S+G-1 phase of the cell cycle between the cursors. 
Once the cells had been sorted, they were resuspended in fresh medium and 
cultured. Samples were taken approximately every 4 hours and counted. A portion 
of each sample was stained for cell surface antibody (see section 2. 10) and fixed 
with 70% alcohol. Samples were stored at 40  C until analysed for cell cycle (see 
section 2. 11). A sample was also taken to determine the secreted antibody 
concentration (see section 2. 5). The results of these experiments are shown in 
Table 4.3. The antibody secretion rate per cell per hour was calculated for each 
sample as follows. The increase in the antibody concentration at each time point 
for each sample was calculated and divided by the cell number. This value, j.tg/ml 
antibody per 10 cells was corrected for time togive an hourly value and was used 
for comparison of antibody secretion rates. These values are shown in Table 4.4. 
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Table 4.5 shows the proportion of cells that are CSAb and in each phase of the 
cell cycle at each time point 
Table 4.3 Cell Growth and Antibody Production of a Synchronised Population 
Cells were sorted by flow cytometry and each subpopulation was cultured and analysed for cell number and antibody 
secretion. Those values marked * show the cell number before and after the cells were subcultured. 
Time Sample SMALL CELLS LARGE CELLS UNSORTED CELLS 




















0 1 7.3 5.1 0.1 2.3 2.2 0.3 2.2 2.2 0.3 
5.5 2 6.0 2.4 0.3 2.1 2.0 0.1 1.9 1.8 0.7 
19.0 3 8.0 2.8 0.9 2.0 1.9 0.8 5.5 4.1/2.0* 0.6 
23.0 4 8.4 2.6 1.4 2.1 2.0 0.6 2.3 2.2 1.7 
27.0 5 9.0 2.8 1.1 4.3 3.9 2.8 2.4 2.2 0.9 
30.0 6 8.4 2.6 1.9 3.8 3.0 2.5 2.2 1.9 3.7 
33.0 7 9.3 2.5 2.8 4.1 2.4 2.9 2.3 1.7 3.2 
38.0 8 9.6 2.3 2.5 5.1 2.2/1.1* 3.4 3.0 2.6 4.7 
43.5 9 8.0 1.4 2.9 2.5 0.7 2.7 2.2 1.3 4.3 
49.0 10 7.2 1.8 2.3 3.6 1.0 2.9 2.2 2.2 3.2 
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Table 4.4 Comparison of Antibody Secretion Rates of a Synchronised Cell Population 
To calculate antibody secretion rates the viable cell number was divided by the total antibody produced in that 
time period. The value was divided by the time to give a value for jig/mi per 10 cells per hour. 
Time Sample SMALL CELLS LARGE CELLS UNSORTED CELLS 
Hours Cell 	No. 





10 cells per 
hour 
Cell 	No. 





i05 cells per 
hour 
Cell 	No. 







0 1 5.1 2.2 2.2 
5.5 2 2.4 0.02 2.0 n/d 1.8 0.03 
19.0 3 2.8 0.02 1.9 0.03 4.1/2.0 n/d 
23.0 4 2.6 0.05 2.0 n/d 2.2 0.10 
27.0 5 2.8 n/d 3.9 0.14 2.2 n/d 
30.0 6 2.6 0.11 3.0 n/d 1.9 0.49 
33.0 7 2.5 0.12 2.4 0.06 1.7 n/d 
38.0 8 2.3 n/d 2.2/1.1* 0.05 2.6 0.12 
43.5 9 1.4 0.05 
11 
0.7 n/d 1.3 n/d 
49.0 10 1.8 n/d 1.0 0.04 2.2 n/d 
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Table 4.5 Cell Surface Antibody and Cell Cycle Analysis of a Synchronised Population 
Cells were cultured as described above and analysed for cell surface antibody and stage of the cell cycle. All values 
are expressed as a percentage of the total. 
Time Sample SMALL CELLS LARGE CELLS UNSORTED CELLS 
Ab 4 S+G2 
M 
G011 Ab S+G2 
M 
G011 Ab S+G2 
M 
G011 
0 1 29 40.0 62.0 26 78.1 21.9 10 20.0 80.0 
5.5 2 36 34.8 65.2 j 46 64.1 35.9 43 17.0 83.0 
19.0 3 60 49.3 50.7 29 60.4 39.6 40 23.3 76.7 
23.0 4 36 53.2 46.8 24 61.0 38.4 21 26.7 73.1 
27.0 5 22 57.8 42.2 19 35.3 64.1 24 45.8 54.1 
30.0 6 29 56.1 43.9 48 46.3 53.7 13 53.8 46.2 
33.0 7 n/d n/d n/d n/d n/d n/d 40 20.0 80.0 
38.0 8 17 56.4 43.6 n/d n/d n/d 38 13.6 86;8 
43.5 9 19 53.8 46.2 n/d n/d n/d 27 48.2 51.9 
49.0 10 21 43.5 56.5 n/d n/d n/d 24 20.8 79.2 
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The expression of CSAb in the unsorted cell population was similar to a typical 
batch culture. Cells initially showed a lag phase of between 16 and 24 hours prior 
to entry to exponential growth. An exponential growth phase of approximately 48 
hours followed the lag phase, after which cells entered a decline phase. Antibody 
secretion rates closely followed growth showing a lag, exponential and a plateau 
phase of antibody production. The cells doubled in the first twenty hours and the 
cell viability was high during the whole culture time. The total antibody 
concentration followed the same pattern to that normally seen in a batch culture (as 
described above). The antibody secretion per cell, rose gradually during the culture 
and was similar to the total antibody secretion rate. Because of some of the 
antibody concentrations being lower than the previous values some of the values of 
antibody secretion per cell could not be calculated. The expression of cell surface 
antibody by the unsorted cells varied from 10% to 43%. The proportion of cells 
expressing CSAb at the start of the culture was 10% but rose to 43% after 5.5 
hours. Why the initial proportion of cells expressing CSAb was only 10% is not 
known, but the value of 43% after 5.5 hours was high compared with the values 
previously found (a value of 23% was previously shown in Figure 4.2). It may be 
that the cells were at the end of exponential growth when the experiment was 
started, as it is known that cells at the end of the exponential phase express low 
levels of CSAb with the decrease in the production and secretion of antibody[80]. 
The rapid rise to 43%, after 5.5 hours, of cells expressing CSAb suggests that the 
cells are readying for cell division, and are manufacturing protein and DNA. The 
antibody concentration at this time did not show that the cells were actively 
secreting antibody, but it may be that antibody is beginning to be secreted as the 
cells enter exponential growth. After this initial rise, the proportion of cells 
expressing CSAb decreased until seven hours after the cells were subcultured (at 
19.0 hours), after which the expression of CSAb rose to 40%, a value just lower 
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than that seen at the start of the culture. The cells appeared to be in lag phase just 
after subculturing although cell division did not occur again. However the 
secretion of antibody increased. The expression of CSAb should increase just 
before antibody secretion increases, but this secretion of antibody may be due to 
the release of stored antibody in the cells, which has previously been shown by a 
number of authors (see section 1.5.3 g). The expression of CSAb did rise to 40% at 
point 7. After reaching 40% the expression of CSAb decreased again which 
suggests that the end of exponential growth was occurring and that the cells have 
entered the decline phase. The cells were not subcultured for a second time and 
nutrient limitation may be the cause of this decline. The cell number also indicated 
that decline had been entered as the cell viability also decreased. The proportion of 
cells in G011 phase also reflected batch characteristics of culture. The high 
proportion of cells in G0 11 at the start of the batch culture again suggested that the 
cells were at the end of exponential growth or had been synchronised by the 
addition of fresh medium, commonly seen in batch culture as growth factors are 
washed out. The proportion of cells in this resting phase gradually decreased, and 
was unaffected by subculturing. The number of cells in G011 rose again as nutrient 
limitation occurred near the end of the culture time, and steadied. 
The small cell population was expected to be less synchronous than the large cell 
population as it will also contain dead cells, which are known to be smaller (see 
section 1.10.2). Culture of the small cell population showed some differences from 
the control cell population. The cell viability was much lower which may be due to 
the presence of cell debris collected during cell sorting which has been included in 
this sample. There was no real increase in cell number during the culture, although 
a slow steady increase in total cell number was seen. The antibody concentration 
did show a steady increase although this may be due to the release of antibody 
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from dead cells. The antibody secretion per cell was fairly uniform, but again was 
not clear due to the absence of some points. The presence of CSAb increased 
slowly, reaching a peak of 60% after 19 hours, and gradually declined, even though 
cell division was not occurring. The proportion of cells in S+G2M phase also rose 
during the entire culture period and reached a plateau after approximately 30 hours. 
It appears that the cells were inhibited in some way either by nutrient limitation or 
by the low viability and stress on the cells caused by sorting, and that at least some 
of the cells were undergoing cell division, but that the rate of cell death exceeded 
the rate of cell growth. 
The large cell population would be expected to be more synchronous than the 
small cell population as the mitotic cells were mainly isolated. When the large cells 
were grown in batch culture they showed a lag phase of approximately 27 hours in 
which nether the total or the viable cell number increased, after which the cell 
number doubled in 3 hours. This rapid cell division strongly suggested that this cell 
population was synchronous. After doubling, the cell viability underwent a slow 
decline from which the cells did not recover, and divide again. There could be a 
number of reasons for this loss of viability, the most likely of which is stress due to 
cell sorting. The small cell population also demonstrated this loss of viability, 
although the control cell population, derived from the same seed culture did not. 
The total antibody concentration also showed this sharp increase after 27 hours, 
after which the antibody concentration did not increase any further. In addition the 
antibody secretion rate per cell followed the same pattern, although, as was the 
case for the other two cell populations, was not clear. The proportion of cells in 
S+G2M phase was 78.1% after cell sorting, compared with 40% for the control cell 
population. This also suggests that this method did provide a synchronous 
population. The proportion of cells in S+G2M phase declined slowly during the 
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culture, only began to rise again after 30 hours. The proportion of cells that were 
CSAb was 26% at the start of the culture, which was higher than at the start of the 
control cell culture. The number of cells expressing CSAb rose rapidly to 43% in 
5.5 hours and declined to 19% by the time that the cells underwent cell division 
and rose after division. Again this suggests that the cells were synchronous. After 
cell division the expression of CSAbrose again. 
4.4 Discussion 
Using flow cytometry it was found that a large and a small population were present 
in a mixed hybridoma population (see Figure 4. 1), and that only the producing 
cells expressed CSAb. When the whole population was stained for expression of 
CSAb, 23% were positive (see Figure 4.2). By placing gates around the two 
populations, the small and the large cells could be isolated and analysed 
individually for CSAb and for stage of the cell cycle (see section 2.10.2). It was 
shown that a higher proportion of the small cells expressed CSAb (46%, see Figure 
4.4) than the large cells (12%, see Figure 4.6). When the two populations were 
analysed for stage of the cell cycle, a higher proportion of the large cells were in 
S+G2M phases of the cell cycle, than the small cells, which were predominantly in 
the Gy  phase of growth (72% and 8% respectively in S-1-G2M phase, see Figures 
4.5 and 4.7). The results presented in this thesis show that the presence (or 
absence) of CSAb indicates antibody secretion, as no CSAb could be detected on 
the non-producing cell line, and it has also been shown that antibody on the cell 
surface is expressed mostly in the Go/i  phase of the cell cycle, and is cell cycle 
associated. As hybridomas only express CSAb at certain times in the cell cycle, 
antibody is unlikely to be present as a cell surface marker, as is the case for mature 
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B-lymphocytes, which are stimulated via cell surface antibody markers to 
differentiate and secrete iinmunoglobulin (see section 1.6.1). The antibody on the 
cell surfaèe is most likely to be immunoglobulin in the process of being secreted as 
it corresponds to periods of the cell cycle when antibody is synthesised and 
secreted. The expression of antibody markers may be at a level that is not 
detectable by the staining technique or may also be cell cycle associated or is a cell 
surface marker that is cell cycle associated. 
A number of previous studies have also determined cell cycle associated synthesis 
and secretion of antibody. The synthesis and secretion of antibody by 
plasmacytomas, lymphoid cell lines, haematopoetic cells and hybridomas is known 
to be regulated with respect to the cell cycle. Buell and Fahey [10] found that the 
synthesis and secretion of antibody from a lymphoid cell population, synchronised 
by thymidine/colcemid blocking was greatest during late G 1 and early 5- phases, 
with very small amounts of immunoglobulin being secreted before, during or after 
mitosis. It has also been shown by Garatun-Tjeldso et al [26] that the secretion of 
immunoglobulin light chains by plasmacytoma cells, synchronised by isoleucine 
deprivation, primarily occurs during late G 1/early S phase. During late S, 02  and 
M phases much lower levels of protein were secreted. Cells, which had undergone 
cell division and had just entered 01  phase, immediately began to synthesise light 
chain immunoglobulin, although this was not immediately secreted. The synthesis 
and secretion of antibody by a synchronised human haematopoietic cell line was 
also shown to occur in the late G and early S-phase [88]. Using a hybridoma 
population, synchronised by thymidine blocking, Al Rubeal et al [2] found that 
hybridoma cells synthesise and secrete the majority of antibody at late G 1/early S-
phase. An unsynchronous hybridoma cell population was also found to synthesise 
and secrete antibody at late G 1/early S phases, and by extending the length of the 
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01 phase of a hybridoma cell, by growing it in low lipid medium, it was 
determined that the specific monoclonal antibody production rate could be 
increased, further suggesting that antibody is synthesised in 01  phase [77]. It has 
been further shown that the transition of cells from resting Go to active 01  phase of 
the cell cycle is associated with the synthesis of the majority of cellular antibody in 
synchronised lymphocytes [52]. Flow cytometric analysis of an unsynchronous 
hybridoma cell population by Borth et al [8] again showed that the secretion of 
antibody occurs mainly in the G 1 phase of the cell cycle. Kromenaker et al [40] 
used flow cytometry to analyse the intracellular accumulation of antibody by a 
hybndoma cell grown in batch culture. It was found that during G phase of cell 
growth, the rate of accumulation of antibody was higher than during S and M 
phases. This suggests that during 01  phase antibody is synthesised, not all of which 
is secreted. During S and M phases the level of antibody synthesis decreases, but 
low levels continue to be secreted. 
The expression of cell surface markers during the cell cycle has been studied by 
several authors. It has been shown that T-lymphocytes and B-cell hybridomas 
express cell surface markers, which are cell cycle dependant [21, 27, 87]. Studies 
by Ernst et al [21] on a synchronous hybridoma population found that the 
expression of a membrane bound activation antigen occurs predominantly in the 
01 phase of the cell cycle and decreases through S and G2M phases, increasing 
again after cell division. 
As described above it has been shown repeatedly that antibody is synthesised and 
secreted by a variety of cells during late 01 and early S-phase. The technique used 
for determination of the stage of the cell surface did not differentiate between G0 
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and G 1 phases of growth. The results presented here indicate that the expression of 
cell surface antibody by ES-4 hybridomas is also cell cycle associated and is 
primarily expressed in the Go/i  phase. If it is assumed that antibody on the cell 
surface is antibody in the process of being secreted (as discussed earlier) then ES-4 
hybridomas also secrete antibody in the G1 phase of cell growth. Cell cycle 
associated membrane expression of markers has also been previously described for 
a number of cell lines and again these results confirm this. It was also found that 
cells which have lost the capacity to synthesise antibody do not express cell surface 
antibody at any stage of the cell cycle on the cell surface and this also is in 
agreement with previous studies, which are discussed below. 
Culture of the unsorted, asynchronous ES-4 cells found that the expression of 
CSAb closely followed the pattern of cell growth. From a low point of 10% of cells 
expressing CSAb at the start of the culture, the expression of CSAb increased 
during the first 5.5 hours of the culture after which it began to decrease. The 
proportion of cells expressing CSAb increased initially as cells entered the 
exponential phase of cell growth and decreased during exponential growth until the 
cells were subcultured, when the expression of CSAb rose again. A partial 
synchronisation of the cells appears to be occurring when the cells were inoculated 
at the start of the batch culture and ready for the onset of rapid cell division. Once 
cells began to divide rapidly when they entered exponential phase CSAb 
expression drops. CSAb could be detected on the surface of some of the cells at the 
start of the culture, before secreted antibody could be detected, which also suggests 
that antibody is expressed on the cell surface prior to antibody secretion. The 
proportion of cells in Go/i  also reflected batch culture, falling during the 
exponential phase and rising at the end of the culture as the cells entered decline 
phase. The proportion of cells in S+G2M rose during exponential growth and fell 
page 125 
Flow Cytometric Analyses of Hybridoma Cells 
as the onset of cell death occurred. 
To determine if the expression of antibody on the cell surface was related to 
antibody secretion and to stage of the cell cycle, experiments were also carried out 
on a synchronous population. Attempts to obtain a synchronous population by 
chemical means, such as thymidine blocking or serum starvation (as described 
above), proved unsuccessful and a method was developed by which a synchronous 
population could be obtained using the cell sorting facility of a flow cytometry (see 
section 2.10.2). By isolating the large cells, more than 80% of the cells were in 
S+G2M phase and it was assumed that a synchronous population had been 
obtained (see Figure 4.10). Several previous studies have also shown that mitotic 
cells are larger than cells in S and G 1 phases. Ramirez et al [74] found that mean 
cell volume (cell size) measured using a coulter counter was greater for mitotic 
cells, and that cell size, and hence the proportion of cells in each phase of cell 
growth, varied during batch cultivation, with the proportion of G1 cells falling 
during exponential growth and rising at the onset of cell death. Cell cycle 
dependent size variation has also been shown by Coco-Martin et a! [13] and is 
discussed below. 
The large cells, mainly in the mitotic phase of cell growth, were isolated by flow 
cytometry (as described in section 2.17.2 b) and batch cultured. Cells were shown 
to be synchronous by the following. The cells all doubled in a three hour period, 
and the proportion of cells in S+0 2M was high initially. The results from the 
asynchronous (control) culture had shown that the proportion of cells expressing 
CSAb was related to the proportion of cells in each stage of batch culture and the 
cell cycle. In the synchronous population the expression of CSAb was at its highest 
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as the proportion of cells in S+G2M was high but was beginning to decrease. This 
suggests that the expression of antibody on the cell surface is at its greatest just 
after the cells have divided and have entered G0 11 phase. Cells which were in Go/I 
phase of the cell cycle, but were beginning to enter S+G 2M expressed very little 
CSAb. The expression of CSAb in the synchronous population also followed the 
growth of cells in batch culture. CSAb was expressed prior to antibody secretion 
from the cell. The onset of antibody secretion is proceeded by the expression of 
cell surface antibody and is lowest during cell division. It appears that just after the 
cells have divided and are in G011 phase antibody is synthesised and secreted. 
As described in section 1. 10, flow cytometry has been widely applied to study the 
cellular physiology of antibody secreting cell lines including the variations of 
antibody secretion, expression of cell surface expressed and cytoplasmic protein, 
the stages of the cell cycle and the mechanism of antibody synthesis and secretion 
in batch cultivation. Coco-Martin et al [13] studied hybridoma cells in batch 
culture, and used flow cytometry to determine the levels of membrane bound and 
cytoplasmic irnmunoglobulin, and the stage of the cell cycle. It was found that 
during cell culture the relative size of the cells increased as the cells entered 
exponential growth, and it was shown that this was due to a higher proportion of 
the cells in the mitotic phase of cell growth (as discussed above). Cell size in 
conjunction with DNA content (by bromodeoxyuridine staining) was used to 
determine the stage of the cell cycle. It was found that the proportion of cells in S-
phases increased during exponential growth, with the proportion of cells in G 1 
decreasing. Upon entry to decline phase the proportion of cells in G 1 phase 
increased, with a corresponding decrease in S-phase cells. The proportion of cells 
expressing CSAb also rose as cells entered exponential growth and decreased 
sharply just prior to the onset of cell death, with the antibody secretion declining. 
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The cytoplasmic IgG content also rose during exponential phase and declined after 
the onset of cell death. A correlation between antibody secretion and mean surface 
fluorescence, and between antibody secretion and cytoplasmic IgG content was not 
shown. 
Sen et al [80], also used flow cytometry to analyse the expression of CSAb and to 
determine if there was a correlation between mean surface fluorescence and 
antibody secretion. The expression of surface fluorescence (CSAb) was shown to 
be dependant on antibody secretion, and non-producing cells did not express 
CSAb. The higher the secretion of antibody, the higher the mean surface 
fluorescence i.e. a linear correlation between mean surface fluorescence and 
antibody secretion existed for the hybridoma used in this study. No studies were 
carried out on the relationship between CSAb and cell cycle. 
A correlation between mean surface fluorescence and total cell associated antibody 
was shown by Meilhoc et al [57], but a correlation between specific secretion rate 
and mean surface fluorescence was not found. Using flow cytometric analysis, it 
was found that mean surface fluorescence rose at the onset of exponential growth 
and declined slowly during the exponential phase, until the onset of cell death, 
when it fell sharply. It was also found from mass balance experiments that not all 
the antibody that was synthesised was secreted, and that the specific antibody 
secretion rate did not vary significantly during batch culture. Investigation of IgG 
production rates of a hybridoma cell cultivated in batch by Leno et al [5 11 found a 
correlation between cytoplasmic IgG and mean surface fluorescence. This 
correlation was found also by Meilhoc et al [57]. The expression of cell surface 
antibody decreased as batch culture progressed, as did cytoplasmic antibody. 
page 128 
Flow Cytometric Analyses of Hybridoma Cells 
As described above the expression of cell surface antibody is related to the stage of 
the cell cycle and to batch culture. The expression of CSAb is highest upon entry of 
the cells into exponential growth, and declines as cells proceed through 
exponential growth. Culture of an unsynchronous population of ES-4 hybridomas 
also found a rapid initial rise in the expression of CSAb followed by a slow 
decline, until the cells were subcultured again, when the rapid initial rise, followed 
by a slow decline was seen again. The proportion of cells in S+G 2M phase also 
rose during exponential growth and declined just prior to subculturing. This 
confirms what would be expected, the most active cells, those at the start of 
exponential growth, synthesizing the most antibody and expressing it on the cell 
surface, and as the culture progresses and the cells become increasingly nutrient 
limited, the rate of cell division decreasing, antibody secretion also decreasing and 
the expression of CSAb falling. It has been shown that antibody synthesis and 
secretion is dependent on cell division, so that the faster the specific growth rate 
the higher the production of antibody [2]. Attempts to halt cell division and to 
maintain cells in one phase of growth by chemical means have been unsuccessful 
(see section 1.9.1), but growth of cells in low lipid media (as described in this 
section), slowing the rate of cell division has been partially successful [77]. 
The method which was used to obtain a synchronous population proved successful, 
and as it is a non-chemical method, it is less likely to physiologically stress the 
cells and interfere with results. Chemical methods may cause changes in the cells 
which may result in false or unrepresentative results. This method may be useful 
for the isolation of the most active cells in a population, for the isolation of the 
highest secreting cells, or the removal of non-viable cells. Cell sorting did appear 
to stress the cells, as those cells that had been sorted did lose cell viability fairly 
quickly after sorting. It may, however, be possible to improve the method of 
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sorting to reduce the stress on the cells. 
Cells that had been cell sorted expressed CSAb in relation to the cell cycle, but the 
proportion of cells expressing CSAb was higher than in the control population 
(23% for the large cells and 10 076 for the small cells). The expression of CSAb by 
the large cells was higher than for the control cells, which does not fit with 
previous results, may be due to the presence of early S-phase cells that are still 
synthesising antibody or slightly later S-phase cells that have ceased antibody 
production, but are still secreting antibody, which can be detected on the cell 
surface. Cells shortly after sorting and inoculation into batch growth (5.5 hours) 
expressed more CSAb, although cell division was not seen (by total and viable cell 
counts). This increase in the expression of CSAb it would be expected to 
correspond to cell division, and a rise in cell number. In fact the cell number did 
not double until 27 hours after cell sorting. It may be that the cells have been 
influenced in some way by cell sorting which prevents cell division but not 
antibody synthesis. The level of secreted antibody in the medium did not indicate 
that antibody secretion was occurring. The proportion of cells in G01 1 phase did 
begin to increase at this time, which may account for the rise in CSAb expression. 
The proportion of cells in G011 phase of the cell cycle increased slowly during the 
first 23 hours and increased sharply to reach a peak of 64.1% in 3 hours at the time 
of cell division. If the cells were truly synchronous, the proportion of cells in G011 
at cell division would be roughly equal to the proportion of cells in S+G2M phase 
at the start of the culture (78.1%). The fact that the proportion of cells in G011 is 
lower suggests that the cells are gradually losing synchrony or that at this time 
point not all the cells had undergone cell division. The results from the 
synchronous population closely follow those from the unsynchronous (control) 
population. Expression of cell surface antibody is greatest at the start of 
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exponential growth, the proportion of cells in Go/i  rises through the culture until 
cells have divided and then begins to fall (although because of only one time point 
after division this is not absolute). CSAb is expressed after cell division and very 
little is expressed as cells divide. Antibody secretion also rose sharply at the time 
of cell division, and the relative proportions of G011 and S+G2M cells suggests that 
in the four hours since the last sample the cells had divided but at the sample time 
obtained the cells appear to have divided some time previous to sampling as 
antibody had been produced. Using a synchronous population it was possible to 
determine the relationships between cell growth and cycle and the expression of 
CSAb. The results of both cultures were similar but the results from the 
synchronous population are likely to be more accurate as variability in the 
population will not affect the results. 
4. 5 Conclusions 
Using flow cytometry it was possible to investigate the relationships between the 
expression of CSAb, the cell cycle and antibody secretion. It was shown that 
antibody expressed on the cell surface is indicative of antibody secretion. It was 
also shown that the expression of antibody is related to the stage of the cell cycle. 
A method was developed by which cells could be synchronised, using the cell 
sorting facility of a flow cytometer. This method of cell synchronisation may be 
extremely useful for the isolation of the most active cells in a population and those 
that secrete the greatest level of antibody, resulting in the ability to secrete more 
antibody. Flow cytometric analysis also showed that the expression of antibody on 
the surface is. useful for monitoring antibody production. The onset of nutrient 
limitation and cell death in batch culture was shown by a decrease in the 
expression of CSAb and an increase in the proportion of cells in GO/, phase, further 
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work could use the expression of CSAb and the stage of the cell cycle to monitor 
hybridoma cultures and to initiate nutrient or growth factor additions that will 
extend cell growth and optimise, antibody production. 
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Chapter 5 
Metabolic Studies of a Hybridoma 
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5. 1 Introduction 
All cells, be they bacterial or animal metabolise nutrients to provide energy for a 
number of cellular processes. The energy can be used for growth or production of 
protein, or as a source of cell carbon or in the maintenance of the cell. A cell that 
is neither dividing nor secreting protein will still need energy for the repair of 
structural damage and for active transport. Most organisms preferentially 
metabolise the available nutrients and often have a limiting nutrient, the 
availability of which determines the rate of growth. 
Hybridoma cells have a complex metabolism and often having no true limiting 
nutrient, but preferentially use the available nutrients, being reliant on a number of 
nutrents. However, a principal or pseudo- limiting nutrient is often found, which 
can be either glucose, glutamine serum, an amino acid or oxygen. The limiting 
nutrient of hybridoma cells has been identified for a number of different cell lines. 
In sections 5. 3 and 5. 4, an attempt will made to determine the limiting nutrient of 
the ES-4 hybridoma by culturing cells in both batch and continuous culture. 
Hybridoma cell metabolism is discussed in more detail in section 1.5.2. 
Commercially the most important feature of a hybridoma is the production of 
antibody, and a number of attempts have been made to improve the levels of 
secreted protein by increasing the concentration of nutrients in the medium. 
Attempts to increase the level of antibody secretion per cell by increasing the 
concentration of important nutrients are often unsuccessful. The concentration of 
secreted protein can be increased by extending the exponential phase of cell 
growth, by fed-batch or continuous culture. It has been shown by a number of 
authors that hybridoma cells can modify their metabolism in relation to the 
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concentration of the limiting nutrient. At limiting nutrient concentrations, 
hybridoma cells have been shown to optimise their metabolism by reducing the 
level of intermediate metabolites, such as lactate, produced (see section 1.5.3). At 
high nutrient concentrations production of toxic metabolites, such as lactate and 
ammonia, is often higher and cell growth can be inhibited by these metabolites. 
It has been shown that B-lymphocytes can devote as much as 50% of their 
available energy to antibody production [38], and by studying the metabolism of 
two related hybridomas, one an antibody producing cell, the other a non-producing 
sub-clone it may be possible to determine the amount of energy devoted to 
maintenance of the cell and the growth yield on the limiting substrate, to show the 
differences between a producing and a non-producing cell line, differences which 
may be attributable to antibody production. 
The experimental aim of this section was to determine values of growth yield and 
maintenance energy of two related subclones of the hybridoma ES-4, one of which 
produces and secretes antibody, and one which does not (see section 2. 1), and to 
examine differences that may be attributable to antibody production. In section 5. 2 
equations are derived which were used to determine the maintenance energy and 
growth yield of cells grown in continuous culture in a chemostat. These 
experiments are based on the limiting nutrient, so prior to calculation of metabolic 
parameters the limiting nutrient was determined. 
Cells were grown in both batch and continuous culture to determine the limiting 
nutrient. In batch mode it is possible to determine which nutrient is limiting, as the 
depletion of this nutrient should correspond to the onset of cell death. The growth 
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of both producing and non-producing ES-4 hybndomas in batch culture are shown 
in section 5. 3. Hybridoma cells were also grown in continuous culture to 
determine the limiting nutrient. Cells were initially grown at approximately half of 
the maximal flow rate. Once steady state had been reached, each cell line was 
pulsed with glucose, glutamine and FCS. The concentration of each nutrient was 
doubled sequentially at each pulse. The results of the nutrient pulsing of ES-4 
hybridomas in continuous culture are shown in section 5. 4 
Once the limiting nutrient was determined the maintenance coefficient was 
determined using equation 18. The method used was growing the hybridoma cell 
line in a chemostat at a variety of specific growth rates, and calculating the 
metabolic quotient for a particular nutrient at each growth rate, from which the 
maintenance coefficient and the growth yield were determined. Cells were grown 
at steady state at a number of dilution rates in a chemostat, and the metabolic 
quotient calculated for each steady state. The specific growth rate i was plotted 
against the metabolic quotient of the limiting substrate (q), to calculate the 
maintenance coefficient. The results of the growth of both producing and non-
producing hybridomas in continuous culture at varying dilution rates is shown in 
section 5. 5. The aim of this series of experiments are described in more detail in 
section 1. 11.2 
5.2 Calculation of Maintenance Energy 
The parameters 'growth yield' and 'maintenance energy' (relative to a particular 
substrate) have been determined for many prokaryotic organisms. In this work it 
was intended to extend these concepts to eukaryotes and to determine 
experimentally values of maintenance energy and growth yield for hybridoma 
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cells. In this way it was hoped by comparison of antibody producing (producers) 
and non-producing (non-producers) strains to identify the metabolic load of 
antibody production. 
In unsteady-state cell growth (batch fermentation), the total yield of biomass (Y E) 
on the consumption of an energy-producing substrate S is defined as the ratio of 




The energy producing substrate consumed can be considered in two parts. 
As = ASG+AS M 
where ASG is the substrate per unit volume consumed for cell growth and AS M the 





= AS G +AS M 
or 
1 	AS 	As 	1 	As  4. 	 - = 	+ = + 
Where YEG  is the yield of cells on the energy containing substrate consumed in 
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growth. 
A frequent assumption is that AS M is directly related to the existing total cell 
number per unit volume, x, and the time interval At: 
ASM = mxAt 
where m is equal to the maintenance coefficient. Therefore 
6. 
1 	1 	mxAt 
—=---+ 
' E 	EG 	LS.x 
If the cells are in the exponential phase of cell growth it follows that 
dx AX - - = ax 
dt At 





' E 	EG 




It is in fact difficult to extract values of YE and g from the record of a batch 
fermentation, so experiments are usually carried out in continuous culture in 
chemostat bioreactors operating at steady state. 
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Figure 5.1 Relationships in a Simple Chemostat 
F 
Figure 5. ishows a chemostat of volume V, fed with a volume flow rate F of sterile 
feed at substrate concentration S0. The product stream also has a volume flow rate 
F; the cell concentration is x and the substrate concentration is reduced to S. 
Because the chemostat is adequately mixed, these last two figures are also 
characteristic of conditions within the chemostat. At steady state cell growth will 
be controlled by the concentration of the limiting nutrient, which is supplied to the 
reactor via the feed. 
A balance of numbers gives 
91 
	
Cells Produced =Fx 
10. 	 =Vjtx (exponential growth) 
so 
F 
- = D the - dilution rate 
page 139 
Metabolic Studies of a Hybridoma 
In this way once a constant biomass concentration x is achieved, the value of p. can 
be calculated by equating it to the dilution rate D=F/V. 
The total yield of biomass on energy producing substrate consumed is give by 
Fx 	x 
Y = F(S 0 —S ) - s 0 —s 
if results are taken at several different dilution rates, and hence several different 
growth rates, the results can be plotted out exactly as are batchwise results, 
1  









(existing biomass x time) 	E 
 
(new biomass produced ) / (unit existing biomass) x time 
(new biomass produced) / (unit energy source consumed) 
=-- 
multiplying 8 by p. gives 
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so a graph of qE versus t will have a slope of 	and an intercept of m 
EG 
qE is calculated by 
 
F (S o  —S) 	D (S o  —S) = 
Vx 	 x 
5. 3 Growth of ES-4 Hybridomas in Batch Culture 
5.3.1 Introduction 
Cells grown in batch culture will grow to a maximal cell density until one or more 
nutrients in the medium become depleted, or toxic products accumulate and limit 
growth. As previously described (see section 1.5.3) hybridoma cells are multi 
growth factor dependent and are often reliant on more than one nutrient, and 
cannot be grown in medium with a single carbon substrate. However a principle or 
pseudo-limiting nutrient is often found and this can be used in the calculations of 
maintenance energy. In batch culture the depletion of the primary or limiting 
nutrient may result in the onset of cell death. 
5.3.2 Results 
Both antibody producing and non-producing hybridomas were grown in 10 cm 3 
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tissue culture flasks. Cell number, metabolite and antibody concentrations were 
determined daily during the period of culture. The results of batch culture of ES-4 
hybridomas are shown in Figures 5.2 to5.6 and Tables 5.1 and 5.2 and are 
discussed in section 5.3.3. 
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0.0 0.7 11.1 2.0 0.0 1.0 
22.0 0.6 8.9 1.1 0.9 2.4 
46.0 1.3 7.8 1.6 2.8 1.9 
70.0 3.2 6.7 1.2 3.1 2.3 
94.5 5.5 4.4 0.6 9.2 2.9 
125.0 7.0 0.6 0.1 12.0 3.4 
144.5 3.8 0.0 0.0 11.8 3.7 
Table 5.1 showing the growth and metabolite concentrations of producing ES-4 hybrido-
mas grown in serum supplemented medium in batch mode. 













0.0 0.7 11.1 2.0 0 1.0 
22.0 0.9 8.9 1.2 1.8 1.9 
46.0 3.1 7.2 0.9 5.2 2.2 
70.0 6.4 2.8 1.5 10.9 1.6 
94.5 8.2 0.0 1.0 12.7 2.1 
125.0 6.0 0.0 0.7 12.5 2.4 
144.5 3.9 0.0 0.0 12.2 4.1 
Table 5.2 showing the growth and metabolite concentrations of non-producing ES-4 hybri-
domas grown in serum supplemented medium in batch mode. 
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5.3.3 Discussion of Batch Culture 
As shown in Figure 5.2 antibody producing hybridomas grow to a slightly lower 
peak cell density than for non-producing hybridomas. It may be assumed therefore 
that the difference in the rate of cell growth and the lower density reached is due to 
the lack of antibody secretion in the non-producing cell. Figure 5.3 shows that the 
concentration of glucose at the onset of cell death for the producing cells was 
0.6mM, approximately 6% of the glucose supplied at the start of batch culture. For 
the non-producing cells all glucose had been taken up by the cells when maximal 
cell density had been reached. Figure 5.4 shows that the producing cell culture had 
0.1 mM of glutamine unused at the onset of cell death which corresponds to 5% of 
glutamine initially supplied. Glutamine was completely depleted during the decline 
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phase. The utilisation of glutamine by non-producing cells was slightly less than 
for producing hybridomas, 1mM remaining at the onset of cell death, which 
corresponds to 50% of that supplied, but again was completely depleted during 
decline phase. The final concentrations of ammonia and lactate were similar in 
both cultures. 
In batch culture it was not possible to determine which nutrient was the principal 
source of cellular energy from these batch cultures, but the greater utilisation of 
glucose and the onset of cell death at low glucose concentrations may suggest that 
glucose is the primary energy source. Further experiments to determine the 
limiting nutrient were carried out in a chemostat, and are shown in section 5. 4. 
5.4 Nutrient Pulsing of Hybridoma Cells in Continuous 
Culture 
5.4.1 Introduction 
In a further attempt to identify the limiting nutrient cells were grown in continuous 
culture at half maximum flow rate using the method described in section 2. 9. Cells 
were pulsed with glucose, glutamine and FCS sequentially. Nutrient pulsing has 
previously been used by other authors to determine the limiting nutrient in 
continuous culture [22]. Experiments carried out in continuous culture enable 
determination of the limiting nutrient to be made with greater certainty, as the 
growth rate of cells at steady state in a chemostat is controlled by the availability of 
the limiting nutrient, which is supplied in the feed. Any increase in the limiting 
nutrient concentration should result in an increase in the rate of cell growth and the 
cell number should rise. It may also be possible that the cell growth is limited by a 
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toxic metabolite such as animoniia or lactate. The cells may also be oxygen 
limited. In the medium used in these experiments the concentration of glucose 
present was far greater than glutamine (11.1mM, 2mM respectively) which may 
also affect nutrient limitation. However as both glucose and glutamine are vital for 
cell growth a deficiency in one, even from a low starting concentration, may result 
in nutrient imitation. 
Cells were grown at maximal flow rates in a chemostat at steady state. The flow 
rate was cut by approximately half and cells were again allowed to reach steady 
state. Cells at half maximal flow rates would be expected to be nutrient limited so 
that an increase in the limiting nutrient should result in an increase in the rate of 
cell growth. 
5.4.2 Results 
Once cells had reached steady state at half maximal flow rate, the concentration of 
glutamine in the feed was increased from 2mM to 4mM. In the case of the 
producing cell chemostat glutaniine was further increased to 6mM. After 
approximately 200 hours the concentration of glutamine in the feed was returned to 
2mM, and cells were allowed to reach steady state. After glutamine pulsing, and 
once the cells had again reached steady state, the concentration of glucose was 
increased from 11.1mM to 2 1. 1 mM and the cells grown at this concentration for 
approximately 100 hours. In the same way the concentration of FCS was increased 
from 5% to 10%, again after cells had reached steady state. Results for the non-
producing cell line are shown in Figures 5.7 to 5.9 and in Table 5.7. The results for 
the producing cell line are shown in Figures5.10 to5.12 and Table5.8. Each steady 
state and nutrient pulse is identified by vertical lines labelled with the treatment 
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showing at which points the cells were pulsed. The results for both cell lines are 
discussed in section 5.4.3. 
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Figure 5.7 Non-Producing Hybridomas Cell No. and Dilution Rate 
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5.4.3 Determination of Limiting Nutrient in Continuous Culture 
The concentrations of each nutrient at maximal flow rates for non-producing cells 
at steady state were found to be 6.6 mM glucose, 66% of that in the feed, and 0.7 
mM glutaniine, 38% of that found in the feed, and for the producing cells 7.0 MM 
glucose, 63% of the feed concentration, and 0.7 mM glutamine, 38% of the feed 
concentration. For half maximal flow rates the figures were 3.9 MM glucose, 35% 
of the feed concentration, and 0.3 mM glutamine, 15% of the feed concentration, 
for the non-producing cells. For the producing cells the concentrations at half 
maximal flow rate were 5.6mM glucose, 50% of the feed concentration and 0.5mM 
glutamine, 25% of the concentration found in the medium. The lower 
concentration of glutaniine and the high concentration of glucose remaining at both 
flow rates may indicate that glutamine is the limiting nutrient in chemostat culture. 
Increasing the concentration of glutamine in the feed from 2mM to 4mM as shown 
in Figures 5.7 and 5.10 shows that for both cell lines an increase in the glutamine 
concentration caused a rapid increase in cell number. At the same time ammonia 
concentrations increased rapidly in both cultures. The increase in cell number only 
occurred during the first 24 hours of the pulse after which the cell number of both 
cells decreased to a lower density than that seen before the cells were pulsed with 
glutamine. After this initial rise and decline the non-producing cell numbers again 
increased and steadied at a slightly higher level than that found prior to pulsing, 
and remained at this level until the concentration of glutamine in the feed was 
returned to 2mM, at which point the cell number dropped rapidly and again 
steadied. About 24 hours after the producing cells were pulsed with glutamine, the 
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cell number steadied at a slightly lower concentration than that seen prior to 
pulsing. The concentration of glutamine in the feed medium was increased to 6mM 
in the producing cell chemostat only, and again cell numbers rose and declined as 
seen when glutaniine was increased to 4mM. Neither glucose or serum pulsing 
caused an increase in the rate of cell growth and the utilisation of glucose did not 
significantly increase. 
These results suggests that glutarnine is the limiting nutrient in chemostat culture, 
but some other factor inhibits cell growth, and this factor becomes important 
approximately 24 hours after pulsing. The concentration of ammonia in the 
cultures rises rapidly after pulsing as glutamine is converted to glutamate and 
ammonia (see section 1.5.3 e) and it may be that ammonia inhibition is occurring. 
Even after the glutaniine concentration was returned to 2mM, the producing cell 
number continued to decline, reaching a cell density of approximately 2.5 x 10 
cells per ml, after which the cell number gradually recovered to reach a cell density 
of 5 x 105 some 350 hours later, which was similar to the cell density prior to 
pulsing,. This suggests that a metabolic by-product, likely to be ammonia, is 
causing cell inhibition, and is gradually washed out, long after it had been removed 
from the chemostat. The inhibition of ES-4 hybridomas by ammonia has been 
demonstrated by Wilson [99] who showed that concentrations of 3mM and above 
strongly inhibit ES-4 hybridoma cell growth. The concentration of ammonia in the 
chemostats 24 hours after glutamine pulsing was 3.3 mM for the non-producing 
line and 2.3 mM for the producing cells, but the concentration of ammonia did 
reach almost 3.5mM in the producing cell chemostat just prior to the decline in the 
cell numbers. It is probable therefore that the inhibition of cell growth is due to 
ammonia. Even if the cell line used preferentially metabolises glucose, the low 
starting concentration of glutamine, and the fact that glutamine is vital for 
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hybridoma cell growth may result in the cells being glutamine limited. From these 
results it was assumed from that in these chemostat cultures glutamine is the 
limiting nutrient of ES-4 hybridomas. A better indication of nutrient limiitation 
may have been obtained by modifying the starting concentrations of glucose and 
glutamine in the feed. The concentrations of both glucose and glutamine in both 
continuous and batch cultures containing the usual concentrations of metabolites 
also show that the proportion of glutamine is lower than the proportion of glucose 
and may again suggests that glutaniine is the limiting nutrient for cell growth. The 
following section, will calculate the maintenance coefficient of the producer and 
the non-producer, using glutamine as the limiting nutrient. 
To obtain an indication of the metabolic load which antibody synthesis places on 
cells, the proportion of antibody secreted in relation to the mass of cells produced 
at each round of cell division was calculated. The dry weight of the hybridoma cell 
used in this study was estimated using previously published studies, which have 
determined the dry weight of a number of cell types including hybridomas. It was 
assumed that the hybridoma used in this study has a similiar mass as other 
hybridoma cells. It has been shown that the volume of hybridoma cells varies both 
during the stages of the cell cycle, during the course of batch culture, and at 
varying dilution rates in continuous culture. It has also been found that the dry 
weight of cells also varies, increasing during mid exponential growth of batch 
culture and at high dilution rates in contiinuous culture [22]. The calculaton of 
antibody secretion per cell mass was calculated by dividing the antibody secretion 
rate at maximum dilution rate in continuous culture by the mass of new cellular 
material produced. The value of dry weight used was that calculated for hybrdoma 
cells grown at high dilution rates in continuous culture by Frame et al, who 
determined a value of 0.36mg/10 6 cells. The antibody secretion rate of ES-4 
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hybridomas at high dilution rate in continuous culture (from Table 5.6) was 
calculated as being 7.8 j.tg per 10 5 cells per hour or 189.5 p.g per 105 cells per day. 
One complete round of the cell cycle was calculated as being 24.3 hours (from 
Figure 5.10). So the growth of cells every 24.3 hours 0.036mg per 10 5 cells or 36 
j.tg per 105cells and 189.5 pg per 105 cells of antibody is produced. Therefore the 
percentage antibody as a proportion of cell mass produced in one round of the cell 
cycle is 526%. Antibody production as a percentage of cell mass is extremely high 
and would be expected to affect cell growth. 
5.5 Growth of ES-4 Hybridomas in Continuous Culture 
for Calculation of Maintenance Energy 
5.5.1 Introduction. 
It was shown in section,5. 4 that the limiting nutrient for ES-4 hybridomas in 
continuous culture is probably glutamine. The equations which were derived in 
section 5. 2 provide a method of calculating the maintenance energy by culturing 
cells at various flow rates in a chemostat. Equation 18 states that by plotting the 
specific growth rate t, which is equal to the dilution rate D at steady state (shown 
by equation 11), against the metabolic quotient of the limiting nutrient, a straight 
line of intercept m, (maintenance coefficient) and slope of 1/YE, where YE is the 
growth yield on the substrate should be obtained. 
5.5.2 Results 
For both hybridomas five chemostat runs were begun, from which nine flow rates 
were obtained. The results for chemostat runs of the producing cell line are shown 
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in Figures 5.25 to 5.39 and in Table 5.10. The results for the non-producing cell 
line are shown in Figures 5.13 to 5.24 and Table 5.10. The results are summarised 
in Tables 5.4 and 5.3 and graphs of specific growth rate against metabolic quotient 
of both glucose and glutamine are shown in Figures5.40 and 5.41 for glutamine 
and Figures5.43 and 5.43 for glucose. The results are discussed in section 5.5.4. 
Each figure shows the values of growth, dilution rate and metabolite 
concentrations for a particular run. Each period of steady state, which was used in 
future calculations, is distinguished by lines which subdivide the graphs. Therefore 
for Run 1, dilution rates 1.1, I.H. 1.ffl, and l.IV are shown. All future figures, 
showing subsequent chemostat runs are shown in this way. 
The data obtained from the continuous culture of ES-4 hybridomas at various flow 
rates, shown in Figures 5.13 to 5.39 and in Tables 5.9 and 5.10 is summarised in 
Tables5.3 and 5.4. The average dilution rate and the standard deviation was 
calculated for each steady state. For each point, the metabolic quotient for each 
substrate and product was calculated and averaged and shown in Tables 5.9 and 
5.10. The standard deviation was also calculated. The data shown in Tables 5.3 and 
5.4 was plotted in Figures 5.40 to 5.43, from which values of maintenance energy 
and growth yield were derived. These results are discussed in section 5.5.4. Tables 
5.3 and 5.4 shows each growth rate in descending order, and labelled with the run 
number and steady state number. i.e. R5.I denotes the first steady state from 
chemostat run 5. 
page 157 
Metabolic Studies of a Hybridoma 












0 	100 200 300 400 500 600 700 800 900 1000 
Time (Hours) 
Cell Growth and Dilution Rate of Non—Producing Cells in a 
Chemostat. Run 1 

















0 	100 200 300 400 500 600 700 800 900 1000 
Time (Hours) 
Glucose and Lactate Concentrations of Non—Producing 











Metabolic Studies of a Hybridoma 














I 	 I 	 I 	 I 	 I 	 I 
I I 	I 	 I I I 
0 	100 200 300 400 500 600 700 800 900 1000 
Time (Hours) 
Glutamine and Ammonia Concentrations of Non—Producing 
Cells in a Chemostat. Runi 


























0_ Il 	11 	1 	 0 
0 100 200 300 400 500 600 700 800 900100011001200130014001500 
Time (Hours) 
Cell Growth and Dilution Rate of Non—Producing 
Cells in a Chemostat. Run2 
page 159 
Metabolic Studies of a Hybridoma 




















0 100 200 300 400 500 600 700 800 900 100011001200130014001500 
Time (Hours) 
Glucose and Lactate Concentrations of Non—Producing 
Cells in a Chemostat. Run2. 


















Glutamine 	 I --..- 
Ammonia 	 Il 	it 
01 
• 	 I 
l 	I 
1 70.  
I 	
1l 
0 100 200 300 400 500 600 700 800 900100011001200130014001500 
Time (Hours) 
Glutamine and Ammonia Concentration of Non—Producing cells 
Grown in a Chemostat. Run2. 
page 160 
Metabolic Studies of a Hybridoma 
Figure 5.19 Non-Producing Run 3: Cell No. and Dilution Rate 
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Figure 533 Producing Cells Run3: Glutamine and Ammonia 
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Figure 537 Producing Cells Run5: Cell No. and Dilution rate 
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Key to Tables 5.3 and 5.4 
metabolic quotient for glucose (10 3 tmol/(105 cells hour)): qgim• metabolic quotient for 
glutamine (10 311mol/(10 5 cells hour): qiac;  metabolic quotient for lactate (10 3J,Lmol/(1& cells 
hour): q. metabolic quotient for ammonia (10 3 imol/(1O5 cells hour): J.L, specific growth 
rate hf 1 ,: Err Standard deviation 
Table 5.3 Summary of Non-Producing Hybridomas: Metabolic Quotients and 
Specific Growth Rates 
The following table summarises the data from the chemostat cultures 
Err qglu Err qgn En CIlac En I qNH Err 
Dilution Rate 1, R3.I 0.046 0.003 7.1 1.2 2.4 0.5 11.9 1.9 3.6 1.0 
Dilution Rate 2 R4.I 0.037 0.003 5.4 0.3 2.7 0.2 8.6 1.0 4.2 0.6 
Dilution Rate 3 R3.I 0.035 0.002 5.1 0.3 1.9 0.2 3.7 1.2 4.5 0.4 
Dilution Rate 4 P.2.1 0.033 0.002 7.2 0.8 1.7 0.2 9.3 1.3 3.5 0.3 
Dilution Rate 5 R1.11 0.032 0.003 4.4 1.7 1.1 0.2 7.6 1.6 1.6 0.4 
Dilution Rate 6 R5.11 0.032 0.004 3.4 1.7 1.0 0.3 3.4 1.0 1.0 0.3 
Dilution Rate 7 Rl.ffl 0.023 0.002 3.0 0.5 0.7 0.1 3.4 1.0 1.8 0.3 
Dilution Rate 8 R1.IV 0.019 0.001 2.4 0.3 0.5 0.2 1.8 1.0 0.6 0.2 
Dilution Rate 9 P.2.11 0.017 0.001 2.0 0.2 0.5 0.0 1.2 0.1 0.5 0.1 
Summary of the culture of ES-4 hybridomas grown in continuous mode. The values for 
each steady state are shown in descending order. Each steady state is identified by the run 
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number and the individual steady state for each chemostat run. 
Table 5.4 Summary of Producing Hybridomas: Metabolic Quotients and Specific Growth 
Rates 
The following table summarises the data from the chemostat cultures 
Err qglu Err qgim Err qiac Err qr1h Err 
Dilution Rate 1, R51 0.041 0.001 5.5 0.6 1.6 0.6 6.7 0.8 1.4 0.2 
Dilution Rate 2 R4.I 0.040 0.001 9.0 0.4 2.4 0.3 6.8 0.8 2.4 0.4 
Dilution Rate 3 R3.I 0.038 0.001 4.3 0.9 2.0 0.5 6.9 0.6 1.8 0.3 
Dilution Rate 4 R1.I 0.034 0.001 3.7 0.4 1.4 0.7 6.1 1.3 2.0 0.8 
Dilution Rate 5 R2.I 0.033 0.002 3.8 0.8 1.2 0.1 5.1 0.6 1.5 0.2 
Dilution Rate 6 R1.11 0.027 0.001 2.0 0.3 1.0 0.1 2.5 1.2 1.5 0.1 
Dilution Rate 7 R1.ffl 0.024 0.001 1.4 0.1 0.8 0.1 2.1 1.5 1.1 0.2 
Dilution Rate 8 R1.W 0.021 0.001 2.5 0.4 1.0 0.1 2.6 0.4 1.4 0.2 
Dilution Rate 9 R2.11 0.019 0.001 2.0 0.2 0.8 0.1 2.5 0.3 1.2 0.2 
Summary of the culture of ES-4 hybndomas grown in continuous mode. The values for 
each steady state are shown in descending order. Each steady state is identified by the run 
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5.5.3 Validation of Steady States 
Cells were assumed to be in steady state when both the dilution rate and cell 
number were steady over three simultaneous timepoints. As can be seen from 
Tables 5.9 and 5.10, where the standard deviation is shown for each steady state, 
the dilution rate and cell number for all steady states fluctuate slightly about the 
mean. At the beginning of each chemostat run the flow rate into the chemos tat was 
measured and adjusted to give maximum flow rates. Once the pump speed was set 
giving the required flow rate the pump speed was unaltered for the entire period of 
steady state. To determine if variations in flow rate were due to slight variations in 
the pump speeds, the flow rate of both pumps (see section 2. 9) were calibrated at 
both maximal and half maximal flow rates. The pump was calibrated by setting the 
required flow rate and collecting samples hourly using an automatic sample 
collector. This showed that the pump speed varied slightly even at set speed. Apart 
from slight variation in pump speed, errors could also be introduced during 
measurements of the volume of the feed bottle. Variations in cell number were 
minimised by using the average of four haemocytometer counts. The accuracy of 
haemoctyometer counting had been previously calibrated against a coulter counter 
and this method had been shown to be accurate (3.2.1). Averaged steady states for 
the producing cell dilution rate varied by little more than 0.001 hr -1 and for the 
non-producing dilution rate by around 0.002 hr -1 . 
5.5.4 Discussion 
The equations derived in section 5. 2 are based on the Monod Model [65], which 
was developed by culturing bacteria in continuous culture at a variety of substrate 
concentrations and flow rates. The Monod model predicts that cells will grow at a 
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rate which is dependant on the concentration of the limiting substrate. As the 
concentration of this substrate increases, the rate of cell growth will increase 
proportionally in response to the increase in the substrate concentration. The 
increase in the rate of cell growth will ultimately reach a maximum, after which 
further increases in substrate concentration will not result in any further increase in 
the rate of cell growth. The Monod model may not be applicable to eukaryotic 
cells, as it was derived using prokaryotic systems. Repeated studies by a number of 
authors studying eukaryotic cells underline the complexity and multi-substrate 
dependance of eukaryotic cells (see section 1. 5), and the ability of eukaryotic cells 
to substitute one substrate for another, or improve metabolic efficiency when 
nutrient limited. Monod-type models have been applied to animal cell cultures to 
describe the relationships between the rate of cell growth and substrate 
concentrations. One study by Tovey [91] on tumour cells showed that the linear 
relationship of a true Monod relationship holds only at low dilution rates, at higher 
dilution rates the utilisation of the limiting nutrient decreases. A mathematical 
model developed by Frame et al for the hybridoma cell line AFP-27 [22, 24] 
compared the consumption of the limiting substrate with the specific growth rate. 
The results of this model were compared to the cell growth of the hybridoma AFP -
27 in continuous culture at varying dilution rates. It was found both by modelling 
and experimentally that at varying flow rates, and hence substrate concentrations, 
a true straight line relationship was not seen. The graph obtained did not fall well 
on a straight line but was composed of two parts, a lower stage and a higher stage 
as shown below (see Figure 5.44). Work by Hiller et al, using hybridoma cells 
grown in perfusion culture at varying flow rates also demonstrated this two phase 
phenomenon, although the graphs were connected with curves and not straight 
lines 
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The above graph taken from results by Frame et al shows the two line relationship 
described overleaf. 
By culturing two strains of ES-4 hybridoma cells at a number of nutrient feed rates 
in a chemostat, a variety of specific growth rates were obtained. The respective 
metabolic quotients were calculated for each flow rate. To determine the 
maintenance coefficient, m, the specific growth rate j.t and the metabolic quotient 
qE were plotted (see Figures 5.40 to 5.43). The point at which the line intercepts 
the y-axis was shown by equation 18 to be equal to the maintenance coefficient. 
As can been seen from Figures 5.40 to 5.43, which show specific growth rate 
plotted against the metabolic quotients of glucose and glutamine for both cell lines, 
the graphs obtained do not fit well on a straight line, a better fit could be obtained 
by a broken line. These results are similar to those shown by Frame et a! [22] and 
page 178 
Metabolic Studies of a Hybridoma 
Huller et al [35]. The graphs plotted using glucose appear to be more linear than 
those obtained for glutamine. Both Hiller et al (35] and Frame et al [22] showed the 
two phase relationship applied primarily to the limiting nutrient, which was 
glucose for the cell lines they used, while a more linear relationship was found for 
glutaimne. Glutamine is the limiting nutrient for the ES-4 hybridoma used in this 
study and the graph obtained for glutamine is less linear than that obtained for 
glucose. The regression equations were calculated for each line and are shown on 
each figure (see 5.40 to 5.43). The r2 values of these graphs range from 0.64 to 
0.74. 
The lines obtained in this work do not intercept the y-axis but intercept the x-axis. 
It was hoped that the slope and the intercept of these graphs could be used to 
determine firstly the maintenance coefficient of the producers and the non-
producers and to compare them, obtaining information on the amount of energy 
expended in the production of antibody. 
There could be a number of reasons for the failure to obtain a 'true' straight line. At 
higher flow rates it may be that the supply of the limiting nutrient into the 
chemostat is greater than the amount which the cells can metabolise and therefore 
the cells are not truly nutrient limited. The concentration of nutrients in the feed 
were identical to those supplied during batch culture (see Figure). In batch culture 
cells do not become nutrient limited until 3 or 4 days from inoculation. If this is the 
case the maximum rate of cell growth will be the limiting factor. It will then follow 
that at lower, sub-maximal flow rates where growth is truly nutrient limited, a 
more representative situation will occur with growth being more closely associated 
to the supply of the limiting nutrient in the feed. It may also be that at the higher 
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flow rates the utilisation of energy is less efficient than at lower flow rates. As 
described overleaf, at high flow rates the supply of nutrients into the chemostat via 
the feed, may be in excess of that required by the cells. As at maximal flow rates 
the specific growth rate of the cells will also be maximal, any excess of the limiting 
nutrient will not be necessary for cell growth. If this reflects conditions in the 
chemostat, the utilisation of nutrients may be less efficient. As described in section, 
hybridoma cells can utilise a number of pathways for the metabolism of nutrients. 
Therefore at high substrate concentrations, metabolism may be predominately 
fermentative or anaerobic, i.e. glucose may be mainly converted to lactate or 
glutamine may be inefficiently utilised even if d02 is not limiting. As the 
concentrations of the substrates falls (by varying flow rates, metabolism may 
become more efficient to compensate for this). 
Increases in the efficiency of the metabolism of energy has been described for a 
number of hybridoma cell lines (see section 1. 5).At high flow rates the cells may 
use the least efficient pathways which enable the cells to obtain enough energy to 
complete one round of the cell cycle quickly. At low flow rates this will be less 
important and it may be that the pathways used yield greater amounts of energy but 
may require more effort from the cells. The metabolism of a hybndoma is 
extremely complex as is the media used to support the cells and aerobic respiration 
may predominate at low flow rates with anaerobic respiration predominant at 
higher flow rates. The conversion ratio of glucose to lactate is discussed later. (see 
section 5.5.5). 
It is difficult to determine at which point(s) of the graph the change from growth 
limitation to nutrient limitation occurs, but by plotting the concentration of the 
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limiting nutrient, determined to be glutamine, against the dilution rate the point at 
which the concentration of the limiting nutrient decreases and hence the point at 
which nutrient limitation will occur might be determined. This is shown in Figure 
5.46 
Figure 5.45 Glutamine Concentration against Dilution Rate 
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As can be seen from Figure 5.45 the gluta.rnine concentration for the producing cell 
line is maximal at high dilution rates, apart from two points that are far lower than 
the rest, and gradually decreases as the dilution rate decreases. The point that 
glutamine limitation appears to become important is at the dilution rate of 0.033 hf 
1, approximately 80% of the maximal flow rate used. For the non-producer the 
effect is less obvious but this change appears to be occurring at a dilution rate of 
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0.032 hr-1 . It is difficult to draw conclusions from these results, but if the point at 
which glutaniine limitation appears to become important in Figure 5.45 is 
compared with Figures 5.40 to 5.43, which show metabolic quotient against 
specific growth rate, the points at which nutrient limitation is occurring do appear 
to fall on the lower slope of the graph. 
Since it has been previously shown that a two-phase relationship is found for 
eukaryotic cells it was decided to split the graph into two sections in an attempt to 
calculate the maintenance energy. Due to the lack of firm evidence indicating at 
which point the slope of the graph changes, the regression equation of the whole 
line was calculated and compared with two lines which could be drawn on the 
graph. The point at which the graph appears to change was decided arbitrarily, 
and the regression coefficients for both segments were calculated. The points that 
gave the most accurate regression equation for a two part graph were chosen for 
further calculations. The point at which the slope of the graph changed was decided 
as being at point 0.033 hr -1 for the producing cell line and 0.032 hr -1 for the non-
producing line. This point was included in both line segments and a two section 
graph was drawn. This is shown in Figures 5.46 and 5.48. The equation of the 
straight line was calculated for both sections of the graph from specific growth rate 
of 0.033 to 0.019 hr4 for the producing cell line and specific growth rate 0.032 to 
0.019 hr for the non-producing cell, both for the lower parts of the graphs). It 
was found that both lines had a positive intercept. The equations for the lower 
portion of the graph was y=23.9x +0.087 (r2 =0.74) and for the higher portion 
y=76.54x -0.88 (r2 =0.40) for the non-producer. If the point corresponding to the 
highest dilution rate was excluded for the higher portion of the non- producing cell 
line (see 5.47) the lines appear to meet and the r 2 value is higher (shown in Figure 
5.47. The regression equation in this case is y=331.82x-9.6. The values for the 
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producing line were y=24.5x+0.35 (r2 =0.65) for the lower part and y=96.lx-1.9 
(r2 =0.51) for the higher section. Using this method the maintenance energy for the 
producer of 0.0035 and 0.00087 p.g 10 5 cells hr -1 for the non-producing cell can be 
deduced from the lower slope. The slope of the line, which is equal to l/YEG  (on 
glutamine), is approximately the same for both cell lines. 
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Unlike the lines obtained in this work, the lines obtained by Frame did not have a 
positive intercept on the y-axis and the values are not directly comparable as Frame 
et al used values calculated using cell dry weight and not cell number as used n this 
study. Comparison of the intercept obtained for the glutamine utilisation by the ES-
4 hybridomas were compared with those obtained by Hiller who obtained values of 
0.019 p.g 105 cells hr for glucose and 0.0038 p.g 10 5 cells hr-1 for glutamine. 
The results shown in this thesis have determined the maintenance coefficients and 
the growth yields (on glutamine) of two related hybridomas, an antibody secreting 
and a non-secreting cell. The equations derived in section 5. 2, allow the 
maintenance coefficient to be determined by plotting the metabolic quotient of the 
limiting nutrient against a variety of specific growth rates. It was found that these 
equations did not fit well on a straight line, but fit better on a two phase line. 
page 185 
Metabolic Studies of a Hybridoma 
Previous work by several authors have also identified this two phase relationship. 
By plotting the best fit of the two lines (by comparison of the regression equations) 
a two phase graph, with the lower portion intercepting the y-axis was obtained. The 
values of maintenance coefficient calculated were 0.0035 and 0.00087 mmol per 
105 cells per hour for the producers and non-producers respectively, with the 
growth yield of glutamine (found to be the primary or limiting nutrient) of 0.24 and 
0.25 minol per 10 5 cells for the producer and the non producer respectively. The 
highest and lowest slopes of the lower line for both cell lines were calculated and 
for the non-producing cell line the maximum and minimum intercepts were 
calculated as 0.70 and -0.086. For the producing cell line the maximum and 
minimum intercepts were calculated as being 1.94 and -1.24. The degree of overlap 
the maximum and minimum values of the two values suggests that the results 
should be treated with caution, as the differences in maintenance coefficient found 
fall well within the calculated errors 
The maintenance coefficient is a measure of the energy required by the cells, 
excluding energy required for cell growth. The maintenance coefficient includes 
energy required for maintenance of cellular organelles, repair of DNA, and repair 
of spontaneously broken chemical bonds. It also contains the energy required for 
the synthesis and secretion of antibody. As the cells used in this study are derived 
from an identical cell line, with the exception that the NP sub-clone does nor 
secrete detectable levels of antibody, and that the cells were cultured identically it 
may be assumed that the only differences between the cell lines are the ability to 
secrete antibody. Therefore the metabolic 'load' of antibody can be assumed to be 
0.0026 mmol 10 5 cells hr -1, which is significantly large. The maximum specific 
growth rates were calculated as being 0.046 and 0.041 hr-1 for the non-producing 
and producing cells respectively indicates that the producing subclone is 
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synthesising antibody with very little detriment to cell division. The producing 
cells appear to be compensating for the metabolic load of antibody production 
perhaps by more efficient use of nutrients. Therefore it is likely that optimisation of 
feeding strategies, which increase the rate of cell division would be expected to 
improve antibody yields. 
The metabolic quotients obtained in this work were compared with those 
calculated by other workers and the values obtained in this study correlate well 
with those of Miller et al [60, 61, 62, 63] and for Hiller et al [35]. 
5.5.5 Comparison of Metabolism at Various Flow Rates 
It has been previously shown by some authors that hybridomas can optimise their 
metabolism at nutrient limitation (see section 1.5.2). It may be that cellular 
metabolism may alter as the cells become nutrient limited. To determine if the 
hybndoma used in this study is optimising metabolism in this way, glucose to 
lactate and glutamine to ammonia conversion ratios were calculated for batch 
culture and for the continuous culture flow rates previously shown. These are 
shown in Table5.5. The background level of ammonia, present from serum, was 
routinely calculated and was found to be approximately 1.2mM so this was 
subtracted from the ammonia values prior to calculation of the conversion ratio. It 
was also assumed that one mol of ammonia was released from each mol of 
glutamine metabolised. As previously mentioned (section 2. 9) d02 levels were 
maintained at greater than 20% of air saturation so variations in oxygen 
concentration could be discounted. 
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Table 53 Glucose and Glutamine Conversion Ratios 
Glucose to Lactate (%) Glutamine to Ammonia (%) 
Producing Non-Producing Producing Non-Producing 
Batch 0.57 0.57 
Flow Rate 1 0.67 0.57 0.36 1.00 
Flow Rate 2 0.54 0.76 0.62 0.50 
Flow Rate 3 0.70 0.50 0.59 0.40 
Flow Rate 4 0.70 0.70 0.59 0.43 
Flow Rate 5 0.60 0.50 0.20 0.40 
Flow Rate 6 0.50 0.48 0.70 0.20 
Flow Rate 7 0.70 0.71 0.90 0.80 
Flow Rate 8 0.44 0.71 0.90 1.0 
Flow Rate 9 0.35 0.40 0.67 0.9 
Table showing the conversion of glucose to lactate and the conversion of glutamine to 
ammonia at various flow rates in a chemostat. 
Glucose conversion to lactate is similar for all producing flow rates, and it appears 
that the level of lactate produced by the cells is similar at all flow rates. The data is 
not as clear in the case of the non-producing cell line, and it is difficult to draw 
conclusions, but it again appears that the conversion of glucose to lactate is broadly 
similar at varying flow rates. Therefore the metabolism of glucose to lactate by ES-
4 hybridomas is similar at varying nutrient concentrations. 
The conversion of glutamine to ammonia shows values that are far more variable, 
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and it may be that other factors such as amino acid metabolism are responsible for 
ammonia production. Because of the variability, it is difficult to draw conclusions 
from the data. 
5.5.6 Comparison of Antibody Secretion at Various Flow Rates 
As described in section 1. 5 a number of types of antibody production by 
hybridoma cells have been demonstrated. By calculating the rate of antibody 
secretion at maximal and sub-maximal flow rates, the production of antibody by 
ES-4 may increase the maintenance energy for the producing cells. The specific 
antibody production rates at each flow rate are shown in Table 5.6. 
Table 5.6 Antibody Secretion by Producing Cells at Varying Flow Rates 
Dilution Rate (hr -1 ) Total (j.tg/ml) 105 Cells hr-1 ) 
Flow Rate l 0.041 6.0 7.8 
Flow Rate 2 0.040 7.8 10.7 
Flow Rate 3 0.038 3.1 3.7 
Flow Rate 4 0.034 3.7 4.4 
Flow Rate 5 0.033 5.0 5.5 
Flow Rate 6 0.027 7.8 5.0 
Flow Rate 7 0.024 3.0 1.5 
Flow Rate 8 0.021 7.6 4.0 
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Table 5.6 Antibody Secretion by Producing Cells at Varying Flow Rates 
Dilution Rate (hr-1 ) Total (p.g/ml) QAb(pg 
105 Cells hr) 
Flow Rate 9 0.019 4.0 1.9 
Table 5.6 showing antibody secretion per cell at varying flow rates in a chemostat. 
As can be seen from Figure 5.6, the antibody production per cell decreases as flow 
rates decrease, the secretiion of antibody being greater at higher flow rates. It 
appears therefore that antibody production is growth associated. At lower flow 
rates when nutrients are limiting and cell growth is reduced, the levels of antibody 
secreted per cell decrease which suggests that antibody secretion is related to the 
rate of cell growth. 
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5. 6 Conclusions 
The work contained in this chapter investigated the metabolism of two related 
hybridomas, a producer and a non-producer. It was found that the maintenance 
coefficient of the producing cell line was four times greater than for the non 
producer. It was also found that the hybridoma used in this study did not optimise 
its metabolism at nutrient limitation. It was also found that the secretion of 
antibody is cell growth associated. Work contained in a previous chapter (see 
Chapter FACS) found that antibody secretion was cell cycle associated. These 
results could provide a means of improving the growth of hybridomas by a better 
understanding of metabolism and growth which would lead to an associated 
increase in the secretion of antibody. A better understanding of metabolism will 
ultimately lead to improvements in the formulation of culture medium and 
development of nutrient feeding strategies. Further work could study the non-linear 
relationship between specific growth rates which was shown and to determine why 
this occurs. The two phase relationship may be indicative of an important feature 
of the cells. It would also be useful to study the utilisation of nutrients other than 
those investigated in this study, such as amino acids and vitamins. Increasing use 
of serum free formulations for hybridoma culture and the production of antibody 
will require further understanding of hybridoma metabolism and physiology for 
which these studies may be useful. 
5.6.1 Tables Containing Data for all Chemostat Runs 
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Key to Table 5.7 
qgiu; metabolic quotient for glucose (10 -3pmoll(105 cells hour)): q; metabolic quotient for 
glutamine (10 3jimol/(105 cells hour): q,,,;  metabolic quotient for lactate (10 3 tmol/(105 cells 
hour): q 3; metabolic quotient for ammonia (10 3pmol/(105 cells hour): SN; sample number Cell; 
cell number (x105 cells nil): Glu; Glucose (mM): Gim; Glutamine (mM): NH 3; Ammonia (mM): 
Lac; Lactate (mM) 
Table 5.7 Nutrient Pulsing of Non-Producing Hybridomas 
This table shows all values for the chemostat culture of non-producing hybridomas which were 
pulsed with glucose, glutamine and FCS. 
Flow Rate 
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Table 5.7 Nutrient Pulsing of Non-Producing Hybridomas (Continued) 
This table shows all values for the chemostat culture of non-producing hybridomas which were 
pulsed with glucose, glutamine and FCS. 
SN CN DR Glu qglu Gim I qgim Lac qlac NH3 cINH3 
18 3.8 0.045 5.0 7.2 0.1 2.3 4.3 5.1 1.7 2.0 
19 3.9 0.035 7.0 3.7 0.2 1.6 4.4 3.9 1.4 1.3 
20 3.6 0.035 5.0 5:9 0.5 1.5 4.3 4.2 1.3 1.3 
Avg 3.7 0.033 6.6 4.1 4.1 1.2 4.1 3.6 1.3 1.2 
Err 0.2 0.006 1.6 1.8 0.3 0.5 0.7 1.0 0.4 0.4 
Flow Rate 2 
21 5 0.016 5.8 1.7 0.6 0.5 4.2 1.3 1.8 0.6 
22 5.2 0.017 4.9 2.0 0.1 0.6 4.3 1.4 2.2 0.7 
23 6 0.017 6.4 1.3 0.0 0.6 4.5 1.3 2.1 0.6 
24 6.2 0.017 3.4 2.1 3 0.3 4.3 1.2 1.6 0.4 
25 6.1 0.017 3.4 2.1 0.1 0.5 4.1 1.1 0.9 0.3 
26 6.2 0.018 3.4 2.2 0.0 0.6 4.4 1.3 0.8 0.2 
27 6.1 0.017 3.4 2.1 0.0 0.6 4.0 1.1 0.9 0.3 
28 5.9 0.018 3.1 2.4 0.2 0.6 4.5 1.4 0.6 0.2 
29 6.3 0.018 4.5 1.9 0.2 0.5 4.2 1.2 1.2 0.3 
30 6.1 0.016 3.5 2.0 2.8 -0.2 4.2 1.1 1.8 0.5 
Avg 6.1 0.017 3.9 2.0 0.8 0.4 4.3 1.2 1.2 0.4 
Err 0.1 0.001 1.0 0.3 1.2 0.3 0.2 0.1 0.5 0.1 
to 	4mM Gim 
31 7.4 0.018 4.1 1.7 0.2 0.9 4.1 1.0 0.9 0.2 
32 0.017 4.7 0.7 0.9 1.0 0.9 4.5 1.3 0.5 0.1 
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Table 5.7 Nutrient Pulsing of Non-Producing Hybridomas (Continued) 
This table shows all values for the chemostat culture of non-producing hybridomas which were 
pulsed with glucose, glutamine and FCS. 
SN CN DR Glu qglu Gim qgim Lac qlac NH3 qNH3 
33 5.8 0.018 7.3 1.2 1.4 0.8 4.9 1.5 1.1 0.2 
34 6.4 0.018 6.1 1.4 0.4 0.9 4.7 1.3 2.2 0.3 
35 6.4 0.019 5.1 1.8 0.0 1.0 3.8 1.1 3.1 0.7 
36 6.5 0.018 5.7 1.5 1.6 0.7 4.4 1.2 3.0 0.9 
37 5.8 0.020 3.4 2.7 1.5 0.9 3.8 1.3 3.2 1.0 
38 6.7 0.019 4.1 2.0 1.5 0.7 3.4 1.0 3.2 0.9 
39 6.3 0.015 4.6 1.5 1.5 0.6 3.6 0.9 3.2 0.8 
Avg 5.7 0.018 5.0 1.5 1.0 0.8 4.1 1.2 2.3 0.6 
Err 2.1 0.001 1.1 0.7 0.6 0.1 0.5 0.2 1.1 0.3 
To 2mM Gim 
40 6.4 0.018 7.1 1.1 1.6 0.1 4.9 1.4 3.2 0.9 
41 6.2 0.015 5.9 1.3 1.8 0.5 4.7 1.1 3.2 0.8 
42 5.7 0.020 5.0 2.1 0.7 0.4 4.6 1.6 3.6 1.3 
43 5.7 0.017 5.6 1.6 0.0 0.6 3.4 1.0 3.7 1.1 
44 5.8 0.018 6.3 1.5 0.0 0.6 4.3 1.3 3.1 1.0 
45 5.6 0.018 6.9 1.3 1.3 0.2 5.1 1.6 3.6 1.2 
46 5.7 0.019 5.9 1.7 1.6 0.1 1.3 0.4 2.9 1.0 
47 5.7 0.018 4.7 2.0 0.5 0.5 4.1 1.3 3.2 1.0 
48 5.5 0.023 4.6 2.7 0.6 0.6 4.8 2.0 3.0 1.3 
Avg 5.8 0.018 5.8 1.7 0.9 0.4 4.1 13 3.3 1.0 
Err 0.3 0.002 0.8 0.5 0.7 0.2 1.1 0.4 1 0.3 0.2 
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Table 5.7 Nutrient Pulsing of Non-Producing Hybridomas (Continued) 
This table shows all values for the chemostat culture of non-producing hybridomas which were 
pulsed with glucose, glutamine and FCS. 
SN I CN 	DR I Glu 	qgiu 	Glin  qgim  Lac I llac I NH3 I  qNH3 _  
Glu 	Pulse 
49 5.6 0.017 7.9 4.0 0.2 0.6 4.4 1.3 2.9 0.9 
50 5.8 0.019 8.2 4.2 0.1 0.6 4.8 1.6 3.3 1.1 
51 5.7 0.013 12.4 2.0 0.4 0.4 4.8 1.1 3.4 0.8 
52 5.9 0.019 9.8 3.6 0.1 0.6 4.9 1.6 3.1 1.0 
53 5.7 0.018 12.4 2.7 0.2 0.6 4.6 1.5 1.4 0.4 
54 5.4 0.018 14.5 2.2 1.2 0.3 4.8 1.6 1.5 0.5 
55 5.4 0.020 17.0 1.5 0.7 0.5 4.6 1.7 1.7 0.6 
Avg 5.6 0.018 11.8 2.9 0.4 0.5 4.7 1.8 1.6 0.7 
Err 0.2 0.002 3.1 1.0 0.4 0.1 0.2 1.8 1.8 0.7 
65 6.3 0.020 4.6 2.1 1.4 0.2 4.8 1.5 2.5 0.8 
66 6.9 0.022 3.9 2.3 1.6 0.1 4.6 1.9 0.8 0.2 
67 6.1 0.022 3.6 2.7 0.1 0.7 4.3 1.8 1.4 0.5 
68 6.7 0.023 1.3 3.4 0.7 0.5 4.5 1.7 1.3 0.5 
69 7.3 0.021 3.9 2.1 0.5 0.4 4.7 1.1 0.6 0.2 
70 7.6 0.025 4.2 2.3 0.6 0.5 4.1 1.7 1.8 0.6 
71 6.3 0.015 3.4 1.8 0.6 0.3 4.2 1.5 1.4 0.4 
72 6.6 0.029 4.6 2.9 0.5 0.7 4.5 1.4 1.8 0.5 
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Table 5.7 Nutrient Pulsing of Non-Producing Hybridomas (Continued) 
This table shows all values for the chemostat culture of non-producing hybndomas which were 
pulsed with glucose, glutamine and FCS. 
SN CN DR Glu qglu Olin qgim Lac qiac NH3 qNH3 
73 6.3 0.014 4.6 1.4 0.4 0.4 3.6 1.5 1.2 0.4 
74 7.2 0.019 3.1 2.1 0.6 0.4 4.5 1.6 1.5 0.5 
75 7.4 0.013 3.4 1.4 0.3 0.3 3.2 1.5 1.4 0.5 
76 7.3 0.019 5.1 1.6 0.5 0.4 6.1 1.4 0.6 0.2 
77 6.4 0.019 4.2 2.0 0.6 0.4 5.4 1.3 1.2 0.4 
78 7.4 0.016 4.4 1.4 0.5 0.3 5.6 1.0 1.5 0.4 
79 7.3 0.017 2.3 2.0 0.6 0.3 3.3 2.0 1.4 0.6 
80 7.4 0.016 1.8 2.0 0.6 0.3 4.6 1.4 1.2 0.4 
81 7 0.017 2.2 2.2 0.3 0.4 3.9 0.4 0.4 0.2 
82 5.1 0.016 2.1 2.8 0.6 0.4 4.1 1.3 1.5 0.5 
83 6.3 0.019 2.2 2.7 0.3 0.5 4.4 0.9 1.4 0.3 
84 6.1 0.19 2 0.3 0.3 0.5 4.5 1.0 1.4 0.4 
85 6.8 0.017 2.2 2.2 0.1 0.5 4.3 0.6 1.2 0.2 
86 6.2 0.02 2.5 2.8 0.5 0.5 4.7 1.1 1.2 0.3 
87 6.2 0.02 10.9 0.1 0.4 0.5 4.2 1.4 1.2 0.4 
88 6.5 0.019 5.9 1.5 1.1 0.3 5.1 1.2 1.4 0.3 
89 6.7 0.019 3.7 2.1 0.2 0.5 4.7 1.0 1.5 0.4 
90 6.7 0.019 5.2 1.7 0.7 0.4 4.9 1.2 1.1 0.3 
91 6.5 0.02 6.7 1.4 0.4 0.5 4.1 1.7 1.2 0.4 
92 6.5 0.019 5.8 1.5 0.6 0.4 3.6 1.3 1.3 0.4 
93 6.4 0.02 5.1 1.9 0.2 0.6 3.6 1.2 1.2 0.4 
94 6 0.019 4.5 2.1 0.3 0.5 4.1 1.1 1.2 0.3 
95 6.4 0.022 5.6 1.9 0.5 0.5 4.5 1.4 1.5 0.5 
96 6.4 0.015 2.9 1.9 0.5 0.4 5.3 1.5 1.2 0.4 
97 6.4 0.019 11 5.1 1.8 0.6 0.4 5.0 1.4 1.5 0.4 
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Table 5.7 Nutrient Pulsing of Non-Producing Hybridomas (Continued) 
This table shows all values for the chemostat culture of non-producing hybridomas which were 
pulsed with glucose, glutamine and FCS. 
- SN CN DR Glu qglu Gim qglm Lac Qac NH3 qNH3 
98 6.2 0.019 5 1.9 0.4 0.5 5.2 1.4 1.5 0.4 
99 6.3 0.019 2.9 2.5 0.4 0.5 4.9 1.4 1.7 0.5 
100 6.1 0.019 3.7 2.3 0.5 0.4 4.5 1.6 1.3 0.4 
101 6.2 0.019 2.8 2.5 0.2 0.6 4.6 1.6 1.4 0.4 
Table 5.8 Nutrient Pulsing of Producing Hybridomas 
This table shows all values for the chemostat culture of non-producing hybridomas which were pulsed with 
the main metabolites 
Flow Rate One 
8 2.7 0.048 7 6.2 0.9 2.0 3.8 3.4 1.1 0.8 16.1 29. 
9 2.8 0.023 6.3 3.4 0.7 1.1 1.9 3.8 1.3 0.5 4.5 3.7 
10 2.8 0.033 6.3 4.9 0.9 1.3 4.6 5.5 1.1 0.6 4.5 3.7 
11 3.0 0.033 6.9 4.0 	1 0.9 1.2 4.7 5.2 1.1 0.5 4.2 5.0 
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Table 5.8 Nutrient Pulsing of Producing Hybridomas (Continued) 
This table shows all values for the chemostat culture of non-producing hybridomas which were pulsed with 
the main metabolites 
SN CN DR Glu qgiu Gliii qglm  Lac iac 3 qNH3 ab QAb 
12 2.8 0.036 7.2 4.2 0.9 1.4 4.4 4.9 1.1 0.6 4.8 5.3 
13 2.8 0.034 6.4 5.0 1.1 1.1 4.9 4.3 0.9 0.5 4.6 5.9 
14 2.9 0.030 6.8 3.8 0.9 1.1 4.9 3.6 1.1 0.5 4.2 5.1 
15 3.1 0.030 7.9 2.5 1.0 1.0 4.7 4.8 1.0 0.4 5.4 5.6 
16 3.5 0.036 8.2 2.4 0.7 1.3 4.2 3.7 1.2 0.5 5.9 5.7 
17 3.1 0.030 7.1 3.3 0.6 1.4 4.6 3.3 1.1 0.5 6.0 6.2 
18 3.2 0.046 5.9 6.6 0.2 2.6 3.8 6.6 1.7 1.3 6.0 5.8 
19 3.0 0.038 6.6 4.9 0.3 2.2 3.5 6.2 1.6 0.9 19.1 3.4 
20 3.0 0.033 7.9 2.9 0.6 1.5 3.5 5.4 1 	1.3 0.5 20.0 3.2 
Avg 3.0 0.035 7.0 4.2 0.7 1.5 4.1 4.7 	1 1.2 0.6 8.1 6.7 
Err 0.2 0.006 0.7 1.3 0.3 0.5 0.8 2.0 0.2 0.2 5.7 6.5 
Flow Rate Two 
21 3.3 0.017 5.4 2.6 0.1 1.0 3.6 2.4 2 0.6 2.5 1.3 
22 3.4 0.019 7.5 1.7 0.3 1.0 3.4 2.6 2 0.4 2.8 1.6 
23 3.5 0.019 7.9 1.4 0.6 0.8 4.6 2.3 1.3 0.3 3.3 1.8 
24 3.6 0.019 5.8 2.5 0.5 0.8 4.9 2.0 1.4 0.5 5.2 2.7 
25 4.0 0.019 6.1 2.1 0.4 0.8 4.9 1.7 2.0 0.6 3.5 1.7 
26 4.2 0.019 5.2 2.4 0.6 0.6 4.9 1.6 1.7 0.6 4.5 2.0 
27 5.0 0.019 5.4 1.9 0.0 0.8 4.7 1.4 2.3 0.8 4.7 1.8 
28 5.1 0.014 5.3 1.4 0.0 0.6 4.6 1.3 3.0 0.8 5.1 1.4 
29 5.2 0.016 1.9 2.6 2.1 0.03 4.2 1.0 0.5 0.4 8.9 2.7 
30 4.8 0.014 5.8 1.4 0.9 0.3 3.8 1.3 2.0 0.5 7.7 2.2 
31 5.3 0.014 5.3 1.4 1.2 0.2 3.5 0.9 1.5 0.4 8.7 2.3 
32 5.3 0.014 5.9 1.2 0.2 0.5 3.5 0.7 2.3 0.6 10.3 2.7 
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Table 5.8 Nutrient Pulsing of Producing Hybridomas (Continued) 
This table shows all values for the chemostat culture of non-producing hybridomas which were pulsed with 
the main metabolites 
SN CN DR Glu qglu  Gim qglm Lac qiac NH3 q3 ab QAb 
33 5.1 0.014 5.7 1.3 0.0 0.6 3.6 1.0 3.5 0.9 14 3.8 
Avg 4.4 0.017 5.6 1.8 0.5 0.6 [4.4 1.7 1.9 0.6 6.2 2.2 
Err 0.8 0.002 1.4 0.5 0.6 0.3 [0.5 0.8 0.6 0.2 3.3 0.7 
Gim to 4mM 
34 5.8 0.016 4.8 1.6 2.1 0.0 3.4 0.8 2.5 0.8 9.4 2.6 
35 4.8 0.013 6.5 1.1 1.7 0.1 4.5 0.8 2.0 0.4 14.7 4.0 
36 4.5 0.015 4.3 2.1 0.6 0.5 3.2 0.8 2.8 1.0 13.0 4.3 
37 5.0 0.016 5.7 1.5 0.3 0.5 2.5 0.8 2.0 0.6 13.7 4.4 
38 4.8 0.017 6 1.6 0.4 0.6 2.8 0.7 2.6 0.7 12.2 4.3 
39 5.1 0.017 5.1 1.8 0.0 0.7 2.9 1.0 2.6 0.9 12.0 4.0 
40 4.8 0.016 5.3 1.7 0.0 0.7 3.1 0.8 2.1 0.6 12.4 4.1 
41 4.4 0.017 5.2 2.0 0.0 0.8 2.5 1.3 2.1 0.7 11.3 4.4 
42 5.1 0.015 2.0 2.5 0.2 0.5 	2.4 1.1 2.2 1.7 11.1 3.3 
43 4.9 0.014 5.7 1.4 0.0 0.6 2.2 0.6 2.7 0.7 11.1 
44 5.0 0.015 5.2 1.6 0.1 0.6 1.9 0.6 2.1 0.6 12.2 3.7 
Avg 4.9 0.016 5.07 1.7 0.5 0.5 	2.9 0.7 2.3 0.6 12.1 3.9 
Err 0.3 
0.001L1.12 
3.6 0.7 0.2 	0.7 0.4 0.3 0.2 1.5 0.5 
to 6mM Gim 
45 5.6 0.015 5.7 1.3 0.0 0.5 2.6 0.5 2.7 0.7 10.1 2.7 
46 5.4 0.016 5.5 1.5 0.2 0.5 3.4 0.8 2.4 0.7 11.4 3.4 
47 4.0 0.017 4.7 2.5 0.1 0.8 3.8 1.1 3.5 1.3 10.3 4.4 
page 199 
Metabolic Studies of a Hybridoma 
Table 5.8 Nutrient Pulsing of Producing Hybridomas (Continued) 
This table shows all values for the chemostat culture of non-producing hybridomas which were pulsed with 
the main metabolites 
SN I CN I DR 	Glu I q,,u Ghfl I qgim I Lac I qiac I NH3 I q3 I ab 	QAb 
to 2mM Gim 
48 4.0 0.020 5.4 2.9 0.2 0.9 2.1 1.0 2.5 0.8 10.1 5.1 
49 4.1 0.016 3.8 2.5 0.2 0.7 3.1 1.0 2.6 1.0 9.8 3.8 
50 3.8 0.017 3.8 3.3 0.1 0.9 1.8 1.3 2.7 1.5 10.0 4.4 
51 3.8 0.013 9.4 2.1 0.3 0.6 2.6 1.2 2.5 0.7 10.7 3.7 
52 3.3 0.017 5.9 3.7 0.6 0.7 2.5 1.7 2.2 1.1 9.3 4.8 
53 3.2 0.016 5.6 3.5 0.2 0.9 1.6 1.4 2.6 1.2 8.7 4.3 
54 2.7 0.020 5.4 3.7 0.0 1.1 2.0 3.3 2.8 2.0 6.7 5.0 
55 2.5 0.016 5.2 3.4 0.0 0.9 2.5 2.8 2.3 0.9 5.9 3.8 
56 2.8 0016 5.0 3.1 0.2 1.0 2.8 2.5 2.1 1.1 6.6 4.8 
57 2.9 0.016 5.5 2.8 0.9 0.6 3.6 2.5 1.3 1.3 4.9 4.3 
58 3.3 0.016 6.4 2.0 1.1 0.5 3.3 2.1 1.1 2.1 5.5 5.0 
59 3.4 0.016 4.9 2.7 0.3 0.9 2.8 2.1 1.9 1.5 5.3 3.8 
60 3.2 0.020 3.8 4.3 0.7 0.8 4.5 2.7 2.3 1.2 5.5 3.8 
61 3.8 0.017 4.5 2.6 0.8 0.2 4.4 1.8 0.7 0.7 6.0 2.8 
62 4.7 0.015 3.9 2.2 0.9 0.3 4.3 1.4 1.0 0.5 7.7 2.7 
63 4.8 0.017 2.9 2.6 0.2 0.7 4.5 1.6 2.3 0.9 9.5 2.5 
64 4.8 0.014 2.7 2.2 0.5 0.4 4.3 1.2 1.7 1.5 7.3 3.5 
65 6.1 0.015 1.9 2.1 0.7 0.3 4.4 1.1 1.5 0.3 9.1 2.6 
66 5.2 0.015 4.6 1.7 1.1 0.3 4.3 1.2 1.1 0.3 8.2 2.5 
67 5.3 0.015 4.1 1.8 0.8 0.3 4.2 1.2 1.4 0.8 9.2 3.3 
68 4.8 0.016 3.9 2.2 0.7 0.4 4.3 1.5 1.5 0.5 14.4 2.1 
69 5.4 0.016 3.0 2.2 0.8 0.4 4.5 1.4 2.1 0.4 11.2 2.2 
70 5.4 0.013 4.9 1.4 0.8 0.3 4.3 1.1 2.1 0.3 8.7 2.3 
71 5.3 0.020 4.1 2.4 0.9 0.4 4.4 1.7 2.0 0.4 11.0 2.5 
72 5.3 0.015 4.8 1.6 0.9 0.3 4.3 1.1 2.0 0.5 10.3 2.7 
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Table 5.8 Nutrient Pulsing of Producing Hybridomas (Continued) 
This table shows all values for the chemostat culture of non-producing hybridomas which were pulsed with 
the main metabolites 
SN CN DR Glu_} qL Gim qg lm  Lac qiac NH3  qNH3 ab QAb 
73 5.3 0.015 6.6 1.1 0.8 0.3 4.2 1.5 2.1 0.7 9.5 3.0 
74 4.9 0.015 6.5 1.3 0.7 0.4 4.3 1.1 2.2 0.6 9.5 2.8 
75 4.8 0.014 8.8 0.5 0.9 0.3 4.8 1.4 2.0 0.8 9.9 3.6 
76 4.9 0.015 7.2 1.0 0.4 0.5 4.3 1.0 2.5 0.2 12.1 7.2 
77 1.9 0.014 10.5 0.0 0.8 0.9 4.6 2.7 2.1 0.4 10.0 3.0 
78 4.7 0.014 11.1 0.2 1.5 0.2 3.9 1.1 1.4 0.7 9.9 3.3 
79 4.9 0.016 10.8 0.1 0.9 0.4 4.1 1.0 2.0 0.7 10.0 2.9 
80 5.1 0.014 9.5 0.3 0.6 0.4 5.4 1.2 2.3 0.6 10.3 3.9 
81 5.0 0.014 12.7 0.6 0.9 0.3 3.6 1.3 2.0 0.7 13.7 4.8 
82 5.2 0.014 11.0 0.2 0.4 0.4 3.3 1.3 2.5 0.7 17.3 3.5 
83 4.9 0.014 9.5 0.3 0.5 0.4 3.7 1.2 2.4 0.3 12.5 1.2 
84 4.7 0.017 7.2 1.2 0.6 0.5 3.5 1.4 2.3 0.6 13.6 4.8 
85 5.2 0.018 7.6 1.0 0.7 0.4 3.1 1.4 2.2 0.9 17.0 5.8 
86 4.9 0.012 6.4 1.0 0.7 0.3 4.1 1.0 2.2 0.6 12.9 3.2 
87 5.1 0.018 8.5 0.7 0.4 0.6 4.5 1.5 2.5 0.7 17.4 6.0 
88 5.1 0.013 4.9 1.4 0.5 0.4 4.6 1.0 2.4 0.3 19.4 4.9 
89 4.8 0.013 7.4 0.8 0.4 0.4 4.8 1.2 2.5 0.7 17.8 4.8 
90 5.1 0.015 7.1 1.0 1.8 0.6 4.2 1.3 1.1 0.9 10.6 3.0 
91 4.9 0.017 7.0 1.2 0.8 0.4 3.9 1.6 2.1 0.5 11.3 4.0 
92 4.5 0.015 7.9 8.9 0.4 0.6 4.1 1.4 2.5 0.6 9.8 2.7 
93 4.8 0.015 5.8 1.5 0.5 0.5 4.0 1.3 2.4 0.5 9.7 4.9 
94 4.6 0.015 5.9 1.5 0.2 0.6 4.2 1.4 1.9 0.8 8.1 3.3 
95 4.4 0.015 6.9 1.2 0.3 0.6 4.0 1.4 1.9 0.6 10.1 2.1 
Avg 4.8 0.015 6.9 1.1 0.6 0.4 4.1 1.0 2.2 0.8 
Err 0.2 0.002 1.0 0.3 0.4 0.1 0.4 0.6 0.4 0.4 
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Table 5.8 Nutrient Pulsing of Producing Hybridomas (Continued) 
This table shows all values for the chemostat culture of non-producing hybndomas which were pulsed with 
the main metabolites 
SN I CN DR 	Glu qgiu  I Ghn qglm I Lac I  q1ac  NH3 q3 ab 	QAb 
FCS to 	10% 
96 3.8 0.013 6.8 1.3 0.5 0.5 4.5 1.5 2.1 0.7 10.6 3.6 
97 4.0 0.016 5.4 2.1 0.4 0.6 4.6 2.1 1.6 0.6 10.5 4.2 
98 4.2 0.017 6.3 1.7 0.6 0.6 4.6 2.0 1.7 0.7 7.4 3.0 
99 4.1 0.016 6.7 1.5 0.7 0.5 4.1 2.3 1.5 0.6 10.4 1 4.0 
Key to Table 5.9 
giu; metabolic quotient for glucose (10 3 J2mo1/(105 cells hour)): qgj ,. metabolic quotient for 
glutamine (10 31.lmol/(105  cells hour): qiac  metabolic quotient for lactate (10 3J.imov(105 cells 
hour): q. metabolic quotient for ammonia (10 -3pmol/(105 cells hour): SN; sample number 
Cell; cell number (x105 cells ml): Glu; Glucose (mM): Gim; Glutamine (mM): NH3; Ammonia 
(mM): Lac; Lactate (mM) 
Table 5.9 Chemostat Culture of Non-Producing Cells 
This table contains all the data for the culture of non-producing cells in a chemostat. The 
average of each steady state is shown and is summarised in . This data is also shown in the 
preceding figures 
LSA 	CN 	DR 	Glu I qglu I Gim I  qgim Lac J. qiac I NH3 NH 
Flow Rate I 	Run 1 
14 3.1 0.034 4.9 6.1 0.7 1.4 10.2 11.1 2.6 2.9 
15 3.0 0.031 3.4 7.3 0.1 2.0 7.5 7.8 3.3 3.4 
16 2.9 0.031 3.9 7.1 0.5 1.6 10.7 11.4 2.9 3.1 
17 2.9 0.037 4.0 8.3 0.5 1.9 8.8 11.2 2.9 3.7 
Avg 3.0 0.033 4.1 7.2 0.5 1.7 8.0 9.3 2.9 3.5 
Err 0.1 0.002 0.5 0.8 0.2 0.2 1.6 1.3 0.3 0.3 
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Table 5.9 Chemostat Culture of Non-Producing Cells (Continued) 
This table contains all the data for the culture of non-producing cells in a chemostat. The 
average of each steady state is shown and is summarised in. This data is also shown in the 
preceding figures 
SN 	CN DR 	Glu q 	Gim I qgn Lac 1lac 	 NH 
Flow Rate II 	Run 1 
21 3.8 0.029 4.4 4.7 1.0 0.8 9.8 7.5 2.4 1.8 
22 3.7 0.030 4.1 5.2 0.7 1.1 9.3 7.5 2.7 2.2 
23 3.7 0.031 4.9 4.7 0.8 1.0 6.7 5.6 2.6 2.2 
24 3.4 0.032 4.9 5.3 0.8 1.1 9.7 9.2 1.4 1.3 
25 3.5 0.038 4.9 6.1 0.7 1.4 9.7 11 1.5 1.6 
26 
J_3.5 
0.032 4.9 5.1 0.7 1.2 7.8 7.1 1.5 1.4 
27 3.2 0.033 4.6 6.1 0.7 1.3 7.3 7.5 1.5 1.5 
28 3.6 0.029 6.0 3.6 0.8 1.0 5.8 4.7 1.4 1.1 
29 3.3 0.037 9.8 0.8 0.7 1.5 7.7 8.7 1.5 1.7 
30 3.5 0.025 7.9 1.9 0.7 0.9 10.0 7.2 1.5 1.1 
Avg 3.5 0.032 
1 
5.6 4.4 0.8 1.1 8.4 7.6 1.8 1.6 
Err 0.2 0.004 1.7 1.7 0.1 0.2 1.4 1.6 0.5 0.4 
Flow Rate ifi 	Run 1 
38 5.0 0.021 3.9 2.8 0.6 0.6 7.1 3.0 1.6 0.7 
39 5.2 0.021 2.8 3.1 0.6 0.6 6.5 2.6 1.6 0.7 
40 5.1 0.023 3.7 3.1 0.6 0.6 6.4 2.9 1.6 0.7 
41 5.0 0.024 4.2 3.0 0.8 0.6 8.0 3.8 1.4 0.7 
42 5.0 0.024 3.1 4.3 0.7 0.8 8.4 4.9 1.5 0.9 
43 5.0 0.024 5.4 2.4 0.3 0.8 8.9 4.3 2.1 1.0 
44 5.0 0.026 5.2 2.8 0.1 1.0 7.5 3.9 2.3 1.2 
45 4.9 0.022 4.5 2.7 0.3 0.8 3.1 1.4 2.1 0.9 
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Table 5.9 Chemostat Culture of Non-Producing Cells (Continued) 
This table contains all the data for the culture of non-producing cells in a chemostat. The 
average of each steady state is shown and is summarised in. This data is also shown in the 
preceding figures 
SN CN DR Glu qgju Gim qglm Lac qlac NH3 cINH 
Avg 5.0 0.023 4.1 3.0 0.5 0.7 7.0 3.4 1.8 0.9 
Err 0.1 0.002 0.9 0.5 0.2 0.1 1.7 1.0 0.3 0.2 
Flow Rate IV 	Run 1 
50 5.5 0.020 4.7 2.1 0.4 0.6 11.5 4.2 2.0 0.7 
51 5.4 0.018 4.5 2.0 0.4 0.5 5.4 1.8 2.0 0.7 
52 5.5 0.018 2.1 2.7 0.0 0.7 6.5 2.1 2.4 0.8 
53 5.7 0.021 4.5 2.2 0.3 0.6 2.1 0.8 2.1 0.8 
54 5.5 0.017 2.9 2.3 0.1 0.6 5.9 1.8 2.3 0.7 
55 5.5 0.018 2.7 2.6 1.2 0.3 4.2 1.4 1.2 0.4 
56 5.4 0.018 3.2 2.4 1.6 0.1 3.8 1.3 0.8 0.3 
57 5.5 0.019 2.7 2.7 0.6 0.5 3.8 1.3 1.8 0.6 
Avg 5.5 0.019 3.4 2.4 0.6 0.5 5.4 1.8 1.8 0.6 
Err 0.1 0.001 0.9 0.3 0.5 0.2 2.6 1.0 0.5 0.2 
Flow Rate I 	Run 2 
8 3.7 0.035 4.8 5.4 0.6 1.3 3.8 3.6 1.4 1.3 
9 4.2 0.034 4.3 5.0 1.3 0.6 1.9 1.5 0.7 0.6 
10 3.4 0.037 5.6 5.3 0.6 1.5 4.6 5.0 1.4 1.5 
11 3.8 0.029 5.6 3.7 0.9 0.8 4.7 3.6 1.1 0.8 
12 3.5 0.030 9.3 1.0 0.9 0.9 4.3 3.7 0.9 0.8 
13 3.6 0.030 8.4 1.8 0.8 1.0 3.9 3.2 1.0 0.8 
14 3.7 0.034 8.4 1.9 0.8 1.1 3.5 4.1 1.0 0.9 
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Table 5.9 Chemostat Culture of Non-Producing Cells (Continued) 
This table contains all the data for the culture of non-producing cells in a chemostat. The 
average of each steady state is shown and is summarised in . This data is also shown in the 
preceding figures 
SN CN DR Glu qglu Gim qglm Lac qiac NH3 'INH 
Avg 3.7 0.033 6.6 3.4 0.8 1.0 4.0 3.4 1.1 1.0 
Err 0.2 0.003 1.9 1.7 0.2 0.3 0.9 1.0 0.2 0.3 
Flow Rate II 	Run 2 
24 6.2 0.017 3.4 1.9 0.1 0.5 4.3 1.2 1.6 4.4 
25 6.1 0.017 3.4 2.0 0.0 0.6 4.1 1.1 1.3 3.6 
26 6.2 0.018 3.4 2.1 0.0 0.6 4.4 1.3 1.6 4.6 
27 6.1 0.017 3.4 2.0 0.2 0.5 4.0 1.1 1.5 4.2 
28 5.9 0.018 3.1 2.3 0.2 0.6 4.5 1.4 1.8 5.5 
29 6.3 0.018 4.5 1.7 0.1 0.5 4.2 1.2 1.6 4.6 
30 6.1 0.016 3.5 1.8 0.2 0.5 4.2 1.1 1.7 4.6 
Avg 6.1 0.017 3.5 2.0 0.1 0.5 4.2 1.2 1.6 4.5 
Err 0.1 0.001 0.4 0.2 0.1 0.03 0.2 0.1 0.2 0.5 
Flow Rate I 	 Run 3 
12 2.9 0.048 5.3 8.6 0.3 2.8 8.2 13.6 2.4 4.0 
13 3.1 0.046 6.0 6.7 0.2 2.7 8.0 11.9 2.5 3.7 
14 3.5 0.041 5.9 5.4 0.8 1.4 8.2 9.6 1.9 2.2 
15 3.4 0.045 6.0 6.0 0.3 2.3 8.3 10.9 2.4 3.2 
16 3.5 0.051 6.6 5.7 0.9 1.6 7.1 14.6 1.8 2.6 
17 2.9 0.051 5.5 8.8 0.6 2.5 8.2 14.4 2.1 3.7 
18 3.0 0.046 5.2 8.1 0.0 3.1 8.0 12.3 3.8 5.8 
19 3.0 0.044 5.4 7.5 0.1 2.8 6.9 10.1 2.6 3.8 
20 3.1 0.045 5.5 7.3 0.2 2.6 6.5 9.4 2.5 3.6 
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Table 5.9 Chemostat Culture of Non-Producing Cells (Continued) 
This table contains all the data for the culture of non-producing cells in a chemostat. Th e 
average of each steady state is shown and is summarised in . This data is also shown in the 
preceding figures 
S 	DR I Glu I qglu I Gim I  qg 	Lac I  Chac NH3 
Avg 3.2 0.046 5.7 7.1 0.4 2.4 7.7 11.9 2.4 3.6 
Err 0.2 0.003 0.4 1.2 0.3 0.5 0.6 1.9 0.5 1.0 
Flow Rate I 	Run 4 
6 2.9 0.041 6.9 5.1 0.1 2.7 6.9 9.8 2.3 3.3 
7 2.9 0.036 6.4 5.1 0.1 2.8 6.5 8.6 3.2 4.2 
8 2.8 0.040 6.5 5.7 0.0 2.9 6.5 9.3 3.6 5.1 
9 2.8 0.035 6.3 5.2 0.6 2.5 6.3 7.9 3.4 4.3 
10 2.8 0.038 6.5 5.4 0.5 2.7 6.5 8.8 3.3 4.5 
11 2.8 0.032 6.1 5.7 0.3 2.3 6.1 7.0 3.3 3.8 
Avg 2.8 0.037 6.5 5.4 0.3 2.7 6.5 	1 8.6 3.2 4.2 
Err 0.1 0.003 0.2 0.3 0.2 0.2 0.2 1.0 0.5 0.6 
Flow Rate I 	Run 5 
18 3.2 0.035 5.2 5.8 0.1 2.1 3.3 3.6 2.2 4.2 
19 3.4 0.034 5.4 5.1 0.2 1.8 3.3 3.3 2.9 4.1 
20 3.5 0.035 5.5 5.0 0.4 1.6 3.6 3.6 3.0 4.2 
22 3.4 0.037 5.3 5.2 0.0 2.2 4.1 4.5 3.0 5.0 
23 3.4 0.032 5.3 4.9 0.1 1.8 4.6 4.3 3.3 4.8 
24 3.1 0.036 6.4 4.8 0.2 2.1 4.4 5.1 2.6 4.9 
Avg 3.2 0.033 6.2 5.1 0.2 1.9 3.9 3.7 4.1 4.5 
Err 0.2 0.004 0.6 0.3 0.1 0.2 0.5 1.2 0.6 0.4 
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Table 5.10 Chemostat Culture of Producing Cells 
This table contains all the data which is plotted in the preceding figures.The average values for each steady state 
is shown and is summarised in 
S 	CN I DR 	Glu I  qgiu  I Olin I qgm Lac qiac I  NH3 qNh3 Ab 	lAb 
Flow Rate I 	Run 1 
12 2.7 0.033 7.3 3.9 0.7 1.6 4.7 5.8 1.6 2.0 3.7 4.5 
13 2.9 0.035 7.7 3.4 0.8 1.5 5.0 6.1 1.5 1.8 3.2 3.9 
14 3.1 0.033 7.3 3.4 1.7 3.2 4.2 4.5 0.6 0.6 3.8 4.1 
15 2.8 0.035 7.1 4.2 0.3 2.1 6.6 8.2 3.1 3.8 4.2 5.2 
mmmmmmmmmmmm mmmmmmmmmmmmm. 
Flow Rate II 	 Run 
30 4.3 0.027 7.6 1.8 0.4 1.0 7.3 4.6 2.2 1.5 5.4 3.4 
31 4.3 0.026 7.4 1.9 0.4 1.0 2.7 1.6 2.2 1.3 6.8 4.1 
32 4.3 0.027 7.6 1.8 0.5 1.0 4.2 2.7 2.1 1.4 11.1 7.1 
33 4.2 0.028 6.5 2.7 0.2 1.2 3.2 2.2 2.4 1.4 9.7 6.5 
34 4.2 0.026 7.3 2.0 0.4 1.0 5.2 3.2 2.2 1.5 10.2 6.2 
35 4.1 0.028 8.1 1.6 0.4 1.1 1.5 1.0 2.2 1.5 3.7 2.5 
Avg 4.2 0.027 7.4 2.0 0.4 1.0 4.0 2.5 2.2 1.5 7.8 5.0 
Err 0.1 0.001 0.5 0.3 0.1 0.1 1.9 1.2 0.1 0.1 2.7 1.7 
Flow Rate ifi 	Run 
37 4.9 0.022 8.7 0.8 0.1 0.8 4.7 2.1 2.5 1.5 3.6 1.6 
38 4.9 0.023 7.7 1.3 0.3 0.8 3.2 1.5 2.1 1.8 5.7 2.7 
39 4.9 0.025 6.3 2.1 0.4 0.8 3.6 1.8 2.0 1.9 2.4 1.2 
40 4.9 0.024 6.1 2.2 0.2 0.9 3.9 1.9 2.2 1.9 2.3 1.1 
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Table 5.10 Chemostat Culture of Producing Cells (Continued) 
This table contains all the data which is plotted in the preceding figures.The average values for each steady state 
is shown and is summarised in 
SN CN DR Glu qglu  Ghn qglm Lac qlac NH3 cITW  Ab 'lAb 
41 4.9 0.024 7.1 1.7 0.3 0.8 6.6 3.2 2.1 1.6 0.9 0.5 
42 4.7 0.024 7.6 1.5 0.3 0.9 5.2 2.7 2.1 2.0 4.2 2.2 
43 3.5 0.025 1 	8.1 1.7 0.6 1.0 4.5 3.2 2.1 1.5 1.8 1.3 
Avg 4.9 0.024 7.6 1.4 0.3 0.8 4.3 2.1 2.2 1.1 3.0 1.5 
Err 0.1 0.001 1.1 0.03 0.1 0.1 1.2 1.5 0.2 0.2 1.5 0.6 
Flow Rate IV 	 Run 
50 3.6 0.022 7.0 2.1 0.4 1.0 3.1 1.9 2.0 1.8 8.5 5.1 
51 3.7 0.022 6.3 2.5 0.2 1.1 5.0 3.0 2.3 1.3 1.5 0.9 
52 3.7 0.021 4.9 3.2 0.3 1.0 5.6 3.2 2.2 1.4 10.0 5.7 
53 4.0 0.020 5.1 2.8 0.3 0.9 4.9 2.5 2.2 0.1 9.4 4.7 
54 5.1 0.021 6.2 1.8 0.1 0.8 5.9 2.4 2.3 1.3 8.6 3.5 
Avg 3.9 0.021 5.9 2.5 0.3 1.0 4.9 2.6 2.2 1.4 7.6 4.0 
Err 0.5 0.001 0.7 0.4 0.1 0.1 0.7 0.4 0.1 0.2 3.0 1.7 
Flow Rate I 	 Run 2 
11 3.0 0.033 6.9 4.0 0.9 1.2 4.7 5.2 1.1 1.2 4.2 5.0 
12 2.8 0.036 7.2 4.2 0.9 1.4 4.9 6.3 1.1 1.4 4.8 5.3 
13 2.8 0.034 6.4 5.0 1.1 1.1 4.9 6.0 1.2 1.5 4.6 5.9 
14 2.9 0.030 6.8 3.8 0.9 1.1 4.9 5.1 1.2 1.2 4.2 5.1 
15 3.1 0.030 7.9 2.5 1.0 1.0 4.7 4.5 1.2 1.2 5.4 5.6 
16 3.5 0.036 8.2 2.4 0.7 1.3 4.6 4.7 2.2 2.3 5.9 5.7 
17 3.1 0.030 7.1 3.3 0.6 1.4 4.2 4.1 1.8 1.7 6.0 6.2 
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Table 5.10 Chemostat Culture of Producing Cells (Continued) 
This table contains all the data which is plotted in the preceding figures.The average values for each steady state 
is shown and is summarised in 
SN CN DR Glu qgiu Gim qglm Lac qiac NH3 qNh3 Ab qAb 
Avg 3.0 0.033 7.1 3.8 0.9 1.2 4.7 5.1 1.4 1.5 5.0 5.5 
Err 0.2 0.002 0.5 0.8 0.1 0.1 0.2 0.6 0.3 0.2 0.8 0.4 
Flow Rate II 	 Run 2 
22 3.4 0.019 7.5 1.7 0.3 1.0 4.6 3.0 2.2 1.2 2.8 1.6 
23 3.5 0.019 7.9 1.4 0.6 0.8 4.9 2.7 2.1 1.1 3.3 1.8 
24 3.6 0.019 5.8 2.5 0.5 0.8 4.9 2.6 1.6 0.9 5.2 2.7 
25 4.0 0.019 6.1 2.1 0.4 0.8 4.9 2.3 2.4 1.3 3.5 1.7 
26 4.2 0.019 5.2 2.4 0.6 0.6 4.7 2.1 2.8 1.3 4.5 2.0 
27 5.0 0.019 5.4 1.9 0.0 0.8 4.6 2.0 2.7 1.2 4.7 1.8 
mmmmmmmmmmmmm mmmmmmmmmmmmm 
Flow Rate I 
	
Run 3 
9 3.3 0.037 4.8 6.4 1.0 1.1 5.4 6.1 2.1 1.6 3.6 4.0 
10 3.4 0.039 7.6 3.3 0.0 2.3 5.8 6.7 3.1 1.6 3.6 4.1 
11 3.2 0.040 7.0 4.4 0.0 2.5 6.2 7.7 3.4 1.9 2.7 3.4 
12 3.4 0.038 7.9 2.9 0.0 2.2 7.0 7.8 3.0 1.4 2.6 2.9 
13 3.3 0.035 6.2 4.5 0.2 1.9 5.9 6.2 2.4 2.5 3.1 4.1 
Avg 3.3 0.038 6.7 4.3 0.2 2.0 6.1 6.9 2.8 1.8 3.1 3.7 
Err 0.1 0.001 1.1 0.9 0.1 0.5 0.4 0.6 0.4 0.3 0.4 0.5 
Flow Rate I 	 Run 4 
29 	I 3.2 	I 0.041 15.7 	6.1 	I 2.6 	I 0.5 	I 0.5 	6.4 	2.5 	11.7 	16.2 	17.97  
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Table 5.10 Chemostat Culture of Producing Cells (Continued) 
This table contains all the data which is plotted in the preceding figures.The average values for each steady state 
is shown and is summarised in 
SN CN DR Glu qgiu GlIfl qgim Lac qiac NH3  qNh3  Ab qAb 
30 3.1 0.041 6.7 5.0 0.0 2.6 4.9 6.5 2.9 1.8 6.3 8.3 
31 3.4 0.042 6.2 5.3 0.6 1.7 4.2 5.2 2.2 1.5 6.2 7.6 
32 3.3 0.040 6.9 4.4 0.5 1.8 5.1 6.2 2.3 1.3 6.2 7.5 
33 3.0 0.043 6.5 5.7 0.7 1.9 5.2 7.5 2.1 1.4 5.5 7.8 
34 2.9 0.041 6.8 5.2 1.0 1.4 5.5 7.8 2.0 1.2 4.9 6.9 
35 	1 3.3 0.041 5.9 5.7 0.9 1.4 5.8 7.2 1.7 1.2 7.0 8.7 
mmmmmmmmmmmmm 
mmmmmmmmmmmmm 
Flow Rate I 	 Run 5 
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